0000916789 02/28 2024 Q3 FALSE P1Y 0000916789 2023-03-01 2023-11-30 0000916789 dei:OtherAddressMember 2023-03-01 2023-11-30 0000916789 2023-12-28 xbrli:shares 0000916789 2023-11-30 iso4217:USD 0000916789 2023-02-28 iso4217:USD xbrli:shares 0000916789 2023-09-01 2023-11-30 0000916789 2022-09-01 2022-11-30 0000916789 2022-03-01 2022-11-30 0000916789 us-gaap:CommonStockMember 2023-02-28 0000916789 us-gaap:AdditionalPaidInCapitalMember 2023-02-28 0000916789 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-02-28 0000916789 us-gaap:RetainedEarningsMember 2023-02-28 0000916789 us-gaap:RetainedEarningsMember 2023-03-01 2023-05-31 0000916789 2023-03-01 2023-05-31 0000916789 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-03-01 2023-05-31 0000916789 us-gaap:CommonStockMember 2023-03-01 2023-05-31 0000916789 us-gaap:AdditionalPaidInCapitalMember 2023-03-01 2023-05-31 0000916789 us-gaap:CommonStockMember 2023-05-31 0000916789 us-gaap:AdditionalPaidInCapitalMember 2023-05-31 0000916789 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-05-31 0000916789 us-gaap:RetainedEarningsMember 2023-05-31 0000916789 2023-05-31 0000916789 us-gaap:RetainedEarningsMember 2023-06-01 2023-08-31 0000916789 2023-06-01 2023-08-31 0000916789 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-06-01 2023-08-31 0000916789 us-gaap:CommonStockMember 2023-06-01 2023-08-31 0000916789 us-gaap:AdditionalPaidInCapitalMember 2023-06-01 2023-08-31 0000916789 us-gaap:CommonStockMember 2023-08-31 0000916789 us-gaap:AdditionalPaidInCapitalMember 2023-08-31 0000916789 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-08-31 0000916789 us-gaap:RetainedEarningsMember 2023-08-31 0000916789 2023-08-31 0000916789 us-gaap:RetainedEarningsMember 2023-09-01 2023-11-30 0000916789 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-09-01 2023-11-30 0000916789 us-gaap:CommonStockMember 2023-09-01 2023-11-30 0000916789 us-gaap:AdditionalPaidInCapitalMember 2023-09-01 2023-11-30 0000916789 us-gaap:CommonStockMember 2023-11-30 0000916789 us-gaap:AdditionalPaidInCapitalMember 2023-11-30 0000916789 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-11-30 0000916789 us-gaap:RetainedEarningsMember 2023-11-30 0000916789 us-gaap:CommonStockMember 2022-02-28 0000916789 us-gaap:AdditionalPaidInCapitalMember 2022-02-28 0000916789 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-02-28 0000916789 us-gaap:RetainedEarningsMember 2022-02-28 0000916789 2022-02-28 0000916789 us-gaap:RetainedEarningsMember 2022-03-01 2022-05-31 0000916789 2022-03-01 2022-05-31 0000916789 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-03-01 2022-05-31 0000916789 us-gaap:CommonStockMember 2022-03-01 2022-05-31 0000916789 us-gaap:AdditionalPaidInCapitalMember 2022-03-01 2022-05-31 0000916789 us-gaap:CommonStockMember 2022-05-31 0000916789 us-gaap:AdditionalPaidInCapitalMember 2022-05-31 0000916789 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-05-31 0000916789 us-gaap:RetainedEarningsMember 2022-05-31 0000916789 2022-05-31 0000916789 us-gaap:RetainedEarningsMember 2022-06-01 2022-08-31 0000916789 2022-06-01 2022-08-31 0000916789 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-06-01 2022-08-31 0000916789 us-gaap:CommonStockMember 2022-06-01 2022-08-31 0000916789 us-gaap:AdditionalPaidInCapitalMember 2022-06-01 2022-08-31 0000916789 us-gaap:CommonStockMember 2022-08-31 0000916789 us-gaap:AdditionalPaidInCapitalMember 2022-08-31 0000916789 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-08-31 0000916789 us-gaap:RetainedEarningsMember 2022-08-31 0000916789 2022-08-31 0000916789 us-gaap:RetainedEarningsMember 2022-09-01 2022-11-30 0000916789 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-09-01 2022-11-30 0000916789 us-gaap:CommonStockMember 2022-09-01 2022-11-30 0000916789 us-gaap:AdditionalPaidInCapitalMember 2022-09-01 2022-11-30 0000916789 us-gaap:CommonStockMember 2022-11-30 0000916789 us-gaap:AdditionalPaidInCapitalMember 2022-11-30 0000916789 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-11-30 0000916789 us-gaap:RetainedEarningsMember 2022-11-30 0000916789 2022-11-30 hele:segment 0000916789 hele:CurlsmithMember 2022-04-22 2022-04-22 0000916789 2021-06-07 2021-06-07 0000916789 hele:LatinAmericaAndCaribbeanPersonalCareBusinessMember 2022-03-25 2022-03-25 0000916789 hele:DistributionAndOfficeFacilitiesElPasoTexasMember 2023-09-28 0000916789 hele:DistributionAndOfficeFacilitiesElPasoTexasMember 2023-09-28 2023-09-28 0000916789 hele:DistributionAndOfficeFacilitiesElPasoTexasMember 2023-09-01 2023-11-30 0000916789 hele:DistributionAndOfficeFacilitiesElPasoTexasMember us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember 2023-09-01 2023-11-30 0000916789 hele:DistributionAndOfficeFacilitiesElPasoTexasMember us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember hele:BeautyWellnessMember 2023-09-01 2023-11-30 0000916789 hele:DistributionAndOfficeFacilitiesElPasoTexasMember us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember hele:HomeOutdoorMember 2023-09-01 2023-11-30 0000916789 hele:DistributionAndOfficeFacilitiesElPasoTexasMember us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember 2023-09-28 0000916789 hele:CurlsmithMember 2022-04-22 0000916789 hele:CurlsmithMember 2022-03-01 2022-11-30 0000916789 us-gaap:TradeNamesMember hele:CurlsmithMember 2022-04-22 2022-04-22 0000916789 us-gaap:CustomerRelationshipsMember hele:CurlsmithMember 2022-04-22 2022-04-22 0000916789 hele:CurlsmithMember 2022-03-01 2023-02-28 0000916789 hele:CurlsmithMember 2023-03-01 2023-05-31 0000916789 us-gaap:TradeNamesMember hele:CurlsmithMember 2022-04-22 0000916789 us-gaap:CustomerRelationshipsMember hele:CurlsmithMember 2022-04-22 0000916789 hele:CurlsmithMember 2022-09-01 2022-11-30 0000916789 us-gaap:RestrictedStockUnitsRSUMember 2023-03-01 2023-05-31 0000916789 us-gaap:RestrictedStockMember 2023-03-01 2023-05-31 0000916789 us-gaap:PerformanceSharesMember 2023-03-01 2023-05-31 0000916789 hele:MarketConditionSharesMember 2023-03-01 2023-05-31 0000916789 us-gaap:SellingGeneralAndAdministrativeExpensesMember srt:DirectorMember 2023-09-01 2023-11-30 0000916789 us-gaap:SellingGeneralAndAdministrativeExpensesMember srt:DirectorMember 2022-09-01 2022-11-30 0000916789 us-gaap:SellingGeneralAndAdministrativeExpensesMember srt:DirectorMember 2023-03-01 2023-11-30 0000916789 us-gaap:SellingGeneralAndAdministrativeExpensesMember srt:DirectorMember 2022-03-01 2022-11-30 0000916789 us-gaap:SellingGeneralAndAdministrativeExpensesMember us-gaap:RestrictedStockUnitsRSUMember 2023-09-01 2023-11-30 0000916789 us-gaap:SellingGeneralAndAdministrativeExpensesMember us-gaap:RestrictedStockUnitsRSUMember 2022-09-01 2022-11-30 0000916789 us-gaap:SellingGeneralAndAdministrativeExpensesMember us-gaap:RestrictedStockUnitsRSUMember 2023-03-01 2023-11-30 0000916789 us-gaap:SellingGeneralAndAdministrativeExpensesMember us-gaap:RestrictedStockUnitsRSUMember 2022-03-01 2022-11-30 0000916789 us-gaap:SellingGeneralAndAdministrativeExpensesMember us-gaap:PerformanceSharesMember 2023-09-01 2023-11-30 0000916789 us-gaap:SellingGeneralAndAdministrativeExpensesMember us-gaap:PerformanceSharesMember 2022-09-01 2022-11-30 0000916789 us-gaap:SellingGeneralAndAdministrativeExpensesMember us-gaap:PerformanceSharesMember 2023-03-01 2023-11-30 0000916789 us-gaap:SellingGeneralAndAdministrativeExpensesMember us-gaap:PerformanceSharesMember 2022-03-01 2022-11-30 0000916789 us-gaap:SellingGeneralAndAdministrativeExpensesMember hele:MarketConditionSharesMember 2023-09-01 2023-11-30 0000916789 us-gaap:SellingGeneralAndAdministrativeExpensesMember hele:MarketConditionSharesMember 2022-09-01 2022-11-30 0000916789 us-gaap:SellingGeneralAndAdministrativeExpensesMember hele:MarketConditionSharesMember 2023-03-01 2023-11-30 0000916789 us-gaap:SellingGeneralAndAdministrativeExpensesMember hele:MarketConditionSharesMember 2022-03-01 2022-11-30 0000916789 us-gaap:SellingGeneralAndAdministrativeExpensesMember us-gaap:EmployeeStockMember 2023-09-01 2023-11-30 0000916789 us-gaap:SellingGeneralAndAdministrativeExpensesMember us-gaap:EmployeeStockMember 2022-09-01 2022-11-30 0000916789 us-gaap:SellingGeneralAndAdministrativeExpensesMember us-gaap:EmployeeStockMember 2023-03-01 2023-11-30 0000916789 us-gaap:SellingGeneralAndAdministrativeExpensesMember us-gaap:EmployeeStockMember 2022-03-01 2022-11-30 0000916789 us-gaap:SellingGeneralAndAdministrativeExpensesMember 2023-09-01 2023-11-30 0000916789 us-gaap:SellingGeneralAndAdministrativeExpensesMember 2022-09-01 2022-11-30 0000916789 us-gaap:SellingGeneralAndAdministrativeExpensesMember 2023-03-01 2023-11-30 0000916789 us-gaap:SellingGeneralAndAdministrativeExpensesMember 2022-03-01 2022-11-30 0000916789 us-gaap:RestrictedStockMember 2023-11-30 xbrli:pure 0000916789 2021-08-31 0000916789 2021-08-25 2021-08-25 0000916789 hele:OpenMarketAndTenderOfferMember 2023-09-01 2023-11-30 0000916789 hele:OpenMarketAndTenderOfferMember 2022-09-01 2022-11-30 0000916789 hele:OpenMarketAndTenderOfferMember 2023-03-01 2023-11-30 0000916789 hele:OpenMarketAndTenderOfferMember 2022-03-01 2022-11-30 0000916789 us-gaap:StockCompensationPlanMember 2023-09-01 2023-11-30 0000916789 us-gaap:StockCompensationPlanMember 2022-09-01 2022-11-30 0000916789 us-gaap:StockCompensationPlanMember 2023-03-01 2023-11-30 0000916789 us-gaap:StockCompensationPlanMember 2022-03-01 2022-11-30 0000916789 hele:ProjectPegasusMember 2023-02-28 0000916789 srt:MinimumMember hele:ProjectPegasusMember 2023-11-30 0000916789 srt:MaximumMember hele:ProjectPegasusMember 2023-11-30 0000916789 us-gaap:EmployeeSeveranceMember srt:MinimumMember hele:ProjectPegasusMember 2023-08-31 0000916789 us-gaap:EmployeeSeveranceMember srt:MaximumMember hele:ProjectPegasusMember 2023-08-31 0000916789 hele:ProjectPegasusMember hele:ProfessionalFeesMember 2023-08-31 0000916789 us-gaap:ContractTerminationMember hele:ProjectPegasusMember 2023-08-31 0000916789 us-gaap:OtherRestructuringMember srt:MinimumMember hele:ProjectPegasusMember 2023-08-31 0000916789 us-gaap:OtherRestructuringMember srt:MaximumMember hele:ProjectPegasusMember 2023-08-31 0000916789 srt:MinimumMember hele:HomeOutdoorMember hele:ProjectPegasusMember 2023-08-31 0000916789 hele:HomeOutdoorMember srt:MaximumMember hele:ProjectPegasusMember 2023-08-31 0000916789 srt:MinimumMember hele:BeautyWellnessMember hele:ProjectPegasusMember 2023-08-31 0000916789 hele:BeautyWellnessMember srt:MaximumMember hele:ProjectPegasusMember 2023-08-31 0000916789 srt:MinimumMember hele:ProjectPegasusMember 2023-09-01 2023-11-30 0000916789 srt:MaximumMember hele:ProjectPegasusMember 2023-09-01 2023-11-30 0000916789 hele:ProjectPegasusMember hele:RestructuringRecognitionOfSavingsPeriodOneMember 2023-03-01 2023-11-30 0000916789 hele:ProjectPegasusMember hele:RestructuringRecognitionOfSavingsPeriodTwoMember 2023-03-01 2023-11-30 0000916789 hele:RestructuringRecognitionOfSavingsPeriodThreeMember hele:ProjectPegasusMember 2023-03-01 2023-11-30 0000916789 hele:ProjectPegasusMember 2023-09-01 2023-11-30 0000916789 hele:ProjectPegasusMember 2023-03-01 2023-11-30 0000916789 hele:ProjectPegasusMember 2022-09-01 2022-11-30 0000916789 hele:ProjectPegasusMember 2022-03-01 2022-11-30 0000916789 hele:HomeOutdoorMember hele:ProjectPegasusMember 2023-09-01 2023-11-30 0000916789 hele:BeautyWellnessMember hele:ProjectPegasusMember 2023-09-01 2023-11-30 0000916789 hele:HomeOutdoorMember hele:ProjectPegasusMember 2022-09-01 2022-11-30 0000916789 hele:BeautyWellnessMember hele:ProjectPegasusMember 2022-09-01 2022-11-30 0000916789 hele:HomeOutdoorMember hele:ProjectPegasusMember 2023-03-01 2023-11-30 0000916789 hele:BeautyWellnessMember hele:ProjectPegasusMember 2023-03-01 2023-11-30 0000916789 hele:ProjectPegasusMember 2022-06-01 2023-11-30 0000916789 hele:HomeOutdoorMember hele:ProjectPegasusMember 2022-03-01 2022-11-30 0000916789 hele:BeautyWellnessMember hele:ProjectPegasusMember 2022-03-01 2022-11-30 0000916789 us-gaap:EmployeeSeveranceMember hele:ProjectPegasusMember 2023-02-28 0000916789 us-gaap:EmployeeSeveranceMember hele:ProjectPegasusMember 2023-03-01 2023-11-30 0000916789 us-gaap:EmployeeSeveranceMember hele:ProjectPegasusMember 2023-11-30 0000916789 hele:ProjectPegasusMember hele:ProfessionalFeesMember 2023-02-28 0000916789 hele:ProjectPegasusMember hele:ProfessionalFeesMember 2023-03-01 2023-11-30 0000916789 hele:ProjectPegasusMember hele:ProfessionalFeesMember 2023-11-30 0000916789 us-gaap:ContractTerminationMember hele:ProjectPegasusMember 2023-02-28 0000916789 us-gaap:ContractTerminationMember hele:ProjectPegasusMember 2023-03-01 2023-11-30 0000916789 us-gaap:ContractTerminationMember hele:ProjectPegasusMember 2023-11-30 0000916789 us-gaap:OtherRestructuringMember hele:ProjectPegasusMember 2023-02-28 0000916789 us-gaap:OtherRestructuringMember hele:ProjectPegasusMember 2023-03-01 2023-11-30 0000916789 us-gaap:OtherRestructuringMember hele:ProjectPegasusMember 2023-11-30 0000916789 hele:ProjectPegasusMember 2023-11-30 0000916789 us-gaap:EmployeeSeveranceMember hele:ProjectPegasusMember 2022-02-28 0000916789 us-gaap:EmployeeSeveranceMember hele:ProjectPegasusMember 2022-03-01 2022-11-30 0000916789 us-gaap:EmployeeSeveranceMember hele:ProjectPegasusMember 2022-11-30 0000916789 hele:ProjectPegasusMember hele:ProfessionalFeesMember 2022-02-28 0000916789 hele:ProjectPegasusMember hele:ProfessionalFeesMember 2022-03-01 2022-11-30 0000916789 hele:ProjectPegasusMember hele:ProfessionalFeesMember 2022-11-30 0000916789 us-gaap:ContractTerminationMember hele:ProjectPegasusMember 2022-02-28 0000916789 us-gaap:ContractTerminationMember hele:ProjectPegasusMember 2022-03-01 2022-11-30 0000916789 us-gaap:ContractTerminationMember hele:ProjectPegasusMember 2022-11-30 0000916789 us-gaap:OtherRestructuringMember hele:ProjectPegasusMember 2022-02-28 0000916789 us-gaap:OtherRestructuringMember hele:ProjectPegasusMember 2022-03-01 2022-11-30 0000916789 us-gaap:OtherRestructuringMember hele:ProjectPegasusMember 2022-11-30 0000916789 hele:ProjectPegasusMember 2022-02-28 0000916789 hele:ProjectPegasusMember 2022-11-30 0000916789 2021-12-23 hele:renewal 0000916789 us-gaap:CostOfSalesMember hele:HealthWellnessMember 2023-09-01 2023-11-30 0000916789 us-gaap:CostOfSalesMember hele:HealthWellnessMember 2022-09-01 2022-11-30 0000916789 us-gaap:CostOfSalesMember hele:HealthWellnessMember 2023-03-01 2023-11-30 0000916789 us-gaap:CostOfSalesMember hele:HealthWellnessMember 2022-03-01 2022-11-30 0000916789 hele:HealthWellnessMember us-gaap:SellingGeneralAndAdministrativeExpensesMember 2023-09-01 2023-11-30 0000916789 hele:HealthWellnessMember us-gaap:SellingGeneralAndAdministrativeExpensesMember 2022-09-01 2022-11-30 0000916789 hele:HealthWellnessMember us-gaap:SellingGeneralAndAdministrativeExpensesMember 2023-03-01 2023-11-30 0000916789 hele:HealthWellnessMember us-gaap:SellingGeneralAndAdministrativeExpensesMember 2022-03-01 2022-11-30 0000916789 hele:HealthWellnessMember 2023-09-01 2023-11-30 0000916789 hele:HealthWellnessMember 2022-09-01 2022-11-30 0000916789 hele:HealthWellnessMember 2023-03-01 2023-11-30 0000916789 hele:HealthWellnessMember 2022-03-01 2022-11-30 0000916789 us-gaap:CostOfSalesMember hele:ObsoletePackagingMember hele:HealthWellnessMember 2022-03-01 2022-05-31 0000916789 hele:WeatherRelatedIncidentMember 2022-03-01 2022-05-31 0000916789 2022-12-01 2022-12-31 0000916789 us-gaap:LineOfCreditMember hele:CreditAgreementWithBankOfAmericaMember us-gaap:RevolvingCreditFacilityMember 2023-11-30 0000916789 us-gaap:LineOfCreditMember hele:CreditAgreementWithBankOfAmericaMember us-gaap:RevolvingCreditFacilityMember 2023-02-28 0000916789 us-gaap:LineOfCreditMember us-gaap:SecuredDebtMember hele:CreditAgreementWithBankOfAmericaMember 2023-11-30 0000916789 us-gaap:LineOfCreditMember us-gaap:SecuredDebtMember hele:CreditAgreementWithBankOfAmericaMember 2023-02-28 0000916789 us-gaap:LineOfCreditMember hele:CreditAgreementWithBankOfAmericaMember 2023-11-30 0000916789 us-gaap:LineOfCreditMember hele:CreditAgreementWithBankOfAmericaMember 2023-02-28 0000916789 us-gaap:LineOfCreditMember 2023-11-30 0000916789 us-gaap:LineOfCreditMember 2023-02-28 0000916789 us-gaap:RevolvingCreditFacilityMember 2023-11-30 0000916789 us-gaap:LineOfCreditMember hele:CreditAgreementWithBankOfAmericaMember us-gaap:RevolvingCreditFacilityMember 2023-03-01 2023-11-30 0000916789 us-gaap:LineOfCreditMember hele:CreditAgreementWithBankOfAmericaMember us-gaap:RevolvingCreditFacilityMember 2022-06-01 2022-06-30 0000916789 us-gaap:LineOfCreditMember hele:CreditAgreementWithBankOfAmericaMember us-gaap:RevolvingCreditFacilityMember 2022-06-30 0000916789 us-gaap:BaseRateMember us-gaap:LineOfCreditMember srt:MinimumMember 2023-03-01 2023-11-30 0000916789 us-gaap:BaseRateMember us-gaap:LineOfCreditMember srt:MaximumMember 2023-03-01 2023-11-30 0000916789 us-gaap:LineOfCreditMember srt:MinimumMember us-gaap:SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember 2023-03-01 2023-11-30 0000916789 us-gaap:LineOfCreditMember srt:MaximumMember us-gaap:SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember 2023-03-01 2023-11-30 0000916789 us-gaap:LineOfCreditMember hele:CreditAgreementWithBankOfAmericaMember us-gaap:SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember 2023-03-01 2023-11-30 0000916789 us-gaap:LineOfCreditMember us-gaap:LetterOfCreditMember 2023-11-30 0000916789 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:EstimateOfFairValueFairValueDisclosureMember 2023-11-30 0000916789 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:EstimateOfFairValueFairValueDisclosureMember 2023-02-28 0000916789 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:USTreasuryBillSecuritiesMember us-gaap:EstimateOfFairValueFairValueDisclosureMember 2023-11-30 0000916789 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:USTreasuryBillSecuritiesMember us-gaap:EstimateOfFairValueFairValueDisclosureMember 2023-02-28 0000916789 us-gaap:InterestRateSwaptionMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:EstimateOfFairValueFairValueDisclosureMember 2023-11-30 0000916789 us-gaap:InterestRateSwaptionMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:EstimateOfFairValueFairValueDisclosureMember 2023-02-28 0000916789 us-gaap:ForeignExchangeContractMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:EstimateOfFairValueFairValueDisclosureMember 2023-11-30 0000916789 us-gaap:ForeignExchangeContractMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:EstimateOfFairValueFairValueDisclosureMember 2023-02-28 0000916789 us-gaap:USTreasuryBillSecuritiesMember us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember 2023-11-30 0000916789 us-gaap:USTreasuryBillSecuritiesMember us-gaap:OtherAssetsMember 2023-11-30 0000916789 srt:MinimumMember us-gaap:USTreasuryBillSecuritiesMember 2023-11-30 0000916789 us-gaap:USTreasuryBillSecuritiesMember srt:MaximumMember 2023-11-30 0000916789 us-gaap:USTreasuryBillSecuritiesMember 2023-09-01 2023-11-30 0000916789 hele:SegmentGeographicalGroupsOfCountriesNonUSDTransactionsMember us-gaap:SalesRevenueNetMember us-gaap:GeographicConcentrationRiskMember 2023-03-01 2023-11-30 0000916789 hele:SegmentGeographicalGroupsOfCountriesNonUSDTransactionsMember us-gaap:SalesRevenueNetMember us-gaap:GeographicConcentrationRiskMember 2022-09-01 2022-11-30 0000916789 hele:SegmentGeographicalGroupsOfCountriesNonUSDTransactionsMember us-gaap:SalesRevenueNetMember us-gaap:GeographicConcentrationRiskMember 2022-03-01 2022-11-30 0000916789 us-gaap:ForeignExchangeContractMember currency:EUR us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:ShortMember 2023-11-30 iso4217:EUR 0000916789 us-gaap:ForeignExchangeContractMember currency:EUR us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember us-gaap:ShortMember 2023-11-30 0000916789 us-gaap:ForeignExchangeContractMember currency:EUR us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:OtherNoncurrentAssetsMember us-gaap:ShortMember 2023-11-30 0000916789 us-gaap:ForeignExchangeContractMember currency:EUR us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:ShortMember us-gaap:AccountsPayableAndAccruedLiabilitiesMember 2023-11-30 0000916789 us-gaap:ForeignExchangeContractMember currency:EUR us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:ShortMember us-gaap:OtherNoncurrentLiabilitiesMember 2023-11-30 0000916789 us-gaap:ForeignExchangeContractMember currency:CAD us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:ShortMember 2023-11-30 iso4217:CAD 0000916789 us-gaap:ForeignExchangeContractMember currency:CAD us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember us-gaap:ShortMember 2023-11-30 0000916789 us-gaap:ForeignExchangeContractMember currency:CAD us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:OtherNoncurrentAssetsMember us-gaap:ShortMember 2023-11-30 0000916789 us-gaap:ForeignExchangeContractMember currency:CAD us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:ShortMember us-gaap:AccountsPayableAndAccruedLiabilitiesMember 2023-11-30 0000916789 us-gaap:ForeignExchangeContractMember currency:CAD us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:ShortMember us-gaap:OtherNoncurrentLiabilitiesMember 2023-11-30 0000916789 us-gaap:ForeignExchangeContractMember currency:GBP us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:ShortMember 2023-11-30 iso4217:GBP 0000916789 us-gaap:ForeignExchangeContractMember currency:GBP us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember us-gaap:ShortMember 2023-11-30 0000916789 us-gaap:ForeignExchangeContractMember currency:GBP us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:OtherNoncurrentAssetsMember us-gaap:ShortMember 2023-11-30 0000916789 us-gaap:ForeignExchangeContractMember currency:GBP us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:ShortMember us-gaap:AccountsPayableAndAccruedLiabilitiesMember 2023-11-30 0000916789 us-gaap:ForeignExchangeContractMember currency:GBP us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:ShortMember us-gaap:OtherNoncurrentLiabilitiesMember 2023-11-30 0000916789 us-gaap:ForeignExchangeContractMember currency:NOK us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:ShortMember 2023-11-30 iso4217:NOK 0000916789 us-gaap:ForeignExchangeContractMember currency:NOK us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember us-gaap:ShortMember 2023-11-30 0000916789 us-gaap:ForeignExchangeContractMember currency:NOK us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:OtherNoncurrentAssetsMember us-gaap:ShortMember 2023-11-30 0000916789 us-gaap:ForeignExchangeContractMember currency:NOK us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:ShortMember us-gaap:AccountsPayableAndAccruedLiabilitiesMember 2023-11-30 0000916789 us-gaap:ForeignExchangeContractMember currency:NOK us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:ShortMember us-gaap:OtherNoncurrentLiabilitiesMember 2023-11-30 0000916789 us-gaap:InterestRateSwapMember us-gaap:DesignatedAsHedgingInstrumentMember 2023-11-30 0000916789 us-gaap:InterestRateSwapMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember 2023-11-30 0000916789 us-gaap:InterestRateSwapMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:OtherNoncurrentAssetsMember 2023-11-30 0000916789 us-gaap:InterestRateSwapMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:AccountsPayableAndAccruedLiabilitiesMember 2023-11-30 0000916789 us-gaap:InterestRateSwapMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:OtherNoncurrentLiabilitiesMember 2023-11-30 0000916789 us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember 2023-11-30 0000916789 us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:OtherNoncurrentAssetsMember 2023-11-30 0000916789 us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:AccountsPayableAndAccruedLiabilitiesMember 2023-11-30 0000916789 us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:OtherNoncurrentLiabilitiesMember 2023-11-30 0000916789 us-gaap:NondesignatedMember us-gaap:CrossCurrencyInterestRateContractMember currency:EUR 2023-11-30 0000916789 us-gaap:NondesignatedMember us-gaap:CrossCurrencyInterestRateContractMember currency:EUR us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember 2023-11-30 0000916789 us-gaap:NondesignatedMember us-gaap:CrossCurrencyInterestRateContractMember currency:EUR us-gaap:OtherNoncurrentAssetsMember 2023-11-30 0000916789 us-gaap:NondesignatedMember us-gaap:CrossCurrencyInterestRateContractMember currency:EUR us-gaap:AccountsPayableAndAccruedLiabilitiesMember 2023-11-30 0000916789 us-gaap:NondesignatedMember us-gaap:CrossCurrencyInterestRateContractMember currency:EUR us-gaap:OtherNoncurrentLiabilitiesMember 2023-11-30 0000916789 us-gaap:NondesignatedMember us-gaap:CrossCurrencyInterestRateContractMember currency:GBP 2023-11-30 0000916789 us-gaap:NondesignatedMember us-gaap:CrossCurrencyInterestRateContractMember currency:GBP us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember 2023-11-30 0000916789 us-gaap:NondesignatedMember us-gaap:CrossCurrencyInterestRateContractMember currency:GBP us-gaap:OtherNoncurrentAssetsMember 2023-11-30 0000916789 us-gaap:NondesignatedMember us-gaap:CrossCurrencyInterestRateContractMember currency:GBP us-gaap:AccountsPayableAndAccruedLiabilitiesMember 2023-11-30 0000916789 us-gaap:NondesignatedMember us-gaap:CrossCurrencyInterestRateContractMember currency:GBP us-gaap:OtherNoncurrentLiabilitiesMember 2023-11-30 0000916789 us-gaap:NondesignatedMember us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember 2023-11-30 0000916789 us-gaap:NondesignatedMember us-gaap:OtherNoncurrentAssetsMember 2023-11-30 0000916789 us-gaap:NondesignatedMember us-gaap:AccountsPayableAndAccruedLiabilitiesMember 2023-11-30 0000916789 us-gaap:NondesignatedMember us-gaap:OtherNoncurrentLiabilitiesMember 2023-11-30 0000916789 us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember 2023-11-30 0000916789 us-gaap:OtherNoncurrentAssetsMember 2023-11-30 0000916789 us-gaap:AccountsPayableAndAccruedLiabilitiesMember 2023-11-30 0000916789 us-gaap:OtherNoncurrentLiabilitiesMember 2023-11-30 0000916789 us-gaap:ForeignExchangeContractMember currency:EUR us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:ShortMember 2023-02-28 0000916789 us-gaap:ForeignExchangeContractMember currency:EUR us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember us-gaap:ShortMember 2023-02-28 0000916789 us-gaap:ForeignExchangeContractMember currency:EUR us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:OtherNoncurrentAssetsMember us-gaap:ShortMember 2023-02-28 0000916789 us-gaap:ForeignExchangeContractMember currency:EUR us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:ShortMember us-gaap:AccountsPayableAndAccruedLiabilitiesMember 2023-02-28 0000916789 us-gaap:ForeignExchangeContractMember currency:EUR us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:ShortMember us-gaap:OtherNoncurrentLiabilitiesMember 2023-02-28 0000916789 us-gaap:ForeignExchangeContractMember currency:CAD us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:ShortMember 2023-02-28 0000916789 us-gaap:ForeignExchangeContractMember currency:CAD us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember us-gaap:ShortMember 2023-02-28 0000916789 us-gaap:ForeignExchangeContractMember currency:CAD us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:OtherNoncurrentAssetsMember us-gaap:ShortMember 2023-02-28 0000916789 us-gaap:ForeignExchangeContractMember currency:CAD us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:ShortMember us-gaap:AccountsPayableAndAccruedLiabilitiesMember 2023-02-28 0000916789 us-gaap:ForeignExchangeContractMember currency:CAD us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:ShortMember us-gaap:OtherNoncurrentLiabilitiesMember 2023-02-28 0000916789 us-gaap:ForeignExchangeContractMember currency:GBP us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:ShortMember 2023-02-28 0000916789 us-gaap:ForeignExchangeContractMember currency:GBP us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember us-gaap:ShortMember 2023-02-28 0000916789 us-gaap:ForeignExchangeContractMember currency:GBP us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:OtherNoncurrentAssetsMember us-gaap:ShortMember 2023-02-28 0000916789 us-gaap:ForeignExchangeContractMember currency:GBP us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:ShortMember us-gaap:AccountsPayableAndAccruedLiabilitiesMember 2023-02-28 0000916789 us-gaap:ForeignExchangeContractMember currency:GBP us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:ShortMember us-gaap:OtherNoncurrentLiabilitiesMember 2023-02-28 0000916789 us-gaap:ForeignExchangeContractMember currency:NOK us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:ShortMember 2023-02-28 0000916789 us-gaap:ForeignExchangeContractMember currency:NOK us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember us-gaap:ShortMember 2023-02-28 0000916789 us-gaap:ForeignExchangeContractMember currency:NOK us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:OtherNoncurrentAssetsMember us-gaap:ShortMember 2023-02-28 0000916789 us-gaap:ForeignExchangeContractMember currency:NOK us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:ShortMember us-gaap:AccountsPayableAndAccruedLiabilitiesMember 2023-02-28 0000916789 us-gaap:ForeignExchangeContractMember currency:NOK us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:ShortMember us-gaap:OtherNoncurrentLiabilitiesMember 2023-02-28 0000916789 us-gaap:InterestRateSwapMember us-gaap:DesignatedAsHedgingInstrumentMember 2023-02-28 0000916789 us-gaap:InterestRateSwapMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember 2023-02-28 0000916789 us-gaap:InterestRateSwapMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:OtherNoncurrentAssetsMember 2023-02-28 0000916789 us-gaap:InterestRateSwapMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:AccountsPayableAndAccruedLiabilitiesMember 2023-02-28 0000916789 us-gaap:InterestRateSwapMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:OtherNoncurrentLiabilitiesMember 2023-02-28 0000916789 us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember 2023-02-28 0000916789 us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:OtherNoncurrentAssetsMember 2023-02-28 0000916789 us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:AccountsPayableAndAccruedLiabilitiesMember 2023-02-28 0000916789 us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:OtherNoncurrentLiabilitiesMember 2023-02-28 0000916789 us-gaap:NondesignatedMember us-gaap:CrossCurrencyInterestRateContractMember currency:EUR 2023-02-28 0000916789 us-gaap:ForeignExchangeContractMember us-gaap:NondesignatedMember currency:EUR us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember 2023-02-28 0000916789 us-gaap:ForeignExchangeContractMember us-gaap:NondesignatedMember currency:EUR us-gaap:OtherNoncurrentAssetsMember 2023-02-28 0000916789 us-gaap:ForeignExchangeContractMember us-gaap:NondesignatedMember currency:EUR us-gaap:AccountsPayableAndAccruedLiabilitiesMember 2023-02-28 0000916789 us-gaap:ForeignExchangeContractMember us-gaap:NondesignatedMember currency:EUR us-gaap:OtherNoncurrentLiabilitiesMember 2023-02-28 0000916789 us-gaap:NondesignatedMember us-gaap:CrossCurrencyInterestRateContractMember currency:GBP 2023-02-28 0000916789 us-gaap:ForeignExchangeContractMember us-gaap:NondesignatedMember currency:GBP us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember 2023-02-28 0000916789 us-gaap:ForeignExchangeContractMember us-gaap:NondesignatedMember currency:GBP us-gaap:OtherNoncurrentAssetsMember 2023-02-28 0000916789 us-gaap:ForeignExchangeContractMember us-gaap:NondesignatedMember currency:GBP us-gaap:AccountsPayableAndAccruedLiabilitiesMember 2023-02-28 0000916789 us-gaap:ForeignExchangeContractMember us-gaap:NondesignatedMember currency:GBP us-gaap:OtherNoncurrentLiabilitiesMember 2023-02-28 0000916789 us-gaap:NondesignatedMember us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember 2023-02-28 0000916789 us-gaap:NondesignatedMember us-gaap:OtherNoncurrentAssetsMember 2023-02-28 0000916789 us-gaap:NondesignatedMember us-gaap:AccountsPayableAndAccruedLiabilitiesMember 2023-02-28 0000916789 us-gaap:NondesignatedMember us-gaap:OtherNoncurrentLiabilitiesMember 2023-02-28 0000916789 us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember 2023-02-28 0000916789 us-gaap:OtherNoncurrentAssetsMember 2023-02-28 0000916789 us-gaap:AccountsPayableAndAccruedLiabilitiesMember 2023-02-28 0000916789 us-gaap:OtherNoncurrentLiabilitiesMember 2023-02-28 0000916789 us-gaap:ForeignExchangeContractMember us-gaap:CashFlowHedgingMember 2023-09-01 2023-11-30 0000916789 us-gaap:ForeignExchangeContractMember us-gaap:CashFlowHedgingMember 2022-09-01 2022-11-30 0000916789 us-gaap:ForeignExchangeContractMember us-gaap:SellingGeneralAndAdministrativeExpensesMember us-gaap:CashFlowHedgingMember 2023-09-01 2023-11-30 0000916789 us-gaap:ForeignExchangeContractMember us-gaap:SellingGeneralAndAdministrativeExpensesMember us-gaap:CashFlowHedgingMember 2022-09-01 2022-11-30 0000916789 us-gaap:InterestRateSwapMember us-gaap:CashFlowHedgingMember 2023-09-01 2023-11-30 0000916789 us-gaap:InterestRateSwapMember us-gaap:CashFlowHedgingMember 2022-09-01 2022-11-30 0000916789 us-gaap:InterestRateSwapMember us-gaap:InterestExpenseMember us-gaap:CashFlowHedgingMember 2023-09-01 2023-11-30 0000916789 us-gaap:InterestRateSwapMember us-gaap:InterestExpenseMember us-gaap:CashFlowHedgingMember 2022-09-01 2022-11-30 0000916789 us-gaap:ForeignExchangeContractMember us-gaap:CashFlowHedgingMember 2023-03-01 2023-11-30 0000916789 us-gaap:ForeignExchangeContractMember us-gaap:CashFlowHedgingMember 2022-03-01 2022-11-30 0000916789 us-gaap:ForeignExchangeContractMember us-gaap:SellingGeneralAndAdministrativeExpensesMember us-gaap:CashFlowHedgingMember 2023-03-01 2023-11-30 0000916789 us-gaap:ForeignExchangeContractMember us-gaap:SellingGeneralAndAdministrativeExpensesMember us-gaap:CashFlowHedgingMember 2022-03-01 2022-11-30 0000916789 us-gaap:InterestRateSwapMember us-gaap:CashFlowHedgingMember 2023-03-01 2023-11-30 0000916789 us-gaap:InterestRateSwapMember us-gaap:CashFlowHedgingMember 2022-03-01 2022-11-30 0000916789 us-gaap:InterestRateSwapMember us-gaap:InterestExpenseMember us-gaap:CashFlowHedgingMember 2023-03-01 2023-11-30 0000916789 us-gaap:InterestRateSwapMember us-gaap:InterestExpenseMember us-gaap:CashFlowHedgingMember 2022-03-01 2022-11-30 0000916789 us-gaap:ForwardContractsMember us-gaap:SellingGeneralAndAdministrativeExpensesMember 2023-09-01 2023-11-30 0000916789 us-gaap:ForwardContractsMember us-gaap:SellingGeneralAndAdministrativeExpensesMember 2022-09-01 2022-11-30 0000916789 us-gaap:ForwardContractsMember us-gaap:SellingGeneralAndAdministrativeExpensesMember 2023-03-01 2023-11-30 0000916789 us-gaap:ForwardContractsMember us-gaap:SellingGeneralAndAdministrativeExpensesMember 2022-03-01 2022-11-30 0000916789 us-gaap:CrossCurrencyInterestRateContractMember us-gaap:SellingGeneralAndAdministrativeExpensesMember 2023-09-01 2023-11-30 0000916789 us-gaap:CrossCurrencyInterestRateContractMember us-gaap:SellingGeneralAndAdministrativeExpensesMember 2022-09-01 2022-11-30 0000916789 us-gaap:CrossCurrencyInterestRateContractMember us-gaap:SellingGeneralAndAdministrativeExpensesMember 2023-03-01 2023-11-30 0000916789 us-gaap:CrossCurrencyInterestRateContractMember us-gaap:SellingGeneralAndAdministrativeExpensesMember 2022-03-01 2022-11-30 0000916789 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2022-02-28 0000916789 us-gaap:AccumulatedTranslationAdjustmentMember 2022-02-28 0000916789 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2022-03-01 2022-11-30 0000916789 us-gaap:AccumulatedTranslationAdjustmentMember 2022-03-01 2022-11-30 0000916789 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2022-11-30 0000916789 us-gaap:AccumulatedTranslationAdjustmentMember 2022-11-30 0000916789 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2023-02-28 0000916789 us-gaap:AccumulatedTranslationAdjustmentMember 2023-02-28 0000916789 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2023-03-01 2023-11-30 0000916789 us-gaap:AccumulatedTranslationAdjustmentMember 2023-03-01 2023-11-30 0000916789 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2023-11-30 0000916789 us-gaap:AccumulatedTranslationAdjustmentMember 2023-11-30 0000916789 hele:HousewaresSegmentMember 2023-09-01 2023-11-30 0000916789 hele:BeautyWellnessMember 2023-09-01 2023-11-30 0000916789 hele:HousewaresSegmentMember 2022-09-01 2022-11-30 0000916789 hele:BeautyWellnessMember 2022-09-01 2022-11-30 0000916789 hele:HousewaresSegmentMember 2023-03-01 2023-11-30 0000916789 hele:BeautyWellnessMember 2023-03-01 2023-11-30 0000916789 hele:HousewaresSegmentMember 2022-03-01 2022-11-30 0000916789 hele:BeautyWellnessMember 2022-03-01 2022-11-30 0000916789 country:US 2023-09-01 2023-11-30 0000916789 country:US us-gaap:GeographicConcentrationRiskMember us-gaap:RevenueFromContractWithCustomerMember 2023-09-01 2023-11-30 0000916789 country:US 2022-09-01 2022-11-30 0000916789 country:US us-gaap:GeographicConcentrationRiskMember us-gaap:RevenueFromContractWithCustomerMember 2022-09-01 2022-11-30 0000916789 country:US 2023-03-01 2023-11-30 0000916789 country:US us-gaap:GeographicConcentrationRiskMember us-gaap:RevenueFromContractWithCustomerMember 2023-03-01 2023-11-30 0000916789 country:US 2022-03-01 2022-11-30 0000916789 country:US us-gaap:GeographicConcentrationRiskMember us-gaap:RevenueFromContractWithCustomerMember 2022-03-01 2022-11-30 0000916789 us-gaap:NonUsMember 2023-09-01 2023-11-30 0000916789 us-gaap:GeographicConcentrationRiskMember us-gaap:RevenueFromContractWithCustomerMember us-gaap:NonUsMember 2023-09-01 2023-11-30 0000916789 us-gaap:NonUsMember 2022-09-01 2022-11-30 0000916789 us-gaap:GeographicConcentrationRiskMember us-gaap:RevenueFromContractWithCustomerMember us-gaap:NonUsMember 2022-09-01 2022-11-30 0000916789 us-gaap:NonUsMember 2023-03-01 2023-11-30 0000916789 us-gaap:GeographicConcentrationRiskMember us-gaap:RevenueFromContractWithCustomerMember us-gaap:NonUsMember 2023-03-01 2023-11-30 0000916789 us-gaap:NonUsMember 2022-03-01 2022-11-30 0000916789 us-gaap:GeographicConcentrationRiskMember us-gaap:RevenueFromContractWithCustomerMember us-gaap:NonUsMember 2022-03-01 2022-11-30 0000916789 us-gaap:GeographicConcentrationRiskMember us-gaap:RevenueFromContractWithCustomerMember 2023-09-01 2023-11-30 0000916789 us-gaap:GeographicConcentrationRiskMember us-gaap:RevenueFromContractWithCustomerMember 2022-09-01 2022-11-30 0000916789 us-gaap:GeographicConcentrationRiskMember us-gaap:RevenueFromContractWithCustomerMember 2023-03-01 2023-11-30 0000916789 us-gaap:GeographicConcentrationRiskMember us-gaap:RevenueFromContractWithCustomerMember 2022-03-01 2022-11-30 0000916789 us-gaap:EmployeeStockOptionMember 2023-09-01 2023-11-30 0000916789 us-gaap:EmployeeStockOptionMember 2022-09-01 2022-11-30 0000916789 us-gaap:EmployeeStockOptionMember 2023-03-01 2023-11-30 0000916789 us-gaap:EmployeeStockOptionMember 2022-03-01 2022-11-30
Table of Contents

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 10-Q
(Mark One)
☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended November 30, 2023
or
☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from __ to __
Commission File Number: 001-14669
HELEN OF TROY LIMITED
(Exact name of registrant as specified in its charter)

Bermuda |  | 74-2692550
(State or other jurisdiction |  | (I.R.S. Employer
of incorporation or organization) |  | Identification No.)

Clarendon House
2 Church Street
Hamilton, Bermuda
(Address of principal executive offices)
1 Helen of Troy Plaza
El Paso, Texas 79912
(Registrant's United States Mailing Address) (Zip Code)
(915) 225-8000
(Registrant’s telephone number, including area code)
Securities registered pursuant to Section 12(b) of the Act:

Title of each class |  | Trading Symbol(s) |  | Name of each exchange on which registered
Common Shares, $0.10 par value per share |  | HELE |  | The NASDAQ Stock Market LLC

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer | ☒ |  | Accelerated filer |  | ☐ |
Non-accelerated filer | ☐ |  | Smaller reporting company | ☐ |
|  |  | Emerging growth company | ☐ |

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒
Indicate the number of shares outstanding of each of the issuer’s classes of common stock, as of the latest practicable date.
As of December 28, 2023, there were 23,746,423 common shares, $0.10 par value per share, outstanding.

Table of Contents
HELEN OF TROY LIMITED AND SUBSIDIARIES
FORM 10-Q
TABLE OF CONTENTS

|  | PAGE
PART I. | FINANCIAL INFORMATION |
Item 1. | Financial Statements | 2
| Note 1 - Basis of Presentation and Related Information | 8
| Note 2 - New Accounting Pronouncements | 9
| Note 3 - G ain on Sale of Distribution and Office Facilities | 10
| Note 4 - Acquisition of Curlsmith | 11
| Note 5 - Accrued Expenses and Other Current Liabilities | 13
| Note 6 - Share-Based Compensation Plans | 13
| Note 7 - Repurchases of Common Stock | 14
| Note 8 - Restructuring Plan | 14
| Note 9 - Commitments and Contingencies | 17
| Note 10 - Long-Term Debt | 19
| Note 11 - Fair Value | 20
| Note 12 - Financial Instruments and Risk Management | 21
| Note 13 - Accumulated Other Comprehensive Income (Loss) | 25
| Note 14 - Segment Information | 25
| Note 15 - Income Taxes | 26
| Note 16 - Earnings Per Share | 27
Item 2. | Management’s Discussion and Analysis of Financial Condition and Results of Operations | 28
Item 3. | Quantitative and Qualitative Disclosures About Market Risk | 55
Item 4. | Controls and Procedures | 55
PART II. | OTHER INFORMATION |
Item 1. | Legal Proceedings | 55
Item 1A. | Risk Factors | 55
Item 2. | Unregistered Sales of Equity Securities and Use of Proceeds | 56
Item 5. | Other Information | 56
Item 6. | Exhibits | 57
SIGNATURES | 58

1

Table of Contents
PART I. FINANCIAL INFORMATION
ITEM 1. FINANCIAL STATEMENTS
HELEN OF TROY LIMITED AND SUBSIDIARIES
Condensed Consolidated Balance Sheets (Unaudited)

(in thousands, except shares and par value) | November 30, 2023 |  | February 28, 2023
Assets |  |  |
Assets, current: |  |  |
Cash and cash equivalents | $ | 25,247 |  |  | $ | 29,073 |
Receivables, less allowances of $6,879 and $1,678 | 463,323 |  |  | 377,604 |
Inventory | 426,026 |  |  | 455,485 |
Prepaid expenses and other current assets | 29,535 |  |  | 24,721 |
Income taxes receivable | 12,307 |  |  | 5,158 |
Total assets, current | 956,438 |  |  | 892,041 |
Property and equipment, net of accumulated depreciation of $162,207 and $178,961 | 335,302 |  |  | 351,793 |
Goodwill | 1,066,730 |  |  | 1,066,479 |
Other intangible assets, net of accumulated amortization of $182,434 and $168,574 | 541,064 |  |  | 553,883 |
Operating lease assets | 37,930 |  |  | 38,751 |
Deferred tax assets, net | 2,972 |  |  | 2,781 |
Other assets | 11,850 |  |  | 7,987 |
Total assets | $ | 2,952,286 |  |  | $ | 2,913,715 |
Liabilities and Stockholders' Equity |  |  |
Liabilities, current: |  |  |
Accounts payable | $ | 293,050 |  |  | $ | 190,598 |
Accrued expenses and other current liabilities | 231,516 |  |  | 200,718 |
Income taxes payable | 12,915 |  |  | 14,778 |
Long-term debt, current maturities | 6,235 |  |  | 6,064 |
Total liabilities, current | 543,716 |  |  | 412,158 |
Long-term debt, excluding current maturities | 729,413 |  |  | 928,348 |
Lease liabilities, non-current | 39,256 |  |  | 42,672 |
Deferred tax liabilities, net | 40,803 |  |  | 28,048 |
Other liabilities, non-current | 12,820 |  |  | 13,678 |
Total liabilities | 1,366,008 |  |  | 1,424,904 |
Commitments and contingencies |  |  |
Stockholders' equity: |  |  |
Cumulative preferred stock, non-voting, $1.00 par. Authorized 2,000,000 shares; none issued | — |  |  | — |
Common stock, $0.10 par. Authorized 50,000,000 shares; 23,744,593 and 23,994,405 shares issued and outstanding | 2,374 |  |  | 2,399 |
Additional paid in capital | 340,351 |  |  | 317,277 |
Accumulated other comprehensive income | 2,058 |  |  | 4,947 |
Retained earnings | 1,241,495 |  |  | 1,164,188 |
Total stockholders' equity | 1,586,278 |  |  | 1,488,811 |
Total liabilities and stockholders' equity | $ | 2,952,286 |  |  | $ | 2,913,715 |

See accompanying notes to condensed consolidated financial statements.
2

Table of Contents
HELEN OF TROY LIMITED AND SUBSIDIARIES
Condensed Consolidated Statements of Income (Unaudited)

| Three Months Ended November 30, |  | Nine Months Ended November 30,
(in thousands, except per share data) | 2023 |  | 2022 |  | 2023 |  | 2022
Sales revenue, net | $ | 549,614 |  |  | $ | 558,606 |  |  | $ | 1,515,849 |  |  | $ | 1,588,084 |
Cost of goods sold | 285,833 |  |  | 301,930 |  |  | 806,784 |  |  | 898,791 |
Gross profit | 263,781 |  |  | 256,676 |  |  | 709,065 |  |  | 689,293 |
Selling, general and administrative expense (“SG&A”) | 152,964 |  |  | 169,020 |  |  | 499,790 |  |  | 515,974 |
Restructuring charges | 3,890 |  |  | 10,463 |  |  | 14,862 |  |  | 15,241 |
Operating income | 106,927 |  |  | 77,193 |  |  | 194,413 |  |  | 158,078 |
Non-operating income, net | 180 |  |  | 5 |  |  | 465 |  |  | 185 |
Interest expense | 12,859 |  |  | 13,149 |  |  | 40,565 |  |  | 26,688 |
Income before income tax | 94,248 |  |  | 64,049 |  |  | 154,313 |  |  | 131,575 |
Income tax expense | 18,350 |  |  | 12,223 |  |  | 28,453 |  |  | 24,482 |
Net income | $ | 75,898 |  |  | $ | 51,826 |  |  | $ | 125,860 |  |  | $ | 107,093 |
Earnings per share (“EPS”): |  |  |  |  |  |  |
Basic | $ | 3.20 |  |  | $ | 2.16 |  |  | $ | 5.27 |  |  | $ | 4.47 |
Diluted | 3.19 |  |  | 2.15 |  |  | 5.25 |  |  | 4.45 |
Weighted average shares used in computing EPS: |  |  |  |  |  |  |
Basic | 23,743 |  |  | 23,991 |  |  | 23,903 |  |  | 23,942 |
Diluted | 23,813 |  |  | 24,078 |  |  | 23,996 |  |  | 24,086 |

See accompanying notes to condensed consolidated financial statements.
3

Table of Contents
HELEN OF TROY LIMITED AND SUBSIDIARIES
Condensed Consolidated Statements of Comprehensive Income (Unaudited)

| Three Months Ended November 30, |  | Nine Months Ended November 30,
(in thousands) | 2023 |  | 2022 |  | 2023 |  | 2022
Net income | $ | 75,898 |  |  | $ | 51,826 |  |  | $ | 125,860 |  |  | $ | 107,093 |
Other comprehensive (loss) income, net of tax: |  |  |  |  |  |  |
Cash flow hedge activity - interest rate swaps | (1,686) |  |  | 995 |  |  | (2,010) |  |  | 4,502 |
Cash flow hedge activity - foreign currency contracts | 58 |  |  | (4,056) |  |  | (879) |  |  | (565) |
Total other comprehensive (loss) income, net of tax | (1,628) |  |  | (3,061) |  |  | (2,889) |  |  | 3,937 |
Comprehensive income | $ | 74,270 |  |  | $ | 48,765 |  |  | $ | 122,971 |  |  | $ | 111,030 |

See accompanying notes to condensed consolidated financial statements.
4

Table of Contents
HELEN OF TROY LIMITED AND SUBSIDIARIES
Condensed Consolidated Statements of Stockholders’ Equity (Unaudited)

| Common Stock | Additional Paid in Capital | Accumulated Other Comprehensive Income | Retained Earnings | Total Stockholders' Equity
(in thousands, including shares) | Shares | Par Value
Balances at February 28, 2023 | 23,994 |  | $ | 2,399 |  | $ | 317,277 |  | $ | 4,947 |  | $ | 1,164,188 |  | $ | 1,488,811 |
Net income | — |  | — |  | — |  | — |  | 22,581 |  | 22,581 |
Other comprehensive loss, net of tax | — |  | — |  | — |  | (3,715) |  | — |  | (3,715) |
Exercise of stock options | 5 |  | 1 |  | 211 |  | — |  | — |  | 212 |
Issuance and settlement of restricted stock | 120 |  | 12 |  | (12) |  | — |  | — |  | — |
Issuance of common stock related to stock purchase plan | 23 |  | 2 |  | 2,166 |  | — |  | — |  | 2,168 |
Common stock repurchased and retired | (45) |  | (4) |  | (4,442) |  | — |  | — |  | (4,446) |
Share-based compensation | — |  | — |  | 9,297 |  | — |  | — |  | 9,297 |
Balances at May 31, 2023 | 24,097 |  | $ | 2,410 |  | $ | 324,497 |  | $ | 1,232 |  | $ | 1,186,769 |  | $ | 1,514,908 |
Net income | — |  | — |  | — |  | — |  | 27,381 |  | 27,381 |
Other comprehensive income, net of tax | — |  | — |  | — |  | 2,454 |  | — |  | 2,454 |
Issuance and settlement of restricted stock | 4 |  | — |  | — |  | — |  | — |  | — |
Common stock repurchased and retired | (382) |  | (38) |  | (1,499) |  | — |  | (48,552) |  | (50,089) |
Share-based compensation | — |  | — |  | 7,229 |  | — |  | — |  | 7,229 |
Balances at August 31, 2023 | 23,719 |  | $ | 2,372 |  | $ | 330,227 |  | $ | 3,686 |  | $ | 1,165,598 |  | $ | 1,501,883 |
Net income | — |  | — |  | — |  | — |  | 75,898 |  | 75,898 |
Other comprehensive loss, net of tax | — |  | — |  | — |  | (1,628) |  | — |  | (1,628) |
Exercise of stock options | 1 |  | — |  | 53 |  | — |  | — |  | 53 |
Issuance and settlement of restricted stock | 8 |  | 1 |  | (1) |  | — |  | — |  | — |
Issuance of common stock related to stock purchase plan | 19 |  | 2 |  | 1,797 |  | — |  | — |  | 1,799 |
Common stock repurchased and retired | (3) |  | (1) |  | (304) |  | — |  | (1) |  | (306) |
Share-based compensation | — |  | — |  | 8,579 |  | — |  | — |  | 8,579 |
Balances at November 30, 2023 | 23,744 |  | $ | 2,374 |  | $ | 340,351 |  | $ | 2,058 |  | $ | 1,241,495 |  | $ | 1,586,278 |

See accompanying notes to condensed consolidated financial statements.
5

Table of Contents
HELEN OF TROY LIMITED AND SUBSIDIARIES
Condensed Consolidated Statements of Stockholders’ Equity - Continued (Unaudited)

| Common Stock | Additional Paid in Capital | Accumulated Other Comprehensive Income | Retained Earnings | Total Stockholders' Equity
(in thousands, including shares) | Shares | Par Value
Balances at February 28, 2022 | 23,800 |  | $ | 2,380 |  | $ | 303,740 |  | $ | 202 |  | $ | 1,021,017 |  | $ | 1,327,339 |
Net income | — |  | — |  | — |  | — |  | 24,595 |  | 24,595 |
Other comprehensive income, net of tax | — |  | — |  | — |  | 3,159 |  | — |  | 3,159 |
Exercise of stock options | 8 |  | 1 |  | 658 |  | — |  | — |  | 659 |
Issuance and settlement of restricted stock | 235 |  | 24 |  | (24) |  | — |  | — |  | — |
Issuance of common stock related to stock purchase plan | 13 |  | 1 |  | 2,274 |  | — |  | — |  | 2,275 |
Common stock repurchased and retired | (89) |  | (9) |  | (18,113) |  | — |  | (102) |  | (18,224) |
Share-based compensation | — |  | — |  | 16,619 |  | — |  | — |  | 16,619 |
Balances at May 31, 2022 | 23,967 |  | $ | 2,397 |  | $ | 305,154 |  | $ | 3,361 |  | $ | 1,045,510 |  | $ | 1,356,422 |
Net income | — |  | — |  | — |  | — |  | 30,672 |  | 30,672 |
Other comprehensive income, net of tax | — |  | — |  | — |  | 3,839 |  | — |  | 3,839 |
Issuance and settlement of restricted stock | 2 |  | — |  | (1) |  | — |  | — |  | (1) |
Common stock repurchased and retired | — |  | — |  | (81) |  | — |  | — |  | (81) |
Share-based compensation | — |  | — |  | 7,495 |  | — |  | — |  | 7,495 |
Balances at August 31, 2022 | 23,969 |  | $ | 2,397 |  | $ | 312,567 |  | $ | 7,200 |  | $ | 1,076,182 |  | $ | 1,398,346 |
Net income | — |  | — |  | — |  | — |  | 51,826 |  | 51,826 |
Other comprehensive loss, net of tax | — |  | — |  | — |  | (3,061) |  | — |  | (3,061) |
Issuance and settlement of restricted stock | 3 |  | — |  | — |  | — |  | — |  | — |
Issuance of common stock related to stock purchase plan | 20 |  | 2 |  | 2,064 |  | — |  | — |  | 2,066 |
Common stock repurchased and retired | (1) |  | — |  | (45) |  | — |  | — |  | (45) |
Share-based compensation | — |  | — |  | 7,941 |  | — |  | — |  | 7,941 |
Balances at November 30, 2022 | 23,991 |  | $ | 2,399 |  | $ | 322,527 |  | $ | 4,139 |  | $ | 1,128,008 |  | $ | 1,457,073 |

See accompanying notes to condensed consolidated financial statements.
6

Table of Contents
HELEN OF TROY LIMITED AND SUBSIDIARIES
Condensed Consolidated Statements of Cash Flows (Unaudited)

| Nine Months Ended November 30,
(in thousands) | 2023 |  | 2022
Cash provided by operating activities: |  |  |
Net income | $ | 125,860 |  |  | $ | 107,093 |
Adjustments to reconcile net income to net cash provided by operating activities: |  |  |
Depreciation and amortization | 37,037 |  |  | 33,330 |
Amortization of financing costs | 923 |  |  | 792 |
Non-cash operating lease expense | 7,537 |  |  | 7,558 |
Provision for credit losses | 5,421 |  |  | 1,373 |
Non-cash share-based compensation | 25,105 |  |  | 32,055 |
Gain on sale of distribution and office facilities | (34,190) |  |  | — |
Gain on sale of Personal Care business | — |  |  | (1,336) |
Gain on the sale or disposal of property and equipment | (326) |  |  | 5 |
Deferred income taxes and tax credits | 13,430 |  |  | 1,479 |
Changes in operating capital, net of effects of acquisitions of businesses: |  |  |
Receivables | (87,575) |  |  | (45,714) |
Inventory | 29,459 |  |  | 28,996 |
Prepaid expenses and other current assets | (5,507) |  |  | 3,926 |
Other assets and liabilities, net | (1,082) |  |  | (1,113) |
Accounts payable | 102,295 |  |  | (78,128) |
Accrued expenses and other current liabilities | 22,484 |  |  | (22,945) |
Accrued income taxes | (8,412) |  |  | (17,848) |
Net cash provided by operating activities | 232,459 |  |  | 49,523 |
Cash provided (used) by investing activities: |  |  |
Capital and intangible asset expenditures | (29,681) |  |  | (146,194) |
Net payments to acquire businesses, net of cash acquired | — |  |  | (146,342) |
Payments for purchases of U.S. Treasury Bills | (7,373) |  |  | — |
Proceeds from sale of distribution and office facilities | 49,456 |  |  | — |
Proceeds from sale of Personal Care business | — |  |  | 1,804 |
Proceeds from the sale of property and equipment | 1,609 |  |  | 63 |
Net cash provided (used) by investing activities | 14,011 |  |  | (290,669) |
Cash (used) provided by financing activities: |  |  |
Proceeds from revolving loans | 635,800 |  |  | 633,500 |
Repayment of revolving loans | (830,800) |  |  | (613,000) |
Proceeds from term loans | — |  |  | 250,000 |
Repayment of long-term debt | (4,687) |  |  | (3,462) |
Payment of financing costs | — |  |  | (586) |
Proceeds from share issuances under share-based compensation plans | 4,232 |  |  | 5,000 |
Payments for repurchases of common stock | (54,841) |  |  | (18,350) |
Net cash (used) provided by financing activities | (250,296) |  |  | 253,102 |
Net (decrease) increase in cash and cash equivalents | (3,826) |  |  | 11,956 |
Cash and cash equivalents, beginning balance | 29,073 |  |  | 33,381 |
Cash and cash equivalents, ending balance | $ | 25,247 |  |  | $ | 45,337 |
Supplemental non-cash investing activity: |  |  |
Capital expenditures included in accounts payable | $ | 2,439 |  |  | $ | 11,038 |

See accompanying notes to condensed consolidated financial statements.
7

Table of Contents
HELEN OF TROY LIMITED AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Unaudited)
November 30, 2023
Note 1 - Basis of Presentation and Related Information
Corporate Overview
The accompanying condensed consolidated financial statements contain all adjustments (consisting of normal recurring adjustments) necessary to present fairly our consolidated financial position as of November 30, 2023 and February 28, 2023, and the results of our consolidated operations for the interim periods presented. We follow the same accounting policies when preparing quarterly financial data as we use for preparing annual data. These statements should be read in conjunction with the consolidated financial statements and the notes included in our latest annual report on Form 10-K for the fiscal year ended February 28, 2023 (“Form 10-K”), and our other reports on file with the Securities and Exchange Commission (the “SEC”).
When used in these notes, unless otherwise indicated or the context suggests otherwise, references to “the Company”, “our Company”, “Helen of Troy”, “we”, “us”, or “our” refer to Helen of Troy Limited and its subsidiaries, which are all wholly-owned. We refer to our common shares, par value $0.10 per share, as “common stock.” References to “the FASB” refer to the Financial Accounting Standards Board. References to “GAAP” refer to accounting principles generally accepted in the United States of America (the “U.S.”). References to “ASU” refer to the codification of GAAP in the Accounting Standards Updates issued by the FASB. References to “ASC” refer to the codification of GAAP in the Accounting Standards Codification issued by the FASB.
We incorporated as Helen of Troy Corporation in Texas in 1968 and were reorganized as Helen of Troy Limited in Bermuda in 1994. We are a leading consumer products company offering creative products and solutions for our customers through a diversified portfolio of brands. As of November 30, 2023, we operated two reportable segments: Home & Outdoor and Beauty & Wellness. During the fourth quarter of fiscal 2023, we made changes to the structure of our organization in connection with our global restructuring plan (as further described below and in Note 8) that resulted in our previous Health & Wellness and Beauty operating segments being combined into a single reportable segment, which is referred to herein as “Beauty & Wellness.” In connection with these organizational structure changes, corresponding changes were made to how our business is managed, how results are reported internally and how our Chief Executive Officer (“CEO”), our chief operating decision maker, assesses performance and allocates resources. We believe that these changes better align internal resources and external go to market activities in order to create a more efficient and effective organizational structure. There were no changes to the products or brands included within our Home & Outdoor reportable segment as part of these organizational changes nor to the way in which our CEO assesses performance and allocates resources for the Home & Outdoor segment. As a result of these changes, our disclosures reflect two reportable segments, Home & Outdoor and Beauty & Wellness. Comparative prior period segment information in this report has been recast to conform to this change in our reportable segments. Our external reportable segments will continue to align with our internal reporting to enable users of the financial statements to better understand our performance, better assess our future net cash flows, and make more informed judgments about the Company as a whole.
Our Home & Outdoor segment provides a broad range of outstanding world-class brands that help consumers enjoy an outdoor lifestyle and make everyday living better. Our innovative products for home activities include food preparation, cooking, cleaning, organization, and beverage service. Our outdoor performance range includes hydration products, backpacks, and travel gear to ease your journey and inspire your next adventure. The Beauty & Wellness segment provides consumers with a broad range of
8

Table of Contents
outstanding world-class brands for beauty and wellness. In Beauty, we deliver innovation through products such as hair styling appliances, grooming tools, and liquid-, solid-, and powder-based personal care products that help make everyone look and feel more beautiful. On the Wellness side, we are there when you need us most with highly regarded humidifiers, thermometers, water and air purifiers, heaters, and fans.
Our business is seasonal due to different calendar events, holidays and seasonal weather and illness patterns. Our fiscal reporting period ends on the last day in February. Historically, our highest sales volume and operating income occur in our third fiscal quarter ending November 30th. We purchase our products from unaffiliated manufacturers, most of which are located in China, Mexico, Vietnam and the U.S.
During the second quarter of fiscal 2023, we focused on developing a global restructuring plan intended to expand operating margins through initiatives designed to improve efficiency and reduce costs (referred to as “Project Pegasus”). See Note 8 for additional information.
On April 22, 2022, we completed the acquisition of Recipe Products Ltd., a producer of innovative prestige hair care products for all types of curly and wavy hair under the Curlsmith brand (“Curlsmith”). The total purchase consideration was $147.9 million in cash, net of a final net working capital adjustment and cash acquired. The Curlsmith brand and products were added to the Beauty & Wellness segment. See Note 4 for additional information.
During fiscal 2022 and fiscal 2023, we divested certain assets within our Beauty & Wellness segment's mass channel personal care business, which included liquid, powder and aerosol products under brands such as Pert, Brut, Sure and Infusium (“Personal Care”). On June 7, 2021, we completed the sale of our North America Personal Care business to HRB Brands LLC, for $44.7 million in cash and recognized a gain on the sale in SG&A totaling $0.5 million. On March 25, 2022, we completed the sale of the Latin America and Caribbean Personal Care business to HRB Brands LLC, for $1.8 million in cash and recognized a gain on the sale in SG&A totaling $1.3 million.
Principles of Consolidation
The accompanying condensed consolidated financial statements are prepared in accordance with GAAP and include all of our subsidiaries. Our condensed consolidated financial statements are prepared in U.S. Dollars. All intercompany balances and transactions are eliminated in consolidation.
The preparation of consolidated financial statements in accordance with GAAP requires management to make estimates and assumptions that affect the amounts reported in our condensed consolidated financial statements and accompanying notes. Actual results may differ materially from those estimates.
Reclassifications
We have reclassified or combined certain amounts in the prior year's accompanying footnotes to conform with the current year's presentation.
Note 2 - New Accounting Pronouncements
Except for the changes discussed below, there have been no changes in the information provided in our Form 10-K.
9

Table of Contents
Adopted
In September 2022, the FASB issued ASU 2022-04, Liabilities—Supplier Finance Programs (Subtopic 405-50): Disclosure of Supplier Finance Program Obligations, which requires a buyer in a supplier finance program to disclose qualitative and quantitative information about its program to allow a user of the financial statements to understand the program’s nature, activity during the period, changes from period to period, and potential magnitude. The amendments in ASU 2022-04 are effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2022, with the exception for the amendment on rollforward information, which is effective for fiscal years beginning after December 15, 2023. The guidance should be applied retrospectively, except for the amendment on rollforward information, which should be applied prospectively. This ASU was effective for us in the first quarter of fiscal 2024, with the exception of the amendment on rollforward information, which will be effective for us in our Form 10-K for fiscal 2025. We adopted this ASU during the first quarter of fiscal 2024 and the adoption did not have an impact on our consolidated financial statement disclosures.
In October 2021, the FASB issued ASU 2021-08, Business Combinations (Topic 805): Accounting for Contract Assets and Contract Liabilities from Contracts with Customers, which requires contract assets and contract liabilities acquired in a business combination to be recognized and measured by the acquirer on the acquisition date in accordance with ASC 606, Revenue from Contracts with Customers. Prior to the issuance of this guidance, contract assets and contract liabilities were recognized by the acquirer at fair value on the acquisition date. The amendments in ASU 2021-08 are effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2022, and should be applied prospectively to acquisitions occurring on or after the effective date. We adopted this ASU during the first quarter of fiscal 2024 and the adoption did not have an impact on our consolidated financial statements.
Not Yet Adopted
In November 2023, the FASB issued ASU 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures, which provides updates to qualitative and quantitative reportable segment disclosure requirements, including enhanced disclosures about significant segment expenses and increased interim disclosure requirements, among others. The amendments in ASU 2023-07 are effective for fiscal years beginning after December 15, 2023, and interim periods within fiscal years beginning after December 15, 2024. Early adoption is permitted, and the amendments should be applied retrospectively. This ASU will be effective for our Form 10-K for fiscal 2025 and our Form 10-Q for the first quarter of fiscal 2026. We are currently evaluating the impact this ASU may have on our consolidated financial statement disclosures.
In December 2023, the FASB issued ASU 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures, which provides qualitative and quantitative updates to the rate reconciliation and income taxes paid disclosures, among others, in order to enhance the transparency of income tax disclosures, including consistent categories and greater disaggregation of information in the rate reconciliation and disaggregation by jurisdiction of income taxes paid. The amendments in ASU 2023-09 are effective for fiscal years beginning after December 15, 2024, with early adoption permitted. The amendments should be applied prospectively; however, retrospective application is also permitted. This ASU will be effective for our Form 10-K for fiscal 2026. We are currently evaluating the impact this ASU may have on our consolidated financial statement disclosures.
Note 3 - Gain on Sale of Distribution and Office Facilities
On September 28, 2023, we completed the sale of our distribution and office facilities in El Paso, Texas for a sales price of $50.6 million, less transaction costs of $1.1 million. Concurrently, we entered into an
10

Table of Contents
agreement to leaseback the office facilities for a period of up to 18 months substantially rent free, which we estimated to have a fair value of approximately $1.9 million. The transaction qualified for sales recognition under the sale leaseback accounting requirements. Accordingly, we increased the sales price by the $1.9 million of prepaid rent and recognized a gain on the sale of $34.2 million within SG&A during the third quarter of fiscal year 2024, of which $18.0 million and $16.2 million was recognized by our Beauty & Wellness and Home & Outdoor segments, respectively. The related property and equipment totaling $17.2 million, net of accumulated depreciation of $36.8 million, was derecognized from the consolidated balance sheet, and at lease commencement, we recorded an operating lease asset, which includes the imputed rent payments described above, and an operating lease liability. We used the proceeds from the sale to repay amounts outstanding under our long-term debt agreement.
Note 4 - Acquisition of Curlsmith
On April 22, 2022, we completed the acquisition of Recipe Products Ltd., a producer of innovative prestige hair care products for all types of curly and wavy hair under the Curlsmith brand. Curlsmith's products are a category leader in the prestige market for curly hair and include conditioners, shampoos and co-washes purposefully designed for the unique joys and challenges of all types of curls and textured hair. The Curlsmith brand and products were added to the Beauty & Wellness segment. The total purchase consideration was $147.9 million in cash, net of a final net working capital adjustment of $2.1 million and cash acquired. The acquisition was funded with cash on hand and borrowings under our existing revolving credit facility. We incurred pre-tax acquisition-related expenses of $2.7 million during the nine months ended November 30, 2022, which were recognized in SG&A within our condensed consolidated statement of income.
We accounted for the acquisition as a purchase of a business and recorded the excess of the purchase price over the estimated fair value of the assets acquired and liabilities assumed as goodwill. The goodwill recognized is attributable primarily to expected synergies including leveraging our Beauty & Wellness segment's existing marketing and sales structure, as well as our global sourcing, distribution, shared service, and international go-to-market capabilities. The goodwill is not expected to be deductible for income tax purposes. We have determined the appropriate fair values of the acquired intangible assets and completed our analysis of the economic lives of the assets acquired. We assigned $21.0 million to trade names and are amortizing over a 20 year expected life. We assigned $12.0 million to customer relationships and are amortizing over a 19.5 year expected life, based on historical attrition rates.
During fiscal 2023, we made adjustments to provisional asset and liability balances, which resulted in a corresponding net increase to goodwill of $0.1 million. We also finalized the net working capital adjustment during fiscal 2023, which resulted in a $1.8 million reduction to the total purchase consideration and goodwill. During the first quarter of fiscal 2024, we made final adjustments to provisional liability balances, which resulted in a corresponding increase to goodwill of $0.3 million.
11

Table of Contents
The following table presents the estimated fair values of assets acquired and liabilities assumed at the acquisition date:

(in thousands) |
Assets: |
Receivables | $ | 4,211 |
Inventory | 7,890 |
Prepaid expenses and other current assets | 119 |
Property and equipment | 212 |
Goodwill | 117,108 |
Trade names - definite | 21,000 |
Customer relationships - definite | 12,000 |
Deferred tax assets, net | 360 |
Total assets | 162,900 |
Liabilities: |
Accounts payable | 1,401 |
Accrued expenses and other current liabilities | 2,813 |
Income taxes payable | 2,572 |
Deferred tax liabilities, net | 8,187 |
Total liabilities | 14,973 |
Net assets recorded | $ | 147,927 |

Both the fair value and gross contractual amount of receivables acquired was $4.2 million, as an immaterial amount was expected to be uncollectible.
The impact of the acquisition of Curlsmith on our condensed consolidated statements of income for the periods presented was as follows:

(in thousands, except earnings per share data) | Three Months Ended November 30, 2022 (1) |  | Nine Months Ended November 30, 2022 (1) (2)
Sales revenue, net | $ | 13,091 |  |  | $ | 26,544 |
Net income | 2,077 |  |  | 3,953 |
EPS: |  |  |
Basic | $ | 0.09 |  |  | $ | 0.17 |
Diluted | $ | 0.09 |  |  | $ | 0.16 |

(1)Net income and EPS amounts include allocations for corporate expenses, interest expense and income tax expense.
(2)Represents approximately thirty-two weeks of operating results from Curlsmith, acquired April 22, 2022.
The following supplemental unaudited pro forma information presents our financial results as if the acquisition of Curlsmith had occurred on March 1, 2021. This supplemental pro forma information has been prepared for comparative purposes and does not necessarily indicate what may have occurred if the acquisition had been completed on March 1, 2021, and this information is not intended to be indicative of future results.

(in thousands, except earnings per share data) | Three Months Ended November 30, 2022 |  |  |  | Nine Months Ended November 30, 2022 |  |
Sales revenue, net | $ | 558,606 |  |  |  |  | $ | 1,595,176 |  |  |
Net income | 51,826 |  |  |  |  | 109,006 |  |  |
EPS: |  |  |  |  |  |  |
Basic | $ | 2.16 |  |  |  |  | $ | 4.55 |  |  |
Diluted | $ | 2.15 |  |  |  |  | $ | 4.53 |  |  |

12

Table of Contents
These amounts have been calculated after applying our accounting policies and adjusting the results of Curlsmith to reflect the effect of definite-lived intangible assets recognized as part of the business combination on amortization expense as if the acquisition had occurred on March 1, 2021.
Note 5 - Accrued Expenses and Other Current Liabilities
A summary of accrued expenses and other current liabilities was as follows:

(in thousands) | November 30, 2023 |  | February 28, 2023
Accrued compensation, benefits and payroll taxes | $ | 37,905 |  |  | $ | 17,380 |
Accrued sales discounts and allowances | 60,267 |  |  | 63,881 |
Accrued sales returns | 25,584 |  |  | 28,498 |
Accrued advertising | 43,224 |  |  | 36,931 |
Other | 64,536 |  |  | 54,028 |
Total accrued expenses and other current liabilities | $ | 231,516 |  |  | $ | 200,718 |

Note 6 - Share-Based Compensation Plans
As part of our compensation structure, we grant share-based compensation awards to certain employees and non-employee members of our Board of Directors during the fiscal year. These awards may be subject to attainment of certain service conditions, performance conditions and/or market conditions. During the first quarter of fiscal 2024, we granted 94,807 service condition awards (“Service Condition Awards”) with a weighted average grant date fair value of $110.85. Additionally, we granted 252,522 performance-based awards during the first quarter of fiscal 2024, of which 126,318 contained performance conditions (“Performance Condition Awards”) and 126,204 contained market conditions (“Market Condition Awards”), with weighted average grant date fair values of $110.85 and $80.50, respectively. Refer to our Form 10-K for further information on the Company's share-based compensation plans.
We recorded share-based compensation expense in SG&A as follows:

| Three Months Ended November 30, |  | Nine Months Ended November 30,
(in thousands) | 2023 |  | 2022 |  | 2023 |  | 2022
Directors stock compensation | $ | 197 |  |  | $ | 197 |  |  | $ | 590 |  |  | $ | 592 |
Service Condition Awards | 3,160 |  |  | 2,211 |  |  | 9,358 |  |  | 7,488 |
Performance Condition Awards | 1,170 |  |  | 3,252 |  |  | 4,306 |  |  | 17,293 |
Market Condition Awards | 3,458 |  |  | 1,793 |  |  | 9,647 |  |  | 5,620 |
Employee stock purchase plan | 594 |  |  | 488 |  |  | 1,204 |  |  | 1,062 |
Share-based compensation expense | 8,579 |  |  | 7,941 |  |  | 25,105 |  |  | 32,055 |
Less income tax benefits | (532) |  |  | (474) |  |  | (1,558) |  |  | (2,128) |
Share-based compensation expense, net of income tax benefits | $ | 8,047 |  |  | $ | 7,467 |  |  | $ | 23,547 |  |  | $ | 29,927 |

Unrecognized Share-Based Compensation Expense
As of November 30, 2023, our total unrecognized share-based compensation for all awards was $25.8 million, which will be recognized over a weighted average amortization period of 1.9 years. The total unrecognized share-based compensation reflects an estimate of target achievement for Performance Condition Awards granted during the first quarter of fiscal 2024, and an estimate of zero percent of target achievement for Performance Condition Awards granted in fiscal 2023 and fiscal 2022.
13

Table of Contents
Note 7 - Repurchases of Common Stock
In August 2021, our Board of Directors authorized the repurchase of up to $500 million of our outstanding common stock. The authorization became effective August 25, 2021, for a period of three years, and replaced our former repurchase authorization. As of November 30, 2023, our repurchase authorization allowed for the purchase of $348.8 million of common stock.
Our current equity-based compensation plans include provisions that allow for the “net exercise” of share-settled awards by all plan participants. In a net exercise, any required payroll taxes, federal withholding taxes and exercise price of the shares due from the option or other share-based award holders are settled by having the holder tender back to us a number of shares at fair value equal to the amounts due. Net exercises are treated as purchases and retirements of shares.
The following table summarizes our share repurchase activity for the periods shown:

| Three Months Ended November 30, |  | Nine Months Ended November 30,
(in thousands, except share and per share data) | 2023 |  | 2022 |  | 2023 |  | 2022
Common stock repurchased on the open market: |  |  |  |  |  |
Number of shares | — |  |  | — |  |  | 381,200 |  |  | — |
Aggregate value of shares | $ | — |  |  | $ | — |  |  | $ | 50,006 |  |  | $ | — |
Average price per share | $ | — |  |  | $ | — |  |  | $ | 131.18 |  |  | $ | — |
Common stock received in connection with share-based compensation: |  |  |  |  |  |
Number of shares | 2,701 |  |  | 382 |  |  | 48,098 |  |  | 90,341 |
Aggregate value of shares | $ | 306 |  |  | $ | 45 |  |  | $ | 4,835 |  |  | $ | 18,350 |
Average price per share | $ | 113.31 |  |  | $ | 117.44 |  |  | $ | 100.51 |  |  | $ | 203.12 |

Note 8 - Restructuring Plan
During the second quarter of fiscal 2023, we focused on developing Project Pegasus, a global restructuring plan intended to expand operating margins through initiatives designed to improve efficiency and reduce costs. Project Pegasus includes initiatives to further optimize our brand portfolio, streamline and simplify the organization, accelerate cost of goods savings projects, enhance the efficiency of our supply chain network, optimize our indirect spending, and improve our cash flow and working capital, as well as other activities. We anticipate these initiatives will create operating efficiencies, as well as provide a platform to fund future growth investments.
During the fourth quarter of fiscal 2023, we made changes to the structure of our organization in connection with Project Pegasus that resulted in our previous Health & Wellness and Beauty operating segments being combined into a single reportable segment, which is referred to herein as “Beauty & Wellness.” In connection with these organizational structure changes, corresponding changes were made to how our business is managed, how results are reported internally and how our CEO, our chief operating decision maker, assesses performance and allocates resources. We believe that these changes better align internal resources and external go to market activities in order to create a more efficient and effective organizational structure. There were no changes to the products or brands included within our Home & Outdoor reportable segment as part of these organizational changes.
As part of our initiative focused on streamlining and simplifying the organization, we made further changes to the structure of our organization, during the fourth quarter of fiscal 2023, which include the creation of a North America Regional Market Organization (“RMO”) responsible for sales and go to market strategies for all categories and channels in the U.S. and Canada, and further centralization of certain functions under shared services, particularly in operations and finance to better support our
14

Table of Contents
business segments and RMOs. This new structure, inclusive of the organizational structure changes described above resulting in the reportable segment change, will reduce the size of our global workforce by approximately 10%. The majority of these role reductions were completed by March 1, 2023. We believe that these changes better focus business segment resources on brand development, consumer-centric innovation and marketing, the RMOs on sales and go to market strategies, and shared services on their respective areas of expertise while also creating a more efficient and effective organizational structure.
During the second quarter of fiscal 2024, we announced plans to geographically consolidate the U.S. Beauty business, currently located in El Paso, Texas, and Irvine, California, and co-locate it with our Wellness business in the Boston, Massachusetts area. This geographical consolidation and relocation is the next step in our initiative to streamline and simplify the organization and it is expected to be completed during fiscal 2025. We expect these changes will enable a greater opportunity to capture synergies and enhance collaboration and innovation within the Beauty & Wellness segment.
As previously disclosed, we continue to have the following expectations regarding Project Pegasus charges:
•Total one-time pre-tax restructuring charges of approximately $60 million to $65 million over the duration of the plan, expected to be completed during fiscal 2025.
•Pre-tax restructuring charges to be comprised of approximately $22 million to $25 million of severance and employee related costs, $30 million of professional fees, $5 million of contract termination costs, and $3 million to $5 million of other exit and disposal costs.
•All of our operating segments and shared services will be impacted by the plan and pre-tax restructuring charges include approximately $17 million to $19 million in Home & Outdoor and $43 million to $46 million in Beauty & Wellness.
•Pre-tax restructuring charges represent primarily cash expenditures, which are expected to be substantially paid by the end of fiscal 2025.
We also continue to have the following expectations regarding Project Pegasus savings:
•Targeted annualized pre-tax operating profit improvements of approximately $75 million to $85 million, which began in fiscal 2024 and we expect to be substantially achieved by the end of fiscal 2026.
•Estimated cadence of the recognition of the savings will be approximately 25% in fiscal 2024, approximately 50% in fiscal 2025 and approximately 25% in fiscal 2026.
•Total profit improvements to be realized approximately 60% through reduced cost of goods sold and 40% through lower SG&A.
During the three and nine month periods ended November 30, 2023, we incurred $3.9 million and $14.9 million, respectively, of pre-tax restructuring costs in connection with Project Pegasus, which were recorded as “Restructuring charges” in the condensed consolidated statements of income. We recognized $10.5 million and $15.2 million of pre-tax restructuring costs during the three and nine month periods ended November 30, 2022, respectively, in connection with Project Pegasus.
15

Table of Contents
The following tables summarize restructuring charges recorded as a result of Project Pegasus for the periods presented:

| Three Months Ended November 30, 2023
(in thousands) | Home & Outdoor |  |  |  |  |  | Beauty & Wellness |  | Total
Severance and employee related costs | $ | 109 |  |  |  |  |  |  | $ | 2,498 |  |  | $ | 2,607 |
Professional fees | 464 |  |  |  |  |  |  | 794 |  |  | 1,258 |
Contract termination | — |  |  |  |  |  |  | — |  |  | — |
Other | 10 |  |  |  |  |  |  | 15 |  |  | 25 |
Total restructuring charges | $ | 583 |  |  |  |  |  |  | $ | 3,307 |  |  | $ | 3,890 |

| Three Months Ended November 30, 2022
(in thousands) | Home & Outdoor |  |  |  |  |  | Beauty & Wellness |  | Total
Severance and employee related costs | $ | 426 |  |  |  |  |  |  | $ | 749 |  |  | $ | 1,175 |
Professional fees | 4,663 |  |  |  |  |  |  | 4,511 |  |  | 9,174 |
Contract termination | — |  |  |  |  |  |  | — |  |  | — |
Other | 1 |  |  |  |  |  |  | 113 |  |  | 114 |
Total restructuring charges | $ | 5,090 |  |  |  |  |  |  | $ | 5,373 |  |  | $ | 10,463 |

| Nine Months Ended November 30, 2023 |  | Total Incurred Since Inception
(in thousands) | Home & Outdoor |  |  |  |  | Beauty & Wellness |  | Total |
Severance and employee related costs | $ | 680 |  |  |  |  |  | $ | 3,407 |  |  | $ | 4,087 |  |  | $ | 13,540 |
Professional fees | 3,915 |  |  |  |  |  | 5,870 |  |  | 9,785 |  |  | 26,534 |
Contract termination | — |  |  |  |  |  | 796 |  |  | 796 |  |  | 1,331 |
Other | 49 |  |  |  |  |  | 145 |  |  | 194 |  |  | 819 |
Total restructuring charges | $ | 4,644 |  |  |  |  |  | $ | 10,218 |  |  | $ | 14,862 |  |  | $ | 42,224 |

| Nine Months Ended November 30, 2022 |  |
(in thousands) | Home & Outdoor |  |  |  |  | Beauty & Wellness |  | Total |
Severance and employee related costs | $ | 898 |  |  |  |  |  | $ | 3,120 |  |  | $ | 4,018 |  |  |
Professional fees | 4,663 |  |  |  |  |  | 4,639 |  |  | 9,302 |  |  |
Contract termination | — |  |  |  |  |  | 1,500 |  |  | 1,500 |  |  |
Other | 1 |  |  |  |  |  | 420 |  |  | 421 |  |  |
Total restructuring charges | $ | 5,562 |  |  |  |  |  | $ | 9,679 |  |  | $ | 15,241 |  |  |

The tables below present a rollforward of our accruals related to Project Pegasus, which are included in accounts payable and accrued expenses and other current liabilities:

(in thousands) | Balance at February 28, 2023 |  | Charges |  | Payments |  | Balance at November 30, 2023
Severance and employee related costs | $ | 3,173 |  |  | $ | 4,087 |  |  | $ | (3,758) |  |  | $ | 3,502 |
Professional fees | 3,201 |  |  | 9,785 |  |  | (12,559) |  |  | 427 |
Contract termination | 160 |  |  | 796 |  |  | (956) |  |  | — |
Other | 34 |  |  | 194 |  |  | (228) |  |  | — |
Total | $ | 6,568 |  |  | $ | 14,862 |  |  | $ | (17,501) |  |  | $ | 3,929 |

16

Table of Contents

(in thousands) | Balance at February 28, 2022 |  | Charges |  | Payments |  | Balance at November 30, 2022
Severance and employee related costs | $ | — |  |  | $ | 4,018 |  |  | $ | (2,805) |  |  | $ | 1,213 |
Professional fees | — |  |  | 9,302 |  |  | (2,196) |  |  | 7,106 |
Contract termination | — |  |  | 1,500 |  |  | — |  |  | 1,500 |
Other | — |  |  | 421 |  |  | (414) |  |  | 7 |
Total | $ | — |  |  | $ | 15,241 |  |  | $ | (5,415) |  |  | $ | 9,826 |

Note 9 - Commitments and Contingencies
Legal Matters
We are involved in various legal claims and proceedings in the normal course of operations. We believe the outcome of these matters will not have a material adverse effect on our consolidated financial position, results of operations or liquidity, except as described below.
On December 23, 2021, Brita LP filed a complaint against Kaz USA, Inc. and Helen of Troy Limited in the United States District Court for the Western District of Texas (the “Patent Litigation”), alleging patent infringement by the Company relating to its PUR gravity-fed water filtration systems. In the Patent Litigation, Brita LP seeks monetary damages and injunctive relief relating to the alleged infringement. Brita LP simultaneously filed a complaint with the United States International Trade Commission (“ITC”) against Kaz USA, Inc., Helen of Troy Limited and five other unrelated companies that sell water filtration systems (the “ITC Action”). The complaint in the ITC Action also alleges patent infringement by the Company with respect to a limited set of PUR gravity-fed water filtration systems. In the ITC Action, Brita LP requested the ITC to initiate an unfair import investigation relating to such filtration systems. This action seeks injunctive relief to prevent entry of certain accused PUR products (and certain other products) into the U.S. and cessation of marketing and sales of existing inventory that is already in the U.S. On January 25, 2022, the ITC instituted the investigation requested by the ITC Action. Discovery closed in the ITC Action in May 2022, and approximately half of the originally identified PUR gravity-fed water filters were removed from the case and are no longer included in the ITC Action. In August 2022, the parties participated in the evidentiary hearing, with additional supplemental hearings in October 2022. On February 28, 2023, the ITC issued an Initial Determination in the ITC Action, tentatively ruling against Kaz USA, Inc. and the other unrelated respondents. The ITC has a guaranteed review process, and thus all respondents, including Kaz USA, Inc., filed a petition with the ITC for a full review of the Initial Determination. On September 19, 2023, the ITC issued its Final Determination in the Company’s favor. The ITC determined there was no violation by the Company and terminated the investigation. Brita LP is appealing the ITC's decision to the Federal Circuit (“CAFC Appeal”) and filed its Notice of Appeal on October 24, 2023. The Company intervened in the CAFC Appeal, but as of the filing date of this Form 10-Q, no hearings have been scheduled. The Patent Litigation remains stayed for the time being. We cannot predict the outcome of these legal proceedings, the amount or range of any potential loss, when the proceedings will be resolved, or customer acceptance of any replacement water filter. Litigation is inherently unpredictable, and the resolution or disposition of these proceedings could, if adversely determined, have a material and adverse impact on our financial position and results of operations.
Regulatory Matters
Our operations are subject to national, state, local, and provincial jurisdictions’ environmental, health and safety laws and regulations and industry-specific product certifications. Many of the products we sell are subject to product safety laws and regulations in various jurisdictions. These laws and regulations specify the maximum allowable levels of certain materials that may be contained in our products, provide statutory prohibitions against misbranded and adulterated products, establish ingredients and manufacturing procedures for certain products, specify product safety testing requirements, and set
17

Table of Contents
product identification, labeling and claim requirements. Some of our product lines are subject to product identification, labeling and claim requirements, which are monitored and enforced by regulatory agencies, such as the U.S. Environmental Protection Agency (the “EPA”), U.S. Customs and Border Protection, the U.S. Food and Drug Administration, and the U.S. Consumer Product Safety Commission.
During fiscal 2022, we were in discussions with the EPA regarding the compliance of packaging claims on certain of our products in the air and water filtration categories and a limited subset of humidifier products within the Beauty & Wellness segment that are sold in the U.S. The EPA did not raise any product quality, safety or performance issues. As a result of these packaging compliance discussions, we voluntarily implemented a temporary stop shipment action on the impacted products as we worked with the EPA towards an expedient resolution. We resumed normalized levels of shipping of the affected inventory during fiscal 2022 and we completed the repackaging and relabeling of our existing inventory of impacted products during fiscal 2023. Additionally, as a result of continuing dialogue with the EPA, we executed further repackaging and relabeling plans on certain additional humidifier products and certain additional air filtration products, which were also completed during fiscal 2023. Although we are not aware of any fines or penalties imposed against us by the EPA related to this matter, there can be no assurances that such fines or penalties will not be imposed in the future.
We recorded charges to cost of goods sold to write-off obsolete packaging for the affected products in our inventory on-hand and in-transit. We have also incurred additional compliance costs comprised of obsolete packaging, storage and other charges from vendors, which were recognized in cost of goods sold and incremental warehouse storage costs and legal fees, which were recognized in SG&A. We refer to these charges as “EPA compliance costs.”
The following table provides a summary of EPA compliance costs incurred during the periods presented:

| Three Months Ended November 30, |  | Nine Months Ended November 30,
(in thousands) | 2023 |  | 2022 |  | 2023 |  | 2022
Cost of goods sold | $ | — |  |  | $ | 370 |  |  | $ | — |  |  |  | $ | 16,928 |  | 1
SG&A | — |  |  | 1,733 |  |  | — |  |  |  | 5,173 |  |
Total EPA compliance costs | $ | — |  |  | $ | 2,103 |  |  | $ | — |  |  |  | $ | 22,101 |  |

(1)Includes a $4.4 million charge to write-off the obsolete packaging for the affected additional humidifier products and affected additional air filtration products in our inventory on-hand and in-transit as of the end of the first quarter of fiscal 2023.
In addition, we incurred and capitalized into inventory costs to repackage a portion of our existing inventory of the affected products beginning in the second quarter of fiscal 2022 through completion of the repackaging in the third quarter of fiscal 2023. For additional information refer to Part I, Item 2., “Management’s Discussion and Analysis of Financial Condition and Results of Operations,” including “EPA Compliance Costs”.
Weather-Related Incident
On March 30, 2022, a third-party facility that we utilized for inventory storage incurred severe damage from a weather-related incident. The inventory that was stored at this facility primarily related to our Beauty & Wellness segment. While the inventory was insured, some seasonal inventory and inventory designated for specific customer promotions was not accessible and subsequently determined to be damaged, and as a result, unfavorably impacted our net sales revenue during the first quarter of fiscal 2023. As a result of the damages to the inventory stored at the facility, we recorded a charge to write-off the damaged inventory totaling $34.4 million during the first quarter of fiscal 2023. These charges were fully offset by probable insurance recoveries of $34.4 million also recorded during the first quarter of fiscal 2023, which represented anticipated insurance proceeds, not to exceed the amount of the associated
18

Table of Contents
losses, for which receipt was deemed probable. The charges for the damaged inventory and the expected insurance recoveries are included in cost of goods sold in our condensed consolidated statement of income for the nine months ended November 30, 2022. During the third quarter of fiscal
2023, we received proceeds of $34.5 million from our insurance carriers related to this incident which were included in cash flows from operating activities in our condensed consolidated statement of cash flows for the nine months ended November 30, 2022. The Company also received final confirmation from our insurance carriers during the third quarter of fiscal 2023 of an additional $11.5 million in proceeds, which was collected during December 2022. As a result, during the third quarter of fiscal 2023, the Company recorded a gain of $9.7 million, net of costs incurred to dispose of the inventory, as a reduction of SG&A expense in our condensed consolidated statement of income.
Note 10 - Long-Term Debt
A summary of our long-term debt follows:

(in thousands) | November 30, 2023 |  | February 28, 2023
Credit Agreement (1): |  |  |
Revolving loans | $ | 495,000 |  |  | $ | 690,000 |
Term loans | 242,188 |  |  | 246,875 |
Total borrowings under Credit Agreement | 737,188 |  |  | 936,875 |
Unamortized prepaid financing fees | (1,540) |  |  | (2,463) |
Total long-term debt | 735,648 |  |  | 934,412 |
Less: current maturities of long-term debt | (6,235) |  |  | (6,064) |
Long-term debt, excluding current maturities | $ | 729,413 |  |  | $ | 928,348 |

(1)The weighted average interest rates on borrowings outstanding under the Credit Agreement (defined below) as of November 30, 2023 and February 28, 2023 were 7.1% and 6.6%, respectively.
Capitalized Interest
During the three month period ended November 30, 2023, we incurred interest costs totaling $12.9 million, of which none was capitalized, compared to $14.8 million for the same period last year, of which we capitalized $1.7 million as part of property and equipment in connection with the construction of a new distribution facility. During the nine month periods ended November 30, 2023 and November 30, 2022, we incurred interest costs totaling $41.5 million and $30.0 million, respectively, of which we capitalized $0.9 million and $3.3 million, respectively, in connection with the previously mentioned distribution facility.
Credit Agreement
We have a credit agreement (the “Credit Agreement”) with Bank of America, N.A., as administrative agent, and other lenders that provides for an unsecured total revolving commitment of $1.25 billion and a $300 million accordion, which can be used for term loan commitments. In June 2022, we exercised $250 million of the $300 million accordion under the Credit Agreement and borrowed $250 million as term loans. The proceeds from the term loans were used to repay revolving loans under the Credit Agreement. The term loans are payable at the end of each fiscal quarter in equal installments of 0.625% of the term loans made, which began in the third quarter of fiscal 2023, with the remaining balance due at the maturity date. The maturity date of the term loans and the revolving loans under the Credit Agreement is March 13, 2025. Borrowings under the Credit Agreement bear floating interest at either the Base Rate or Term SOFR (as defined in the Credit Agreement), plus a margin based on the Net Leverage Ratio (as defined in the Credit Agreement) of 0% to 1.0% and 1.0% to 2.0% for Base Rate and Term SOFR borrowings, respectively, plus a credit spread of 0.10% for Term SOFR borrowings.
19

Table of Contents
The floating interest rates on our borrowings under the Credit Agreement are hedged with interest rate swaps to effectively fix interest rates on $625 million and $425 million of the outstanding principal balance under the revolving loans as of November 30, 2023 and February 28, 2023, respectively. See Notes 11, 12, and 13 for additional information regarding our interest rate swaps.
As of November 30, 2023, the balance of outstanding letters of credit was $15.5 million and the amount available for revolving loans under the Credit Agreement was $739.5 million. Covenants in the Credit Agreement limit the amount of total indebtedness we can incur. As of November 30, 2023, these covenants effectively limited our ability to incur more than $336.2 million of additional debt from all sources, including the Credit Agreement, or $569.6 million in the event a qualified acquisition is consummated.
Debt Covenants
As of November 30, 2023, we were in compliance with all covenants as defined under the terms of the Credit Agreement.
Note 11 - Fair Value
Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. Valuation techniques under the accounting guidance related to fair value measurements are based on observable and unobservable inputs. These inputs are classified into the following hierarchy:
Level 1:Quoted prices for identical assets or liabilities in active markets;
Level 2:Observable inputs other than quoted prices that are directly or indirectly observable for the asset or liability, including quoted prices for similar assets or liabilities in active markets; quoted prices for similar or identical assets or liabilities in markets that are not active; and model-derived valuations whose inputs are observable or whose significant value drivers are observable; and
Level 3:Unobservable inputs that reflect the reporting entity’s own assumptions.
All of our financial assets and liabilities, except for our investments in U.S. Treasury Bills, are classified as Level 2 because their valuation is dependent on observable inputs and other quoted prices for similar assets or liabilities, or model-derived valuations whose significant value drivers are observable. Our investments in U.S. Treasury Bills are classified as Level 1 because their value is based on quoted prices in active markets for identical assets.
20

Table of Contents
The following table presents the fair value of our financial assets and liabilities:

| Fair Value
(in thousands) | November 30, 2023 |  | February 28, 2023
Assets: |  |  |
Cash equivalents (money market accounts) | $ | 2,829 |  |  | $ | 381 |
U.S. Treasury Bills | 7,435 |  |  | — |
Interest rate swaps | 3,117 |  |  | 5,746 |
Foreign currency derivatives | 204 |  |  | 1,423 |
Total assets | $ | 13,585 |  |  | $ | 7,550 |
Liabilities: |  |  |
Foreign currency derivatives | 699 |  |  | 711 |
Total liabilities | $ | 699 |  |  | $ | 711 |

All of our financial assets and liabilities, except for our investments in U.S. Treasury Bills, are measured and recorded at fair value on a recurring basis. Our investments in U.S. Treasury Bills, are recorded at amortized cost. As of November 30, 2023, the current and non-current carrying amounts of our U.S. Treasury Bills were $2.4 million and $5.0 million, respectively, and were included within Prepaid expenses and other current assets and Other assets, respectively, in our condensed consolidated balance sheet.
The carrying amounts of cash, accounts payable, accrued expenses and other current liabilities and income taxes payable approximate fair value because of the short maturity of these items. The carrying amounts of receivables approximate fair value due to the effect of the related allowance for credit losses. The carrying amount of our floating rate long-term debt approximates its fair value.
Our investments in U.S. Treasury Bills are classified as held-to-maturity because we have the positive intent and ability to hold the securities to maturity. We invest in U.S. Treasury Bills with maturities ranging from one to three years. Gross unrealized gains and losses are not material for any period presented. During both the three and nine month periods ended November 30, 2023, we recognized interest income on these investments of $0.1 million, which is included in Non-operating income, net in our condensed consolidated statements of income.
We use derivatives to manage our exposure to changes in foreign currency exchange rates, which include foreign currency forward contracts and cross-currency debt swaps. In addition, we use interest rate swaps to manage our exposure to changes in interest rates. All of our derivative assets and liabilities are recorded at fair value. See Notes 12 and 13 for more information on our derivatives.
Note 12 - Financial Instruments and Risk Management
Foreign Currency Risk
The U.S. Dollar is the functional currency for the Company and all of its subsidiaries and is also the reporting currency for the Company. By operating internationally, we are subject to foreign currency risk from transactions denominated in currencies other than the U.S. Dollar (“foreign currencies”). Such transactions include sales and operating expenses. As a result of such transactions, portions of our cash, trade accounts receivable and trade accounts payable are denominated in foreign currencies. Approximately 14% of our net sales revenue was denominated in foreign currencies during both the three and nine month periods ended November 30, 2023, respectively, compared to 15% and 13% for the same periods last year, respectively. These sales were primarily denominated in Euros, British Pounds
21

Table of Contents
and Canadian Dollars. We make most of our inventory purchases from manufacturers in Asia and primarily use the U.S. Dollar for such purchases.
During the three and nine month periods ended November 30, 2023, we recorded foreign currency exchange rate net gains of $0.1 million and net losses of $0.3 million, respectively, in SG&A, compared to net gains of $1.1 million and net losses of $1.4 million for the same periods last year, respectively. We mitigate certain foreign currency exchange rate risk by using forward contracts and cross-currency debt swaps to protect against the foreign currency exchange rate risk inherent in our transactions denominated in foreign currencies. We do not enter into any derivatives or similar instruments for trading or other speculative purposes. Certain of our forward contracts are designated as cash flow hedges (“foreign currency contracts”) and are recorded on the balance sheet at fair value with changes in fair value recorded in Other Comprehensive Income (Loss) (“OCI”) until the hedge transaction is settled, at which point amounts are reclassified from Accumulated Other Comprehensive Income (Loss) (“AOCI”) to our condensed consolidated statements of income. Foreign currency derivatives for which we have not elected hedge accounting consist of certain forward contracts and cross-currency debt swaps, and any changes in the fair value of these derivatives are recorded in our condensed consolidated statements of income. These undesignated derivatives are used to hedge monetary net asset and liability positions. Cash flows from our foreign currency derivatives are classified as cash flows from operating activities in our condensed consolidated statements of cash flows, which is consistent with the classification of the cash flows from the underlying hedged item. We evaluate our derivatives designated as cash flow hedges each quarter to assess hedge effectiveness.
Interest Rate Risk
Interest on our outstanding debt as of November 30, 2023 is based on floating interest rates. If short-term interest rates increase, we will incur higher interest expense on any future outstanding balances of floating rate debt. Floating interest rates are hedged with interest rate swaps to effectively fix interest rates on a portion of our outstanding principal balance under the Credit Agreement, which totaled $737.2 million and $936.9 million as of November 30, 2023 and February 28, 2023, respectively. As of November 30, 2023 and February 28, 2023, $625.0 million and $425.0 million of the outstanding principal balance under the Credit Agreement, respectively, was hedged with interest rate swaps to fix the interest rate we pay. Our interest rate swaps are designated as cash flow hedges and are recorded on the balance sheet at fair value with changes in fair value recorded in OCI until the hedge transaction is settled, at which point amounts are reclassified from AOCI to our condensed consolidated statements of income. Cash flows from our interest rate swaps are classified as cash flows from operating activities in our condensed consolidated statements of cash flows, which is consistent with the classification of the cash flows from the underlying hedged item. We evaluate our derivatives designated as cash flow hedges each quarter to assess hedge effectiveness.
22

Table of Contents
The following tables summarize the fair values of our derivative instruments as of the end of the periods presented:

(in thousands) | November 30, 2023
Derivatives designated as hedging instruments | Hedge Type |  | Final Settlement Date |  | Notional Amount |  | Prepaid Expenses and Other Current Assets |  | Other Assets |  | Accrued Expenses and Other Current Liabilities |  | Other Liabilities, Non- Current
Forward contracts - sell Euro | Cash flow |  | 1/2025 |  | € | 32,000 |  |  | $ | — |  |  | $ | 44 |  |  | $ | 104 |  |  | $ | — |
Forward contracts - sell Canadian Dollars | Cash flow |  | 2/2025 |  | $ | 22,250 |  |  | 103 |  |  | 18 |  |  | — |  |  | 4 |
Forward contracts - sell Pounds | Cash flow |  | 2/2025 |  | £ | 26,760 |  |  | — |  |  | — |  |  | 474 |  |  | 53 |
Forward contracts - sell Norwegian Kroner | Cash flow |  | 2/2024 |  | kr | 5,000 |  |  | 39 |  |  | — |  |  | — |  |  | — |
Interest rate swaps | Cash flow |  | 2/2026 |  | $ | 625,000 |  |  | 2,006 |  |  | 1,111 |  |  | — |  |  | — |
Subtotal |  |  |  |  |  |  | 2,148 |  |  | 1,173 |  |  | 578 |  |  | 57 |
Derivatives not designated under hedge accounting |  |  |  |  |  |  |  |  |  |  |  |  |
Forward contracts - sell Euro | (1) |  | 12/2023 |  | € | 740 |  |  | — |  |  | — |  |  | 14 |  |  | — |
Forward contracts - sell Pounds | (1) |  | 12/2023 |  | £ | 1,400 |  |  | — |  |  | — |  |  | 50 |  |  | — |
Subtotal |  |  |  |  |  |  | — |  |  | — |  |  | 64 |  |  | — |
Total fair value |  |  |  |  |  |  | $ | 2,148 |  |  | $ | 1,173 |  |  | $ | 642 |  |  | $ | 57 |

(in thousands) | February 28, 2023
Derivatives designated as hedging instruments | Hedge Type |  | Final Settlement Date |  | Notional Amount |  | Prepaid Expenses and Other Current Assets |  | Other Assets |  | Accrued Expenses and Other Current Liabilities |  | Other Liabilities Non- Current
Forward contracts - sell Euro | Cash flow |  | 2/2024 |  | € | 29,310 |  |  | $ | 257 |  |  | $ | — |  |  | $ | — |  |  | $ | — |
Forward contracts - sell Canadian Dollars | Cash flow |  | 2/2024 |  | $ | 30,000 |  |  | 962 |  |  | 11 |  |  | — |  |  | — |
Forward contracts - sell Pounds | Cash flow |  | 1/2024 |  | £ | 19,400 |  |  | — |  |  | — |  |  | 711 |  |  | — |
Forward contracts - sell Norwegian Kroner | Cash flow |  | 2/2024 |  | kr | 40,000 |  |  | 185 |  |  | — |  |  | — |  |  | — |
Interest rate swaps | Cash flow |  | 2/2026 |  | $ | 425,000 |  |  | 3,941 |  |  | 1,805 |  |  | — |  |  | — |
Subtotal |  |  |  |  |  |  | 5,345 |  |  | 1,816 |  |  | 711 |  |  | — |
Derivatives not designated under hedge accounting |  |  |  |  |  |  |  |  |  |  |  |  |
Forward contracts - buy Euro | (1) |  | 3/2023 |  | € | 500 |  |  | 6 |  |  | — |  |  | — |  |  | — |
Forward contracts - buy Pounds | (1) |  | 3/2023 |  | £ | 400 |  |  | 2 |  |  | — |  |  | — |  |  | — |
Subtotal |  |  |  |  |  |  | 8 |  |  | — |  |  | — |  |  | — |
Total fair value |  |  |  |  |  |  | $ | 5,353 |  |  | $ | 1,816 |  |  | $ | 711 |  |  | $ | — |

(1)These forward contracts, for which we have not elected hedge accounting, hedge monetary net asset and liability positions for the notional amounts reported, creating an economic hedge against currency movements.
The pre-tax effects of derivative instruments designated as cash flow hedges were as follows for the periods presented:

| Three Months Ended November 30,
| Gain (Loss) Recognized in AOCI |  | Gain (Loss) Reclassified from AOCI into Income
(in thousands) | 2023 |  | 2022 |  | Location |  | 2023 |  | 2022
Foreign currency contracts - cash flow hedges | $ | 278 |  |  | $ | (685) |  |  | Sales revenue, net |  | $ | 212 |  |  | $ | 4,484 |
Interest rate swaps - cash flow hedges | 8 |  |  | 1,471 |  |  | Interest expense |  | 2,213 |  |  | 168 |
Total | $ | 286 |  |  | $ | 786 |  |  |  |  | $ | 2,425 |  |  | $ | 4,652 |

23

Table of Contents

| Nine Months Ended November 30,
| Gain (Loss) Recognized in AOCI |  | Gain (Loss) Reclassified from AOCI into Income
(in thousands) | 2023 |  | 2022 |  | Location |  | 2023 |  | 2022
Foreign currency contracts - cash flow hedges | $ | (968) |  |  | $ | 7,860 |  |  | Sales revenue, net |  | $ | 167 |  |  | $ | 8,395 |
Interest rate swaps - cash flow hedges | 3,018 |  |  | 5,100 |  |  | Interest expense |  | 5,647 |  |  | (793) |
Total | $ | 2,050 |  |  | $ | 12,960 |  |  |  |  | $ | 5,814 |  |  | $ | 7,602 |

The pre-tax effects of derivative instruments not designated under hedge accounting were as follows for the periods presented:

| Gain (Loss) Recognized in Income
|  |  | Three Months Ended November 30, |  | Nine Months Ended November 30,
(in thousands) | Location |  | 2023 |  | 2022 |  | 2023 |  | 2022
Forward contracts | SG&A |  | $ | (225) |  |  | $ | (12) |  |  | $ | (265) |  |  | $ | (262) |
Cross-currency debt swaps - principal | SG&A |  | — |  |  | — |  |  | — |  |  | 875 |
Total |  |  | $ | (225) |  |  | $ | (12) |  |  | $ | (265) |  |  | $ | 613 |

We expect a net gain of $1.6 million associated with foreign currency contracts and interest rate swaps currently recorded in AOCI to be reclassified into income over the next twelve months. The amount ultimately realized, however, will differ as exchange rates and interest rates change and the underlying contracts settle. See Notes 11 and 13 to these condensed consolidated financial statements for more information.
Counterparty Credit Risk
Financial instruments, including foreign currency contracts, forward contracts, cross-currency debt swaps and interest rate swaps, expose us to counterparty credit risk for non-performance. We manage our exposure to counterparty credit risk by only dealing with counterparties who are substantial international financial institutions with significant experience using such derivative instruments. We believe that the risk of incurring credit losses is remote.
24

Table of Contents
Note 13 - Accumulated Other Comprehensive Income (Loss)
The changes in AOCI by component and related tax effects for the periods presented were as follows:

(in thousands) | Interest Rate Swaps |  | Foreign Currency Contracts |  | Total
Balance at February 28, 2022 | $ | (2,126) |  |  | $ | 2,328 |  |  | $ | 202 |
Other comprehensive income before reclassification | 5,100 |  |  | 7,860 |  |  | 12,960 |
Amounts reclassified out of AOCI | 793 |  |  | (8,395) |  |  | (7,602) |
Tax effects | (1,391) |  |  | (30) |  |  | (1,421) |
Other comprehensive income (loss) | 4,502 |  |  | (565) |  |  | 3,937 |
Balance at November 30, 2022 | $ | 2,376 |  |  | $ | 1,763 |  |  | $ | 4,139 |
Balance at February 28, 2023 | $ | 4,394 |  |  | $ | 553 |  |  | $ | 4,947 |
Other comprehensive income (loss) before reclassification | 3,018 |  |  | (968) |  |  | 2,050 |
Amounts reclassified out of AOCI | (5,647) |  |  | (167) |  |  | (5,814) |
Tax effects | 619 |  |  | 256 |  |  | 875 |
Other comprehensive loss | (2,010) |  |  | (879) |  |  | (2,889) |
Balance at November 30, 2023 | $ | 2,384 |  |  | $ | (326) |  |  | $ | 2,058 |

See Notes 10, 11 and 12 to these condensed consolidated financial statements for additional information regarding our cash flow hedges.
Note 14 - Segment Information
We currently operate two reportable segments consisting of Home & Outdoor and Beauty & Wellness. During the fourth quarter of fiscal 2023, we made changes to the structure of our organization in connection with our global restructuring plan that resulted in our previous Health & Wellness and Beauty operating segments being combined into a single reportable segment, which is referred to herein as “Beauty & Wellness.” Comparative prior period segment information in this report has been recast to conform to this change in our reportable segments. See Note 1 to these condensed consolidated financial statements for additional information.
The following tables summarize segment information for the periods presented:

| Three Months Ended November 30, 2023
(in thousands) | Home & Outdoor |  |  |  |  |  | Beauty & Wellness |  | Total
Sales revenue, net | $ | 235,948 |  |  |  |  |  |  | $ | 313,666 |  |  | $ | 549,614 |
Restructuring charges | 583 |  |  |  |  |  |  | 3,307 |  |  | 3,890 |
Operating income | 49,514 |  |  |  |  |  |  | 57,413 |  |  | 106,927 |
Capital and intangible asset expenditures | 7,674 |  |  |  |  |  |  | 1,450 |  |  | 9,124 |
Depreciation and amortization | 6,025 |  |  |  |  |  |  | 6,406 |  |  | 12,431 |

| Three Months Ended November 30, 2022
(in thousands) | Home & Outdoor |  |  |  |  |  | Beauty & Wellness |  | Total
Sales revenue, net | $ | 228,937 |  |  |  |  |  |  | $ | 329,669 |  |  | $ | 558,606 |
Restructuring charges | 5,090 |  |  |  |  |  |  | 5,373 |  |  | 10,463 |
Operating income | 30,847 |  |  |  |  |  |  | 46,346 |  |  | 77,193 |
Capital and intangible asset expenditures | 28,788 |  |  |  |  |  |  | 4,771 |  |  | 33,559 |
Depreciation and amortization | 4,716 |  |  |  |  |  |  | 6,997 |  |  | 11,713 |

25

Table of Contents

| Nine Months Ended November 30, 2023
(in thousands) | Home & Outdoor |  |  |  |  |  | Beauty & Wellness |  | Total
Sales revenue, net | $ | 693,069 |  |  |  |  |  |  | $ | 822,780 |  |  | $ | 1,515,849 |
Restructuring charges | 4,644 |  |  |  |  |  |  | 10,218 |  |  | 14,862 |
Operating income | 107,729 |  |  |  |  |  |  | 86,684 |  |  | 194,413 |
Capital and intangible asset expenditures | 23,513 |  |  |  |  |  |  | 6,168 |  |  | 29,681 |
Depreciation and amortization | 17,033 |  |  |  |  |  |  | 20,004 |  |  | 37,037 |

| Nine Months Ended November 30, 2022
(in thousands) | Home & Outdoor |  |  |  |  |  | Beauty & Wellness |  | Total
Sales revenue, net | $ | 703,759 |  |  |  |  |  |  | $ | 884,325 |  |  | $ | 1,588,084 |
Restructuring charges | 5,562 |  |  |  |  |  |  | 9,679 |  |  | 15,241 |
Operating income | 102,722 |  |  |  |  |  |  | 55,356 |  |  | 158,078 |
Capital and intangible asset expenditures | 133,939 |  |  |  |  |  |  | 12,255 |  |  | 146,194 |
Depreciation and amortization | 13,704 |  |  |  |  |  |  | 19,626 |  |  | 33,330 |

The following table presents net sales revenue by geographic region, in U.S. Dollars:

| Three Months Ended November 30, |  | Nine Months Ended November 30,
(in thousands) | 2023 |  | 2022 |  | 2023 |  | 2022
Domestic sales revenue, net (1) | $ | 428,582 |  |  | 78.0 | % |  | $ | 437,894 |  |  | 78.4 | % |  | $ | 1,176,190 |  |  | 77.6 | % |  | $ | 1,254,545 |  |  | 79.0 | %
International sales revenue, net | 121,032 |  |  | 22.0 | % |  | 120,712 |  |  | 21.6 | % |  | 339,659 |  |  | 22.4 | % |  | 333,539 |  |  | 21.0 | %
Total sales revenue, net | $ | 549,614 |  |  | 100.0 | % |  | $ | 558,606 |  |  | 100.0 | % |  | $ | 1,515,849 |  |  | 100.0 | % |  | $ | 1,588,084 |  |  | 100.0 | %

(1)Beginning in the fourth quarter of fiscal 2023, we included net sales revenue from the U.S. and Canada as domestic net sales revenue. Previously, we reported sales revenue from Canada within international net sales revenue. We have recast the prior period domestic and international net sales revenue presented to conform with this current presentation.
Note 15 - Income Taxes
We reorganized the Company in Bermuda in 1994 and many of our foreign subsidiaries are not directly or indirectly owned by a U.S. parent. As such, a large portion of our foreign income is not subject to U.S. taxation on a permanent basis under current law. Additionally, our intellectual property is largely owned by foreign subsidiaries, resulting in proportionally higher earnings in jurisdictions with lower statutory tax rates, which decreases our overall effective tax rate. The taxable income earned in each jurisdiction, whether U.S. or foreign, is determined by the subsidiary's operating results and transfer pricing and tax regulations in the related jurisdictions.
For interim periods, our income tax expense and resulting effective tax rate are based upon an estimated annual effective tax rate adjusted for the effects of items required to be treated as discrete to the period, including changes in tax laws, changes in estimated exposures for uncertain tax positions and other items.
For the three months ended November 30, 2023, income tax expense as a percentage of income before income tax was 19.5% compared to 19.1% for the same period last year. The year-over-year increase in the effective tax rate is primarily due to tax expense recognized for the gain on the sale of our distribution and office facilities in El Paso, Texas during the third quarter of fiscal 2023 and an increase in tax expense for other discrete items, partially offset by shifts in the mix of income in our various tax jurisdictions. For the nine months ended November 30, 2023, income tax expense as a percentage of income before income tax was 18.4% compared to 18.6% for the same period last year primarily due to a decrease in tax expense for discrete items (excluding the gain on the sale of our El Paso facilities) and shifts in the mix of income in our various tax jurisdictions, partially offset by tax expense recognized for
26

Table of Contents
the gain on the sale of our distribution and office facilities in El Paso, Texas during the third quarter of fiscal 2023.
Note 16 - Earnings Per Share
We compute basic earnings per share using the weighted average number of shares of common stock outstanding during the period. We compute diluted earnings per share using the weighted average number of shares of common stock outstanding plus the effect of dilutive securities. Dilutive securities at any given point in time may consist of outstanding options to purchase common stock and issued and contingently issuable unvested restricted stock units, performance stock units, restricted stock awards and performance restricted stock awards and other stock-based awards. Anti-dilutive securities are not included in the computation of diluted earnings per share under the treasury stock method. See Note 6 to these condensed consolidated financial statements for more information regarding stock-based awards.
The following table presents our weighted average basic and diluted shares outstanding for the periods shown:

| Three Months Ended November 30, |  | Nine Months Ended November 30,
(in thousands) | 2023 |  | 2022 |  | 2023 |  | 2022
Weighted average shares outstanding, basic | 23,743 |  |  | 23,991 |  |  | 23,903 |  |  | 23,942 |
Incremental shares from share-based compensation arrangements | 70 |  |  | 87 |  |  | 93 |  |  | 144 |
Weighted average shares outstanding, diluted | 23,813 |  |  | 24,078 |  |  | 23,996 |  |  | 24,086 |
Anti-dilutive securities | 9 |  |  | 53 |  |  | 57 |  |  | 45 |

27

Table of Contents
ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
This Management’s Discussion and Analysis of Financial Condition and Results of Operations (“MD&A”) should be read in conjunction with our condensed consolidated financial statements included under Part I, Item 1., “Financial Statements.” The various sections of this MD&A contain a number of forward-looking statements, all of which are based on our current expectations. Actual results may differ materially due to a number of factors, including those discussed in the section entitled “Information Regarding Forward-Looking Statements” following this MD&A, and in Part I, Item 3., “Quantitative and Qualitative Disclosures About Market Risk” in this report, as well as in Part I, Item IA., “Risk Factors” in the Company’s most recent annual report on Form 10-K for the fiscal year ended February 28, 2023 (“Form 10-K”) and its other filings with the Securities and Exchange Commission (the “SEC”). When used in this MD&A, unless otherwise indicated or the context suggests otherwise, references to “the Company”, “our Company”, “Helen of Troy”, “we”, “us”, or “our” refer to Helen of Troy Limited and its subsidiaries. Throughout this MD&A, we refer to our Leadership Brands, which are brands that have number-one and number-two positions in their respective categories and include OXO, Hydro Flask, Osprey, Vicks, Braun, Honeywell, PUR, Hot Tools and Drybar.
This MD&A, including the tables under the headings “Operating Income, Operating Margin, Adjusted Operating Income (non-GAAP), and Adjusted Operating Margin (non-GAAP) by Segment” and “Net Income, Diluted EPS, Adjusted Income (non-GAAP), and Adjusted Diluted EPS (non-GAAP),” reports operating income, operating margin, net income and diluted earnings per share (“EPS”) without the impact of acquisition-related expenses, a charge for uncollectible receivables due to the bankruptcy of Bed, Bath & Beyond (“Bed, Bath & Beyond bankruptcy”), EPA compliance costs, gain from insurance recoveries, gain on sale of distribution and office facilities, restructuring charges, amortization of intangible assets, and non-cash share-based compensation for the periods presented, as applicable. These measures may be considered non-GAAP financial measures as defined by SEC Regulation G, Rule 100. The tables reconcile these measures to their corresponding GAAP-based financial measures presented in our condensed consolidated statements of income. We believe that adjusted operating income, adjusted operating margin, adjusted income, and adjusted diluted EPS provide useful information to management and investors regarding financial and business trends relating to our financial condition and results of operations. We believe that these non-GAAP financial measures, in combination with our financial results calculated in accordance with GAAP, provide investors with additional perspective regarding the impact of such charges and benefits on applicable income, margin and earnings per share measures. We also believe that these non-GAAP measures facilitate a more direct comparison of our performance to our competitors. We further believe that including the excluded charges and benefits would not accurately reflect the underlying performance of our operations for the period in which the charges and benefits are incurred, even though such charges and benefits may be incurred and reflected in our GAAP financial results in the near future. The material limitation associated with the use of the non-GAAP financial measures is that the non-GAAP measures do not reflect the full economic impact of our activities. Our adjusted operating income, adjusted operating margin, adjusted income, and adjusted diluted EPS are not prepared in accordance with GAAP, are not an alternative to GAAP financial measures and may be calculated differently than non-GAAP financial measures disclosed by other companies. Accordingly, undue reliance should not be placed on non-GAAP financial measures. These non-GAAP financial measures are discussed further and reconciled to their applicable GAAP-based financial measures contained in this MD&A beginning on page 44.
There were no material changes to the key financial measures discussed in our Form 10-K.
28

Table of Contents
Overview
We incorporated as Helen of Troy Corporation in Texas in 1968 and were reorganized as Helen of Troy Limited in Bermuda in 1994. We are a leading global consumer products company offering creative products and solutions for our customers through a diversified portfolio of brands. We have built leading market positions through new product innovation, product quality and competitive pricing. We currently operate two segments consisting of Home & Outdoor and Beauty & Wellness.
During the fourth quarter of fiscal 2023, we made changes to the structure of our organization in connection with our global restructuring plan (as further described below and in Note 8 to the accompanying condensed consolidated financial statements) that resulted in our previous Health & Wellness and Beauty operating segments being combined into a single reportable segment, which is referred to herein as “Beauty & Wellness.” In connection with these organizational structure changes, corresponding changes were made to how our business is managed, how results are reported internally and how our Chief Executive Officer (“CEO”), our chief operating decision maker, assesses performance and allocates resources. We believe that these changes better align internal resources and external go to market activities in order to create a more efficient and effective organizational structure. There were no changes to the products or brands included within our Home & Outdoor reportable segment as part of these organizational changes nor to the way in which our CEO assesses performance and allocates resources for the Home & Outdoor segment. As a result of these changes, our disclosures reflect two reportable segments, Home & Outdoor and Beauty & Wellness. Comparative prior period segment information in this report has been recast to conform to this change in our reportable segments. Our external reportable segments will continue to align with our internal reporting to enable users of the financial statements to better understand our performance, better assess our future net cash flows, and make more informed judgments about the Company as a whole.
Fiscal 2020 began Phase II of our transformation, which was designed to drive the next five years of progress. The long-term objectives of Phase II include improved organic sales growth, continued margin expansion, and strategic and effective capital deployment. Phase II includes continued investment in our Leadership Brands, with a focus on growing them through consumer-centric innovation, expanding them more aggressively outside the United States of America (the “U.S.”), and adding new brands through acquisition. We are building further shared service capability and operating efficiency, as well as focusing on attracting, retaining, unifying and training the best people. Additionally, we are continuing to enhance and consolidate our environmental, social and governance efforts and accelerate programs related to diversity, equity, inclusion and belonging to support our Phase II transformation.
During the second quarter of fiscal 2023, we focused on developing a global restructuring plan intended to expand operating margins through initiatives designed to improve efficiency and reduce costs (referred to as “Project Pegasus”). Project Pegasus includes initiatives to further optimize our brand portfolio, streamline and simplify the organization, accelerate cost of goods savings projects, enhance the efficiency of our supply chain network, optimize our indirect spending, and improve our cash flow and working capital, as well as other activities. We anticipate these initiatives will create operating efficiencies, as well as provide a platform to fund future growth investments. During the three and nine month periods ended November 30, 2023, we incurred $3.9 million and $14.9 million, respectively, of pre-tax restructuring costs in connection with Project Pegasus, which were recorded as “Restructuring charges” in the condensed consolidated statements of income. We recognized $10.5 million and $15.2 million of pre-tax restructuring costs during the three and nine month periods ended November 30, 2022, respectively, in connection with Project Pegasus. See further discussion below within “Significant Trends Impacting the Business” under “Project Pegasus” and Note 8 to the accompanying condensed consolidated financial statements.
29

Table of Contents
On April 22, 2022, we completed the acquisition of Recipe Products Ltd., a producer of innovative prestige hair care products for all types of curly and wavy hair under the Curlsmith brand (“Curlsmith”). The Curlsmith brand and products were added to the Beauty & Wellness segment. The total purchase consideration was $147.9 million in cash, net of a final net working capital adjustment and cash acquired.
On March 30, 2022, a third-party facility that we utilized for inventory storage incurred severe damage from a weather-related incident. The inventory that was stored at this facility primarily related to our Beauty & Wellness segment. While the inventory was insured, some seasonal inventory and inventory designated for specific customer promotions was not accessible and subsequently determined to be damaged, and as a result, unfavorably impacted our net sales revenue during the first quarter of fiscal 2023. As a result of the damages to the inventory stored at the facility, we recorded a charge to write-off the damaged inventory totaling $34.4 million during the first quarter of fiscal 2023. These charges were fully offset by probable insurance recoveries of $34.4 million also recorded during the first quarter of fiscal 2023, which represented anticipated insurance proceeds, not to exceed the amount of the associated losses, for which receipt was deemed probable. The charges for the damaged inventory and the expected insurance recoveries are included in cost of goods sold in our condensed consolidated statement of income for the nine months ended November 30, 2022. During the third quarter of fiscal
2023, we received proceeds of $34.5 million from our insurance carriers related to this incident which were included in cash flows from operating activities in our condensed consolidated statement of cash flows for the nine months ended November 30, 2022. The Company also received final confirmation from our insurance carriers during the third quarter of fiscal 2023 of an additional $11.5 million in proceeds, which was collected during December 2022. As a result, during the third quarter of fiscal 2023, the Company recorded a gain of $9.7 million, net of costs incurred to dispose of the inventory, as a reduction of SG&A expense in our condensed consolidated statement of income.
On September 28, 2023, we completed the sale of our distribution and office facilities in El Paso, Texas for a sales price of $50.6 million, less transaction costs of $1.1 million. Concurrently, we entered into an agreement to leaseback the office facilities for a period of up to 18 months substantially rent free, which we estimated to have a fair value of approximately $1.9 million. The transaction qualified for sales recognition under the sale leaseback accounting requirements. Accordingly, we increased the sales price by the $1.9 million of prepaid rent and recognized a gain on the sale of $34.2 million within SG&A during the third quarter of fiscal year 2024, of which $18.0 million and $16.2 million was recognized by our Beauty & Wellness and Home & Outdoor segments, respectively. The related property and equipment totaling $17.2 million, net of accumulated depreciation of $36.8 million, was derecognized from the consolidated balance sheet, and at lease commencement, we recorded an operating lease asset, which includes the imputed rent payments described above, and an operating lease liability. We used the proceeds from the sale to repay amounts outstanding under our long-term debt agreement.
Significant Trends Impacting the Business
Project Pegasus
During the second quarter of fiscal 2023, we focused on developing Project Pegasus, a global restructuring plan intended to expand operating margins through initiatives designed to improve efficiency and reduce costs. Project Pegasus includes initiatives to further optimize our brand portfolio, streamline and simplify the organization, accelerate cost of goods savings projects, enhance the efficiency of our supply chain network, optimize our indirect spending, and improve our cash flow and working capital, as well as other activities. We anticipate these initiatives will create operating efficiencies, as well as provide a platform to fund future growth investments.
As part of our initiative focused on streamlining and simplifying the organization, we made further changes to the structure of our organization, during the fourth quarter of fiscal 2023, which include the creation of a North America Regional Market Organization (“RMO”) responsible for sales and go to
30

Table of Contents
market strategies for all categories and channels in the U.S. and Canada, and further centralization of certain functions under shared services, particularly in operations and finance to better support our business segments and RMOs. This new structure, inclusive of the organizational structure changes described above resulting in the reportable segment change, will reduce the size of our global workforce by approximately 10%. The majority of these role reductions were completed by March 1, 2023. We believe that these changes better focus business segment resources on brand development, consumer-centric innovation and marketing, the RMOs on sales and go to market strategies, and shared services on their respective areas of expertise while also creating a more efficient and effective organizational structure.
During the second quarter of fiscal 2024, we announced plans to geographically consolidate the U.S. Beauty business, currently located in El Paso, Texas, and Irvine, California, and co-locate it with our Wellness business in the Boston, Massachusetts area. This geographical consolidation and relocation is the next step in our initiative to streamline and simplify the organization and it is expected to be completed during fiscal 2025. We expect these changes will enable a greater opportunity to capture synergies and enhance collaboration and innovation within the Beauty & Wellness segment.
As previously disclosed, we continue to have the following expectations regarding Project Pegasus charges:
•Total one-time pre-tax restructuring charges of approximately $60 million to $65 million over the duration of the plan, expected to be completed during fiscal 2025.
•Pre-tax restructuring charges to be comprised of approximately $22 million to $25 million of severance and employee related costs, $30 million of professional fees, $5 million of contract termination costs, and $3 million to $5 million of other exit and disposal costs.
•All of our operating segments and shared services will be impacted by the plan and pre-tax restructuring charges include approximately $17 million to $19 million in Home & Outdoor and $43 million to $46 million in Beauty & Wellness.
•Pre-tax restructuring charges represent primarily cash expenditures, which are expected to be substantially paid by the end of fiscal 2025.
We also continue to have the following expectations regarding Project Pegasus savings:
•Targeted annualized pre-tax operating profit improvements of approximately $75 million to $85 million, which began in fiscal 2024 and we expect to be substantially achieved by the end of fiscal 2026.
•Estimated cadence of the recognition of the savings will be approximately 25% in fiscal 2024, approximately 50% in fiscal 2025 and approximately 25% in fiscal 2026.
•Total profit improvements to be realized approximately 60% through reduced cost of goods sold and 40% through lower SG&A.
In addition, we implemented plans to reduce inventory levels, increase inventory turns, and improve cash flow and working capital during the second quarter of fiscal 2023. Improvements related to these initiatives began in the second half of fiscal 2023, and have continued during fiscal 2024. During the nine month period ended November 30, 2023, our gross margin and operating margins have been favorably impacted by our SKU rationalization efforts in Beauty & Wellness. In addition, during the third quarter of fiscal 2024, we had lower salary and wage costs primarily as a result of our Project Pegasus role reductions despite higher annual merit increases. Expectations regarding our Project Pegasus initiatives and our ability to realize targeted savings, including expectations concerning costs and savings, are based on management’s estimates available at the time and are subject to a number of assumptions that could materially impact our estimates.
During the three and nine month periods ended November 30, 2023, we incurred $3.9 million and $14.9 million, respectively, of pre-tax restructuring costs in connection with Project Pegasus, which were
31

Table of Contents
recorded as “Restructuring charges” in the condensed consolidated statements of income. We recognized $10.5 million and $15.2 million of pre-tax restructuring costs during the three and nine month periods ended November 30, 2022, respectively, in connection with Project Pegasus. We made total cash restructuring payments of $17.5 million and $5.4 million during the nine month periods ended November 30, 2023 and November 30, 2022, respectively, and had a remaining liability of $3.9 million as of November 30, 2023. See Note 8 to the accompanying condensed consolidated financial statements for additional information.
Water Filtration Patent Litigation
On December 23, 2021, Brita LP filed a complaint against Kaz USA, Inc. and Helen of Troy Limited in the United States District Court for the Western District of Texas (the “Patent Litigation”), alleging patent infringement by the Company relating to its PUR gravity-fed water filtration systems. Brita LP simultaneously filed a complaint with the United States International Trade Commission (“ITC”) against Kaz USA, Inc., Helen of Troy Limited and five other unrelated companies that sell water filtration systems (the “ITC Action”). The complaint in the ITC Action also alleges patent infringement by the Company with respect to a limited set of PUR gravity-fed water filtration systems. This action seeks injunctive relief to prevent entry of certain accused PUR products (and certain other products) into the U.S. and cessation of marketing and sales of existing inventory that is already in the U.S. On February 28, 2023, the ITC issued an Initial Determination in the ITC Action, tentatively ruling against Kaz USA, Inc. and the other unrelated respondents. The ITC has a guaranteed review process, and thus all respondents, including Kaz USA, Inc., filed a petition with the ITC for a full review of the Initial Determination. On September 19, 2023, the ITC issued its Final Determination in the Company’s favor. The ITC determined there was no violation by the Company and terminated the investigation. Brita LP is appealing the ITC's decision to the Federal Circuit (“CAFC Appeal”) and filed its Notice of Appeal on October 24, 2023. The Company intervened in the CAFC Appeal, but as of the date of the filing of this Form 10-Q, no hearings have been scheduled. The Patent Litigation remains stayed for the time being. We cannot predict the outcome of these legal proceedings, the amount or range of any potential loss, when the proceedings will be resolved, or customer acceptance of any replacement water filter. Litigation is inherently unpredictable, and the resolution or disposition of these proceedings could, if adversely determined, have a material and adverse impact on our financial position and results of operations. For additional information regarding the Patent Litigation and the ITC Action, see Note 9 to the accompanying condensed consolidated financial statements.
Impact of Macroeconomic Trends
The Federal Open Market Committee increased the benchmark interest rate by 75 basis points to date during fiscal 2024 and by 450 basis points during fiscal year 2023. As a result, we incurred higher average interest rates during the first three quarters of fiscal 2024 compared to the same periods last year, and we expect this trend to continue during the remainder of fiscal 2024. While the actual timing and extent of future changes in interest rates remains unknown, higher average interest rates are expected to increase interest expense on our outstanding debt. The financial markets, the global economy and global supply chain may also be adversely affected by the current or anticipated impact of military conflict, including the current conflict between Hamas and Israel and the ongoing conflict between Russia and Ukraine, or other geopolitical events. High inflation and interest rates have also negatively impacted consumer disposable income, credit availability and spending, among others, which have adversely impacted our business, financial condition, cash flows and results of operations during the first three quarters of fiscal 2024 and may continue to have an adverse impact during the remainder of fiscal year 2024. See further discussion below under “Consumer Spending and Changes in Shopping Preferences.” We expect continued uncertainty in our business and the global economy due to pressure from inflation, volatility in employment trends and consumer confidence, any of which may adversely impact our results.
32

Table of Contents
Consumer Spending and Changes in Shopping Preference s
Our business depends upon discretionary consumer demand for most of our products and primarily operates within mature and highly developed consumer markets. The principal driver of our operating performance is the strength of the U.S. retail economy. Approximately 74% of our consolidated net sales revenue was from U.S. shipments during both the three month periods ended November 30, 2023 and 2022.
For the nine month periods ended November 30, 2023 and 2022, U.S. shipments were approximately 73% and 74% of our consolidated net sales revenue, respectively.
Among other things, high levels of inflation and interest rates may negatively impact consumer disposable income, credit availability and spending. Consumer purchases of discretionary items, including the products that we offer, generally decline during recessionary periods or periods of economic uncertainty, when disposable income is reduced or when there is a reduction in consumer confidence. Dynamic changes in consumer spending and shopping patterns are also having an impact on retailer inventory levels. Our ability to sell to retailers is predicated on their ability to sell to the end consumer. During fiscal year 2023, we experienced an adverse impact on orders from retail customers as they aimed to rebalance their inventory levels due to lower consumer demand and shifts in consumer spending patterns. We experienced some improvement in replenishment orders from certain retail customers in certain product categories during the first three quarters of fiscal 2024. If orders from our retail customers continue to be adversely impacted, our sales, results of operations and cash flows may continue to be adversely impacted. We expect continued uncertainty in our business and the global economy due to inflation and changes in consumer spending patterns. Accordingly, our liquidity and financial results could be impacted in ways that we are not able to predict today.
Our concentration of sales reflects the evolution of consumer shopping preferences to online or multichannel shopping experiences. Our net sales to retail customers fulfilling end-consumer online orders and online sales directly to consumers comprised approximately 31% and 28% of our total consolidated net sales revenue for the three and nine month periods ended November 30, 2023, respectively, and grew approximately 15% and 14%, respectively, compared to the same periods in the prior year. For the three and nine month periods ended November 30, 2022, our net sales to retail customers fulfilling end-consumer online orders and online sales directly to consumers comprised approximately 26% and 23% of our total consolidated net sales revenue, respectively, and grew approximately 3% and 1% as compared to the same periods in the prior year, respectively.
With the continued importance of online sales in the retail landscape, many brick and mortar retailers are aggressively looking for ways to improve their customer delivery capabilities to be able to meet customer expectations. As a result, it has become increasingly important for us to leverage our distribution capabilities in order to meet the changing demands of our customers, including increasing our online capabilities to support our direct-to-consumer sales channels and online channel sales by our retail customers. In March 2023, we completed the construction of an additional distribution facility in Gallaway, Tennessee that became operational during the first quarter of fiscal 2024 and includes state-of-the-art automation. Additionally, we continue to invest in a centralized cloud-based e-commerce platform that we anticipate will enable us to leverage a common system and rapidly deploy new capabilities across all of our brands, as well as more easily integrate new brands. We anticipate this platform will enhance the customer experience by strengthening the digital presentation and product browsing capabilities and improving the checkout process, order delivery and post-order customer care.
EPA Compliance Costs
Some of our product lines are subject to product identification, labeling and claim requirements, which are monitored and enforced by regulatory agencies, such as the U.S. Environmental Protection Agency (the
33

Table of Contents
“EPA”), U.S. Customs and Border Protection, the U.S. Food and Drug Administration, and the U.S. Consumer Product Safety Commission.
During fiscal 2022, we were in discussions with the EPA regarding the compliance of packaging claims on certain of our products in the air and water filtration categories and a limited subset of humidifier products within the Beauty & Wellness segment that are sold in the U.S. The EPA did not raise any product quality, safety or performance issues. As a result of these packaging compliance discussions, we voluntarily implemented a temporary stop shipment action on the impacted products as we worked with the EPA towards an expedient resolution. We resumed normalized levels of shipping of the affected inventory during fiscal 2022 and we completed the repackaging and relabeling of our existing inventory of impacted products during fiscal 2023. Additionally, as a result of continuing dialogue with the EPA, we executed further repackaging and relabeling plans on certain additional humidifier products and certain additional air filtration products, which were also completed during fiscal 2023.
We recorded charges to cost of goods sold to write-off obsolete packaging for the affected products in our inventory on-hand and in-transit. We have also incurred additional compliance costs comprised of obsolete packaging, storage and other charges from vendors, which were recognized in cost of goods sold and incremental warehouse storage costs and legal fees, which were recognized in SG&A. We refer to these charges as “EPA compliance costs.” The following table provides a summary of EPA compliance costs incurred during the periods presented:

| Three Months Ended November 30, |  | Nine Months Ended November 30,
(in thousands) | 2023 |  | 2022 |  | 2023 |  | 2022
Cost of goods sold | $ | — |  |  | $ | 370 |  |  | $ | — |  |  |  | $ | 16,928 |  | 1
SG&A | — |  |  | 1,733 |  |  | — |  |  |  | 5,173 |  |
Total EPA compliance costs | $ | — |  |  | $ | 2,103 |  |  | $ | — |  |  |  | $ | 22,101 |  |

(1)Includes a $4.4 million charge to write-off the obsolete packaging for the affected additional humidifier products and affected additional air filtration products in our inventory on-hand and in-transit as of the end of the first quarter of fiscal 2023.
In addition, we incurred and capitalized into inventory costs to repackage a portion of our existing inventory of the affected products beginning in the second quarter of fiscal 2022 through completion of the repackaging in the third quarter of fiscal 2023.
Although we are not aware of any fines or penalties imposed against us by the EPA related to this matter, there can be no assurances that such fines or penalties will not be imposed in the future.
See Note 9 to our condensed consolidated financial statements for additional information.
Foreign Currency Exchange Rate Fluctuations
Due to the nature of our operations, we have exposure to the impact of fluctuations in exchange rates from transactions that are denominated in a currency other than our functional currency (the U.S. Dollar). Such transactions include sales and operating expenses. The most significant currencies affecting our operating results are the Euro, British Pound and Canadian Dollar.
For the three months ended November 30, 2023, changes in foreign currency exchange rates had a favorable year-over-year impact on consolidated U.S. Dollar reported net sales revenue of approximately $4.6 million, or 0.8%, compared to an unfavorable year-over-year impact of $7.1 million, or 1.1%, for the same period last year. For the nine months ended November 30, 2023, changes in foreign currency exchange rates had a favorable year-over-year impact on consolidated U.S. Dollar reported net sales revenue of approximately $5.4 million, or 0.3%, compared to an unfavorable year-over-year impact of $14.8 million, or 0.9% for the same period last year.
34

Table of Contents
Variability of the Cough/Cold/Flu Season
Sales in several of our Beauty & Wellness segment categories are highly correlated to the severity of winter weather and cough/cold/flu incidence. In the U.S., the cough/cold/flu season historically runs from November through March, with peak activity normally in January to March. The 2022-2023 cough/cold/flu season was above historical averages, primarily early in the season, as respiratory infections surged in both children and adults and COVID-19 continued to be prevalent. The 2021-2022 cough/cold/flu season was below historical averages.
35

Table of Contents
RESULTS OF OPERATIONS
The following table provides selected operating data, in U.S. Dollars, as a percentage of net sales revenue, and as a year-over-year percentage change.

| Three Months Ended November 30, |  |  |  |  |  | % of Sales Revenue, net
(in thousands) | 2023 (1) |  | 2022 (1) |  | $ Change |  | % Change |  | 2023 |  | 2022
Sales revenue by segment, net |  |  |  |  |  |  |  |  |  |  |
Home & Outdoor | $ | 235,948 |  |  | $ | 228,937 |  |  | $ | 7,011 |  |  | 3.1 | % |  | 42.9 | % |  | 41.0 | %
Beauty & Wellness | 313,666 |  |  | 329,669 |  |  | (16,003) |  |  | (4.9) | % |  | 57.1 | % |  | 59.0 | %
Total sales revenue, net | 549,614 |  |  | 558,606 |  |  | (8,992) |  |  | (1.6) | % |  | 100.0 | % |  | 100.0 | %
Cost of goods sold | 285,833 |  |  | 301,930 |  |  | (16,097) |  |  | (5.3) | % |  | 52.0 | % |  | 54.1 | %
Gross profit | 263,781 |  |  | 256,676 |  |  | 7,105 |  |  | 2.8 | % |  | 48.0 | % |  | 45.9 | %
SG&A | 152,964 |  |  | 169,020 |  |  | (16,056) |  |  | (9.5) | % |  | 27.8 | % |  | 30.3 | %
Restructuring charges | 3,890 |  |  | 10,463 |  |  | (6,573) |  |  | (62.8) | % |  | 0.7 | % |  | 1.9 | %
Operating income | 106,927 |  |  | 77,193 |  |  | 29,734 |  |  | 38.5 | % |  | 19.5 | % |  | 13.8 | %
Non-operating income, net | 180 |  |  | 5 |  |  | 175 |  |  | * |  | — | % |  | — | %
Interest expense | 12,859 |  |  | 13,149 |  |  | (290) |  |  | (2.2) | % |  | 2.3 | % |  | 2.4 | %
Income before income tax | 94,248 |  |  | 64,049 |  |  | 30,199 |  |  | 47.1 | % |  | 17.1 | % |  | 11.5 | %
Income tax expense | 18,350 |  |  | 12,223 |  |  | 6,127 |  |  | 50.1 | % |  | 3.3 | % |  | 2.2 | %
Net income | $ | 75,898 |  |  | $ | 51,826 |  |  | $ | 24,072 |  |  | 46.4 | % |  | 13.8 | % |  | 9.3 | %
| Nine Months Ended November 30, |  |  |  |  |  | % of Sales Revenue, net
(in thousands) | 2023 (1) |  | 2022 (1) |  | $ Change |  | % Change |  | 2023 |  | 2022
Sales revenue by segment, net |  |  |  |  |  |  |  |  |  |  |
Home & Outdoor | $ | 693,069 |  |  | $ | 703,759 |  |  | $ | (10,690) |  |  | (1.5) | % |  | 45.7 | % |  | 44.3 | %
Beauty & Wellness | 822,780 |  |  | 884,325 |  |  | (61,545) |  |  | (7.0) | % |  | 54.3 | % |  | 55.7 | %
Total sales revenue, net | 1,515,849 |  |  | 1,588,084 |  |  | (72,235) |  |  | (4.5) | % |  | 100.0 | % |  | 100.0 | %
Cost of goods sold | 806,784 |  |  | 898,791 |  |  | (92,007) |  |  | (10.2) | % |  | 53.2 | % |  | 56.6 | %
Gross profit | 709,065 |  |  | 689,293 |  |  | 19,772 |  |  | 2.9 | % |  | 46.8 | % |  | 43.4 | %
SG&A | 499,790 |  |  | 515,974 |  |  | (16,184) |  |  | (3.1) | % |  | 33.0 | % |  | 32.5 | %
Restructuring charges | 14,862 |  |  | 15,241 |  |  | (379) |  |  | (2.5) | % |  | 1.0 | % |  | 1.0 | %
Operating income | 194,413 |  |  | 158,078 |  |  | 36,335 |  |  | 23.0 | % |  | 12.8 | % |  | 10.0 | %
Non-operating income, net | 465 |  |  | 185 |  |  | 280 |  |  | * |  | — | % |  | — | %
Interest expense | 40,565 |  |  | 26,688 |  |  | 13,877 |  |  | 52.0 | % |  | 2.7 | % |  | 1.7 | %
Income before income tax | 154,313 |  |  | 131,575 |  |  | 22,738 |  |  | 17.3 | % |  | 10.2 | % |  | 8.3 | %
Income tax expense | 28,453 |  |  | 24,482 |  |  | 3,971 |  |  | 16.2 | % |  | 1.9 | % |  | 1.5 | %
Net income | $ | 125,860 |  |  | $ | 107,093 |  |  | $ | 18,767 |  |  | 17.5 | % |  | 8.3 | % |  | 6.7 | %

(1)The three and nine month periods ended November 30, 2023 includes a full three and nine months, respectively, of operating results from Curlsmith, acquired on April 22, 2022, compared to approximately thirteen and thirty-two weeks of operating results in the three and nine month periods ended November 30, 2022, respectively. For additional information see Note 4 to the accompanying condensed consolidated financial statements.
* Calculation is not meaningful.
36

Table of Contents
Third Quarter Fiscal 2024 Financial Results
•Consolidated net sales revenue decreased 1.6%, or $9.0 million, to $549.6 million for the three months ended November 30, 2023, compared to $558.6 million for the same period last year.
•Consolidated operating income increased 38.5%, or $29.7 million, to $106.9 million for the three months ended November 30, 2023, compared to $77.2 million for the same period last year. Consolidated operating margin increased 5.7 percentage points to 19.5% of consolidated net sales revenue for the three months ended November 30, 2023, compared to 13.8% for the same period last year.
•Consolidated adjusted operating income decreased 3.1%, or $2.9 million, to $89.8 million for the three months ended November 30, 2023, compared to $92.7 million for the same period last year. Consolidated adjusted operating margin decreased 0.3 percentage points to 16.3% of consolidated net sales revenue for the three months ended November 30, 2023, compared to 16.6% for the same period last year.
•Net income increased 46.4%, or $24.1 million, to $75.9 million for the three months ended November 30, 2023, compared to $51.8 million for the same period last year. Diluted EPS increased 48.4% to $3.19 for the three months ended November 30, 2023, compared to $2.15 for the same period last year.
•Adjusted income increased 0.2%, or $0.1 million, to $66.4 million for the three months ended November 30, 2023, compared to $66.3 million for the same period last year. Adjusted diluted EPS increased 1.5% to $2.79 for the three months ended November 30, 2023, compared to $2.75 for the same period last year.
Year-To-Date Fiscal 2024 Financial Results
•Consolidated net sales revenue decreased 4.5%, or $72.2 million, to $1,515.8 million for the nine months ended November 30, 2023, compared to $1,588.1 million for the same period last year.
•Consolidated operating income increased 23.0%, or $36.3 million, to $194.4 million for the nine months ended November 30, 2023, compared to $158.1 million for the same period last year. Consolidated operating margin increased 2.8 percentage points to 12.8% of consolidated net sales revenue for the nine months ended November 30, 2023, compared to 10.0% for the same period last year.
•Consolidated adjusted operating income decreased 6.8%, or $16.0 million, to $218.3 million for the nine months ended November 30, 2023, compared to $234.2 million for the same period last year. Consolidated adjusted operating margin decreased 0.4 percentage points to 14.4% of consolidated net sales revenue for the nine months ended November 30, 2023, compared to 14.8% for the same period last year.
•Net income increased 17.5%, or $18.8 million, to $125.9 million for the nine months ended November 30, 2023, compared to $107.1 million for the same period last year. Diluted EPS increased 18.0% to $5.25 for the nine months ended November 30, 2023, compared to $4.45 for the same period last year.
•Adjusted income decreased 13.5%, or $24.3 million, to 154.9 million for the nine months ended November 30, 2023, compared to $179.1 million for the same period last year. Adjusted diluted
37

Table of Contents
EPS decreased 13.3% to $6.45 for the nine months ended November 30, 2023, compared to $7.44 for the same period last year.
Consolidated and Segment Net Sales Revenue
The following table summarizes the impact that Organic business, foreign currency and acquisitions had on our net sales revenue by segment:

| Three Months Ended November 30,
(in thousands) | Home & Outdoor |  |  |  |  |  | Beauty & Wellness |  | Total
Fiscal 2023 sales revenue, net | $ | 228,937 |  |  |  |  |  |  | $ | 329,669 |  |  | $ | 558,606 |
Organic business | 4,518 |  |  |  |  |  |  | (18,076) |  |  | (13,558) |
Impact of foreign currency | 2,493 |  |  |  |  |  |  | 2,073 |  |  | 4,566 |
Change in sales revenue, net | 7,011 |  |  |  |  |  |  | (16,003) |  |  | (8,992) |
Fiscal 2024 sales revenue, net | $ | 235,948 |  |  |  |  |  |  | $ | 313,666 |  |  | $ | 549,614 |
Total net sales revenue growth (decline) | 3.1 | % |  |  |  |  |  | (4.9) | % |  | (1.6) | %
Organic business | 2.0 | % |  |  |  |  |  | (5.5) | % |  | (2.4) | %
Impact of foreign currency | 1.1 | % |  |  |  |  |  | 0.6 | % |  | 0.8 | %

| Nine Months Ended November 30,
(in thousands) | Home & Outdoor |  |  |  |  |  | Beauty & Wellness |  | Total
Fiscal 2023 sales revenue, net | $ | 703,759 |  |  |  |  |  |  | $ | 884,325 |  |  | $ | 1,588,084 |
Organic business | (13,317) |  |  |  |  |  |  | (70,448) |  |  | (83,765) |
Impact of foreign currency | 2,627 |  |  |  |  |  |  | 2,801 |  |  | 5,428 |
Acquisition (1) | — |  |  |  |  |  |  | 6,102 |  |  | 6,102 |
Change in sales revenue, net | (10,690) |  |  |  |  |  |  | (61,545) |  |  | (72,235) |
Fiscal 2024 sales revenue, net | $ | 693,069 |  |  |  |  |  |  | $ | 822,780 |  |  | $ | 1,515,849 |
Total net sales revenue growth (decline) | (1.5) | % |  |  |  |  |  | (7.0) | % |  | (4.5) | %
Organic business | (1.9) | % |  |  |  |  |  | (8.0) | % |  | (5.3) | %
Impact of foreign currency | 0.4 | % |  |  |  |  |  | 0.3 | % |  | 0.3 | %
Acquisition | — | % |  |  |  |  |  | 0.7 | % |  | 0.4 | %

(1)On April 22, 2022, we completed the acquisition of Curlsmith. Curlsmith sales prior to the first annual anniversary of the acquisition are reported in Acquisition for the Beauty & Wellness segment in the nine month period ended November 30, 2023 and consist of approximately seven weeks of incremental operating results. For additional information see Note 4 to the accompanying condensed consolidated financial statements.
In the above tables, Organic business refers to our net sales revenue associated with product lines or brands after the first twelve months from the date the product line or brand was acquired, excluding the impact that foreign currency remeasurement had on reported net sales revenue. Net sales revenue from internally developed brands or product lines is considered Organic business activity.
38

Table of Contents
Leadership Brand and Other Net Sales Revenue
The following table summarizes our Leadership Brand and other net sales revenue:

| Three Months Ended November 30,
(in thousands) | 2023 |  | 2022 |  | $ Change |  | % Change
Leadership Brand sales revenue, net | $ | 457,700 |  |  | $ | 451,500 |  |  | $ | 6,200 |  |  | 1.4 | %
All other sales revenue, net | 91,914 |  |  | 107,106 |  |  | (15,192) |  |  | (14.2) | %
Total sales revenue, net | $ | 549,614 |  |  | $ | 558,606 |  |  | $ | (8,992) |  |  | (1.6) | %

| Nine Months Ended November 30,
(in thousands) | 2023 |  | 2022 |  | $ Change |  | % Change
Leadership Brand sales revenue, net | $ | 1,289,027 |  |  | $ | 1,338,849 |  |  | $ | (49,822) |  |  | (3.7) | %
All other sales revenue, net | 226,822 |  |  | 249,235 |  |  | (22,413) |  |  | (9.0) | %
Total sales revenue, net | $ | 1,515,849 |  |  | $ | 1,588,084 |  |  | $ | (72,235) |  |  | (4.5) | %

Consolidated Net Sales Revenue
Comparison of Third Quarter Fiscal 2024 to Third Quarter Fiscal 2023
Consolidated net sales revenue decreased $9.0 million, or 1.6%, to $549.6 million, compared to $558.6 million, primarily driven by a decrease from Organic business of $13.6 million, or 2.4%. The decline in Organic business was primarily due to:
•a decline in sales of hair appliance, humidification and air filtration products in Beauty & Wellness primarily driven by softer consumer demand, a later start to the illness season, and our SKU rationalization efforts; and
•a brick and mortar sales decline in the insulated beverageware category in Home & Outdoor.
These factors were partially offset by:
•an increase in consolidated online channel sales;
•stronger consumer demand for products in the home and travel categories in Home & Outdoor; and
•higher sales of thermometry, heaters, and water filtration products in Beauty & Wellness.
Net sales revenue was favorably impacted by net foreign currency fluctuations of approximately $4.6 million, or 0.8%.
Net sales revenue from our Leadership Brands was $457.7 million, compared to $451.5 million for the same period last year, representing an increase of 1.4%.
Comparison of First Nine Months of Fiscal 2024 to First Nine Months of Fiscal 2023
Consolidated net sales revenue decreased $72.2 million, or 4.5%, to $1,515.8 million, compared to $1,588.1 million, primarily driven by a decrease from Organic business of $83.8 million, or 5.3%. The decline in Organic business was primarily due to:
•lower sales of fans, heaters, humidification and air filtration products in Beauty & Wellness primarily driven by softer consumer demand, our SKU rationalization efforts, and reduced orders from retail customers as they rebalance trade inventory in line with softer consumer demand in certain categories;
•a decline in Home & Outdoor primarily due to lower home category sales in the club and closeout channels and lower brick and mortar sales in the insulated beverageware category; and
•a decline in sales of hair appliances in Beauty & Wellness.
39

Table of Contents
These factors were partially offset by:
•an increase in consolidated online channel sales reflecting improved replenishment orders from certain retail customers;
•stronger consumer demand for travel-related products in Home & Outdoor; and
•growth in sales of thermometry which drove higher international sales.
The Curlsmith acquisition contributed $6.1 million, or 0.4%, to consolidated net sales revenue growth.
Net sales revenue was favorably impacted by net foreign currency fluctuations of approximately $5.4 million, or 0.3%.
Net sales revenue from our Leadership Brands was $1,289.0 million, compared to $1,338.8 million for the same period last year, representing a decrease of 3.7%.
Segment Net Sales Revenue
Home & Outdoor
Comparison of Third Quarter Fiscal 2024 to Third Quarter Fiscal 2023
Net sales revenue increased $7.0 million, or 3.1%, to $235.9 million, compared to $228.9 million. The increase was driven by a growth from Organic business of $4.5 million, or 2.0%, primarily due to:
•higher home category sales in the club and online channels due to strong consumer demand and in the brick and mortar channel due to expanded distribution;
•an increase in online channel sales in the insulated beverageware category, primarily driven by the expanded distribution of our new travel tumbler;
•higher travel-related product sales; and
•an increase in closeout channel sales in the insulated beverageware category.
These factors were partially offset by:
•reduced sales to Bed, Bath & Beyond as a result of their bankruptcy;
•a brick and mortar sales decline in the insulated beverageware category; and
•lower home category sales in the closeout channel.
Net sales revenue wa s favorably impacted by net foreign currency fluctuations of approximately $2.5 million, or 1.1%.
Comparison of First Nine Months of Fiscal 2024 to First Nine Months of Fiscal 2023
Net sales revenue decreased $10.7 million, or 1.5%, to $693.1 million, compared to $703.8 million. The decrease was driven by a decline from Organic business of $13.3 million, or 1.9%, primarily due to:
•a brick and mortar sales decline in the insulated beverageware category;
•reduced sales to Bed, Bath & Beyond as a result of their bankruptcy; and
•lower home category sales in the club and closeout channels.
These factors were partially offset by:
•an increase in online channel sales reflecting improved replenishment orders from certain retail customers, stronger demand for products in the home category and the launch of our new travel tumbler;
•higher brick and mortar home category sales due to new and expanded retailer distribution and improved replenishment orders from certain retail customers;
•stronger consumer demand for travel-related products; and
•an increase in closeout channel sales in the insulated beverageware and travel categories.
40

Table of Contents
Net sales revenue was favorably impacted by net foreign currency fluctuations of approximately $2.6 million, or 0.4%.
Beauty & Wellness
Comparison of Third Quarter Fiscal 2024 to Third Quarter Fiscal 2023
Net sales revenue decreased $16.0 million, or 4.9%, to $313.7 million, compared to $329.7 million. The decline was driven by a decrease from Organic business of $18.1 million, or 5.5%, primarily due to:
•a decline in sales of hair appliances;
•a decline in humidification reflecting a slow start to the cough/cold/flu season as compared to the prior year period; and
•lower sales of air filtration products and fans, primarily driven by softer consumer demand and our SKU rationalization efforts.
The decline was partially offset by:
•growth in sales of thermometry which drove higher international sales;
•an increase in sales of heaters and water filtration products; and
•an increase in sales of prestige hair care products.
Net sales revenue was favorably impacted by net foreign currency fluctuations of approximately $2.1 million, or 0.6%.
Comparison of First Nine Months of Fiscal 2024 to First Nine Months of Fiscal 2023
Net sales revenue decreased $61.5 million, or 7.0%, to $822.8 million, compared to $884.3 million. The decline was driven by a decrease from Organic business of $70.4 million, or 8.0%, primarily due to:
•lower sales of fans, air filtration products, and heaters, primarily driven by softer consumer demand, our SKU rationalization efforts, and reduced orders from retail customers as they rebalance trade inventory in line with softer consumer demand in certain categories;
•a decline in humidification reflecting reduced orders from retail customers as they rebalance trade inventory levels, a slow start to the cough/cold/flu season and the comparative impact of high COVID-related incidence in the prior year period; and
•a decline in sales of hair appliances.
The decline was partially offset by:
•growth in sales of thermometry which drove higher international sales;
•an increase in sales of prestige hair care products; and
•an increase in water filtration product sales.
The Curlsmith acquisition contributed $6.1 million, or 0.7%, to segment net sales revenue growth.
Net sales revenue was favorably impacted by net foreign currency fluctuations of approximately $2.8 million, or 0.3%.
Consolidated Gross Profit Margin
Comparison of Third Quarter Fiscal 2024 to Third Quarter Fiscal 2023
Consolidated gross profit margin increased 2.1 percentage points to 48.0%, compared to 45.9%. The increase in consolidated gross profit margin was primarily due to:
•lower inbound freight costs;
•the favorable impact of our SKU rationalization efforts in Beauty & Wellness; and
•a more favorable customer mix within Home & Outdoor.
These factors were partially offset by a less favorable product mix within Beauty & Wellness.
41

Table of Contents
Comparison of First Nine Months of Fiscal 2024 to First Nine Months of Fiscal 2023
Consolidated gross profit margin increased 3.4 percentage points to 46.8%, compared to 43.4%. The increase in consolidated gross profit margin was primarily due to:
•lower inbound freight costs;
•the favorable comparative impact of EPA compliance costs of $16.9 million incurred in the prior year period;
•the favorable impact of our SKU rationalization efforts in Beauty & Wellness; and
•a more favorable customer mix within Home & Outdoor.
Consolidated SG&A
Comparison of Third Quarter Fiscal 2024 to Third Quarter Fiscal 2023
Consolidated SG&A ratio decreased 2.5 percentage points to 27.8%, compared to 30.3%. The decrease in the consolidated SG&A ratio was primarily due to:
•a gain on the sale of our distribution and office facilities in El Paso, Texas of $34.2 million;
•lower salary and wage costs primarily as a result of our Project Pegasus role reductions;
•the favorable comparative impact of EPA compliance costs of $1.7 million incurred in the prior year period; and
•lower outbound freight costs.
These factors were partially offset by:
•the unfavorable comparative impact of a gain from insurance recoveries of $9.7 million recognized in the prior year period;
•an increase in annual incentive compensation expense;
•higher marketing expense;
•a charge of $1.4 million related to the bankruptcy of Rite Aid; and
•increased distribution expense.
Comparison of First Nine Months of Fiscal 2024 to First Nine Months of Fiscal 2023
Consolidated SG&A ratio increased 0.5 percentage points to 33.0%, compared to 32.5%. The increase in the consolidated SG&A ratio was primarily due to:
•an increase in annual incentive compensation expense;
•higher marketing expense;
•the unfavorable comparative impact of a gain from insurance recoveries of $9.7 million recognized in the prior year period;
•increased distribution expense;
•a charge of $4.2 million related to the bankruptcy of Bed, Bath & Beyond;
•a charge of $1.4 million related to the bankruptcy of Rite Aid;
•an increase in depreciation expense primarily due to our new distribution facility; and
•the unfavorable leverage impact of the overall decrease in net sales.
These factors were partially offset by:
•a gain on the sale of our distribution and office facilities in El Paso, Texas of $34.2 million;
•lower share-based compensation expense;
•the favorable comparative impact of EPA compliance costs of $5.2 million incurred in the prior year period; and
•lower outbound freight costs.
42

Table of Contents
Restructuring Charges
During the three and nine month periods ended November 30, 2023, we incurred $3.9 million and $14.9 million, respectively, of pre-tax restructuring costs in connection with Project Pegasus, which were primarily comprised of professional fees and severance and employee related costs. We recognized $10.5 million and $15.2 million of pre-tax restructuring costs during the three and nine month periods ended November 30, 2022, respectively, in connection with Project Pegasus, which primarily included professional fees and severance and employee related costs. During the nine month periods ended November 30, 2023 and November 30, 2022, we made total cash restructuring payments of $17.5 million and $5.4 million, respectively. We had a remaining liability of $3.9 million as of November 30, 2023.
43

Table of Contents
Operating Income, Operating Margin, Adjusted Operating Income (non-GAAP), and Adjusted Operating Margin (non-GAAP) by Segment
In order to provide a better understanding of the impact of certain items on our operating income, the tables that follow report the comparative pre-tax impact of acquisition-related expenses, Bed, Bath & Beyond bankruptcy, EPA compliance costs, gain from insurance recoveries, gain on sale of distribution and office facilities, restructuring charges, amortization of intangible assets, and non-cash share-based compensation, as applicable, on operating income and operating margin for each segment and in total for the periods presented below. Adjusted operating income and adjusted operating margin may be considered non-GAAP financial measures as contemplated by SEC Regulation G, Rule 100. For additional information regarding management’s decision to present this non-GAAP financial information, see the introduction to this Item 2., “Management’s Discussion and Analysis of Financial Condition and Results of Operations.”

| Three Months Ended November 30, 2023
(in thousands) | Home & Outdoor |  |  |  |  |  | Beauty & Wellness (1) |  | Total
Operating income, as reported (GAAP) | $ | 49,514 |  |  | 21.0 | % |  |  |  |  |  |  |  |  |  | $ | 57,413 |  |  | 18.3 | % |  | $ | 106,927 |  |  | 19.5 | %
Gain on sale of distribution and office facilities | (16,175) |  |  | (6.9) | % |  |  |  |  |  |  |  |  |  | (18,015) |  |  | (5.7) | % |  | (34,190) |  |  | (6.2) | %
Restructuring charges | 583 |  |  | 0.2 | % |  |  |  |  |  |  |  |  |  | 3,307 |  |  | 1.1 | % |  | 3,890 |  |  | 0.7 | %
Subtotal | 33,922 |  |  | 14.4 | % |  |  |  |  |  |  |  |  |  | 42,705 |  |  | 13.6 | % |  | 76,627 |  |  | 13.9 | %
Amortization of intangible assets | 1,781 |  |  | 0.8 | % |  |  |  |  |  |  |  |  |  | 2,827 |  |  | 0.9 | % |  | 4,608 |  |  | 0.8 | %
Non-cash share-based compensation | 4,061 |  |  | 1.7 | % |  |  |  |  |  |  |  |  |  | 4,518 |  |  | 1.4 | % |  | 8,579 |  |  | 1.6 | %
Adjusted operating income (non-GAAP) | $ | 39,764 |  |  | 16.9 | % |  |  |  |  |  |  |  |  |  | $ | 50,050 |  |  | 16.0 | % |  | $ | 89,814 |  |  | 16.3 | %

| Three Months Ended November 30, 2022
(in thousands) | Home & Outdoor |  |  |  |  |  | Beauty & Wellness (1) |  | Total
Operating income, as reported (GAAP) | $ | 30,847 |  |  | 13.5 | % |  |  |  |  |  |  |  |  |  | $ | 46,346 |  |  | 14.1 | % |  | $ | 77,193 |  |  | 13.8 | %
Acquisition-related expenses | (2) |  |  | — | % |  |  |  |  |  |  |  |  |  | 2 |  |  | — | % |  | — |  |  | — | %
EPA compliance costs | — |  |  | — | % |  |  |  |  |  |  |  |  |  | 2,103 |  |  | 0.6 | % |  | 2,103 |  |  | 0.4 | %
Gain from insurance recoveries | — |  |  | — | % |  |  |  |  |  |  |  |  |  | (9,676) |  |  | (2.9) | % |  | (9,676) |  |  | (1.7) | %
Restructuring charges | 5,090 |  |  | 2.2 | % |  |  |  |  |  |  |  |  |  | 5,373 |  |  | 1.6 | % |  | 10,463 |  |  | 1.9 | %
Subtotal | 35,935 |  |  | 15.7 | % |  |  |  |  |  |  |  |  |  | 44,148 |  |  | 13.4 | % |  | 80,083 |  |  | 14.3 | %
Amortization of intangible assets | 1,756 |  |  | 0.8 | % |  |  |  |  |  |  |  |  |  | 2,896 |  |  | 0.9 | % |  | 4,652 |  |  | 0.8 | %
Non-cash share-based compensation | 2,169 |  |  | 0.9 | % |  |  |  |  |  |  |  |  |  | 5,772 |  |  | 1.8 | % |  | 7,941 |  |  | 1.4 | %
Adjusted operating income (non-GAAP) | $ | 39,860 |  |  | 17.4 | % |  |  |  |  |  |  |  |  |  | $ | 52,816 |  |  | 16.0 | % |  | $ | 92,676 |  |  | 16.6 | %

| Nine Months Ended November 30, 2023
(in thousands) | Home & Outdoor |  |  |  |  |  | Beauty & Wellness (1) |  | Total
Operating income, as reported (GAAP) | $ | 107,729 |  |  | 15.5 | % |  |  |  |  |  |  |  |  |  | $ | 86,684 |  |  | 10.5 | % |  | $ | 194,413 |  |  | 12.8 | %
Bed, Bath & Beyond bankruptcy | 3,087 |  |  | 0.4 | % |  |  |  |  |  |  |  |  |  | 1,126 |  |  | 0.1 | % |  | 4,213 |  |  | 0.3 | %
Gain on sale of distribution and office facilities | (16,175) |  |  | (2.3) | % |  |  |  |  |  |  |  |  |  | (18,015) |  |  | (2.2) | % |  | (34,190) |  |  | (2.3) | %
Restructuring charges | 4,644 |  |  | 0.7 | % |  |  |  |  |  |  |  |  |  | 10,218 |  |  | 1.2 | % |  | 14,862 |  |  | 1.0 | %
Subtotal | 99,285 |  |  | 14.3 | % |  |  |  |  |  |  |  |  |  | 80,013 |  |  | 9.7 | % |  | 179,298 |  |  | 11.8 | %
Amortization of intangible assets | 5,322 |  |  | 0.8 | % |  |  |  |  |  |  |  |  |  | 8,537 |  |  | 1.0 | % |  | 13,859 |  |  | 0.9 | %
Non-cash share-based compensation | 11,846 |  |  | 1.7 | % |  |  |  |  |  |  |  |  |  | 13,259 |  |  | 1.6 | % |  | 25,105 |  |  | 1.7 | %
Adjusted operating income (non-GAAP) | $ | 116,453 |  |  | 16.8 | % |  |  |  |  |  |  |  |  |  | $ | 101,809 |  |  | 12.4 | % |  | $ | 218,262 |  |  | 14.4 | %

44

Table of Contents

| Nine Months Ended November 30, 2022
(in thousands) | Home & Outdoor |  |  |  |  |  | Beauty & Wellness (1) |  | Total
Operating income, as reported (GAAP) | $ | 102,722 |  |  | 14.6 | % |  |  |  |  |  |  |  |  |  | $ | 55,356 |  |  | 6.3 | % |  | $ | 158,078 |  |  | 10.0 | %
Acquisition-related expenses | 117 |  |  | — | % |  |  |  |  |  |  |  |  |  | 2,667 |  |  | 0.3 | % |  | 2,784 |  |  | 0.2 | %
EPA compliance costs | — |  |  | — | % |  |  |  |  |  |  |  |  |  | 22,101 |  |  | 2.5 | % |  | 22,101 |  |  | 1.4 | %
Gain from insurance recoveries | — |  |  | — | % |  |  |  |  |  |  |  |  |  | (9,676) |  |  | (1.1) | % |  | (9,676) |  |  | (0.6) | %
Restructuring charges | 5,562 |  |  | 0.8 | % |  |  |  |  |  |  |  |  |  | 9,679 |  |  | 1.1 | % |  | 15,241 |  |  | 1.0 | %
Subtotal | 108,401 |  |  | 15.4 | % |  |  |  |  |  |  |  |  |  | 80,127 |  |  | 9.1 | % |  | 188,528 |  |  | 11.9 | %
Amortization of intangible assets | 5,255 |  |  | 0.7 | % |  |  |  |  |  |  |  |  |  | 8,407 |  |  | 1.0 | % |  | 13,662 |  |  | 0.9 | %
Non-cash share-based compensation | 10,807 |  |  | 1.5 | % |  |  |  |  |  |  |  |  |  | 21,248 |  |  | 2.4 | % |  | 32,055 |  |  | 2.0 | %
Adjusted operating income (non-GAAP) | $ | 124,463 |  |  | 17.7 | % |  |  |  |  |  |  |  |  |  | $ | 109,782 |  |  | 12.4 | % |  | $ | 234,245 |  |  | 14.8 | %

(1)The three and nine month periods ended November 30, 2023 includes a full three and nine months, respectively, of operating results from Curlsmith, acquired on April 22, 2022, compared to approximately thirteen and thirty-two weeks of operating results in the three and nine month periods ended November 30, 2022, respectively. For additional information see Note 4 to the accompanying condensed consolidated financial statements.
Consolidated Operating Income
Comparison of Third Quarter Fiscal 2024 to Third Quarter Fiscal 2023
Consolidated operating income was $106.9 million, or 19.5% of net sales revenue, compared to $77.2 million, or 13.8% of net sales revenue. The 5.7 percentage point increase in consolidated operating margin was primarily due to:
•a gain on the sale of our distribution and office facilities in El Paso, Texas of $34.2 million;
•lower inbound and outbound freight costs;
•a decrease in restructuring charges of $6.6 million;
•lower salary and wage costs primarily as a result of our Project Pegasus role reductions;
•the favorable comparative impact of EPA compliance costs of $2.1 million incurred in the prior year period;
•the favorable impact of our SKU rationalization efforts in Beauty & Wellness; and
•a more favorable customer mix within Home & Outdoor.
These factors were partially offset by:
•the unfavorable comparative impact of a gain from insurance recoveries of $9.7 million recognized in the prior year period;
•an increase in annual incentive compensation expense;
•higher marketing expense;
•increased distribution expense;
•a charge of $1.4 million related to the bankruptcy of Rite Aid; and
•a less favorable product mix within Beauty & Wellness.
Consolidated adjusted operating income decreased 3.1% to $89.8 million, or 16.3% of net sales revenue, compared to $92.7 million, or 16.6% of net sales revenue.
Comparison of First Nine Months of Fiscal 2024 to First Nine Months of Fiscal 2023
Consolidated operating income was $194.4 million, or 12.8% of net sales revenue, compared to $158.1 million, or 10.0% of net sales revenue. The 2.8 percentage point increase in consolidated operating margin was primarily due to:
•lower inbound and outbound freight costs;
•a gain on the sale of our distribution and office facilities in El Paso, Texas of $34.2 million;
•the favorable comparative impact of EPA compliance costs of $22.1 million incurred in the prior year period;
•reduced share-based compensation expense;
45

Table of Contents
•the favorable impact of our SKU rationalization efforts in Beauty & Wellness; and
•a more favorable customer mix within Home & Outdoor.
These factors were partially offset by:
•increased annual incentive compensation expense;
•higher marketing expense;
•the unfavorable comparative impact of a gain from insurance recoveries of $9.7 million recognized in the prior year period;
•higher distribution expense;
•a charge of $4.2 million related to the bankruptcy of Bed, Bath & Beyond;
•a charge of $1.4 million related to the bankruptcy of Rite Aid;
•an increase in depreciation expense primarily due to our new distribution facility; and
•unfavorable leverage impact of the overall decrease in net sales.
Consolidated adjusted operating income decreased 6.8% to $218.3 million, or 14.4% of net sales revenue, compared to $234.2 million, or 14.8% of net sales revenue.
Home & Outdoor
Comparison of Third Quarter Fiscal 2024 to Third Quarter Fiscal 2023
Operating income was $49.5 million, or 21.0% of segment net sales revenue, compared to $30.8 million, or 13.5% of segment net sales revenue. The 7.5 percentage point increase in segment operating margin was primarily due to:
•a gain on the sale of our distribution and office facilities in El Paso, Texas of $16.2 million;
•lower inbound and outbound freight costs;
•a decrease in restructuring charges of $4.5 million;
•lower commodity costs;
•lower salary and wage costs primarily as a result of our Project Pegasus role reductions; and
•a more favorable customer mix.
These factors were partially offset by:
•higher distribution expense;
•increased marketing expense;
•an increase in inventory obsolescence expense;
•higher share-based compensation expense;
•increased annual incentive compensation expense; and
•an increase in depreciation expense primarily due to our new distribution facility.
Adjusted operating income decreased 0.2% to $39.8 million, or 16.9% of segment net sales revenue, compared to $39.9 million, or 17.4% of segment net sales revenue.
Comparison of First Nine Months of Fiscal 2024 to First Nine Months of Fiscal 2023
Operating income was $107.7 million, or 15.5% of segment net sales revenue, compared to $102.7 million, or 14.6% of segment net sales revenue. The 0.9 percentage point increase in segment operating margin was primarily due to:
•lower inbound freight costs;
•a gain on the sale of our distribution and office facilities in El Paso, Texas of $16.2 million; and
•a more favorable customer mix.
These factors were partially offset by:
•higher distribution expense;
•increased marketing expense;
46

Table of Contents
•an increase in inventory obsolescence expense;
•an increase in depreciation expense primarily due to our new distribution facility;
•a charge of $3.1 million related to the bankruptcy of Bed, Bath & Beyond; and
•increased annual incentive compensation expense.
Adjusted operating income decreased 6.4% to $116.5 million, or 16.8% of segment net sales revenue, compared to $124.5 million, or 17.7% of segment net sales revenue.
Beauty & Wellness
Comparison of Third Quarter Fiscal 2024 to Third Quarter Fiscal 2023
Operating income was $57.4 million, or 18.3% of segment net sales revenue, compared to $46.3 million, or 14.1% of segment net sales revenue. The 4.2 percentage point increase in segment operating margin was primarily due to:
•a gain on the sale of our distribution and office facilities in El Paso, Texas of $18.0 million;
•lower inbound and outbound freight costs;
•reduced inventory obsolescence expense;
•the favorable comparative impact of EPA compliance costs of $2.1 million incurred in the prior year period;
•a decrease in restructuring charges of $2.1 million;
•the favorable impact of our SKU rationalization efforts;
•decreased distribution expense;
•reduced share-based compensation expense; and
•lower salary and wage costs primarily as a result of Project Pegasus role reductions.
These factors were partially offset by:
•the unfavorable comparative impact of a gain from insurance recoveries of $9.7 million recognized in the prior year period;
•an increase in annual incentive compensation expense;
•higher marketing expense;
•the unfavorable comparative impact of duty refunds received in the prior year period;
•a charge of $1.4 million related to the bankruptcy of Rite Aid;
•unfavorable operating leverage; and
•a less favorable product mix.
Adjusted operating income decreased 5.2% to $50.1 million, or 16.0% of segment net sales revenue, compared to $52.8 million, or 16.0% of segment net sales revenue.
Comparison of First Nine Months of Fiscal 2024 to First Nine Months of Fiscal 2023
Operating income was $86.7 million, or 10.5% of segment net sales revenue, compared to $55.4 million, or 6.3% of segment net sales revenue. The 4.2 percentage point increase in segment operating margin was primarily due to:
•lower inbound and outbound freight costs;
•the favorable comparative impact of EPA compliance costs of $22.1 million incurred in the prior year period;
•a gain on the sale of our distribution and office facilities in El Paso, Texas of $18.0 million;
•reduced share-based compensation expense;
•decreased distribution expense;
•the favorable impact of our SKU rationalization efforts;
•a decrease in inventory obsolescence expense; and
•the favorable comparative impact of acquisition-related expense incurred in connection with the Curlsmith transaction during the prior year period.
47

Table of Contents
These factors were partially offset by:
•higher annual incentive compensation expense;
•the unfavorable comparative impact of a gain from insurance recoveries of $9.7 million recognized in the prior year period;
•higher marketing expense;
•a charge of $1.4 million related to the bankruptcy of Rite Aid; and
•unfavorable operating leverage.
Adjusted operating income decreased 7.3% to $101.8 million, or 12.4% of segment net sales revenue, compared to $109.8 million, or 12.4% of segment net sales revenue.
Interest Expense
Comparison of Third Quarter Fiscal 2024 to Third Quarter Fiscal 2023
Interest expense was $12.9 million, compared to $13.1 million. The decrease in interest expense was primarily due to lower average levels of debt outstanding, partially offset by a higher average interest rate compared to the same period last year.
Comparison of First Nine Months of Fiscal 2024 to First Nine Months of Fiscal 2023
Interest expense was $40.6 million, compared to $26.7 million. The increase in interest expense was primarily due to a higher average interest rate, partially offset by lower average levels of debt outstanding compared to the same period last year.
Income Tax Expense
The period-over-period comparison of our effective tax rate is often impacted by the mix of taxable income in our various tax jurisdictions. Due to our organization in Bermuda and the ownership structure of our foreign subsidiaries, many of which are not owned directly or indirectly by a U.S. parent company, an immaterial amount of our foreign income is subject to U.S. taxation on a permanent basis under current law. Additionally, our intellectual property is largely owned by our foreign subsidiaries, resulting in proportionally higher earnings in jurisdictions with lower statutory tax rates, which decreases our overall effective tax rate.
For the three months ended November 30, 2023, income tax expense as a percentage of income before income tax was 19.5% compared to 19.1% for the same period last year. The year-over-year increase in the effective tax rate is primarily due to tax expense recognized for the gain on the sale of our distribution and office facilities in El Paso, Texas during the third quarter of fiscal 2023 and an increase in tax expense for other discrete items, partially offset by shifts in the mix of income in our various tax jurisdictions. For the nine months ended November 30, 2023, income tax expense as a percentage of income before income tax was 18.4% compared to 18.6% for the same period last year primarily due to a decrease in tax expense for discrete items (excluding the gain on the sale of our El Paso facilities) and shifts in the mix of income in our various tax jurisdictions, partially offset by tax expense recognized for the gain on the sale of our distribution and office facilities in El Paso, Texas during the third quarter of fiscal 2023.
48

Table of Contents
Net Income, Diluted EPS, Adjusted Income (non-GAAP), and Adjusted Diluted EPS (non-GAAP)
In order to provide a better understanding of the impact of certain items on our income and diluted EPS, the tables that follow report the comparative after-tax impact of acquisition-related expenses, Bed, Bath & Beyond bankruptcy, EPA compliance costs, gain from insurance recoveries, gain on sale of distribution and office facilities, restructuring charges, amortization of intangible assets, and non-cash share-based compensation, as applicable, on income and diluted EPS for the periods presented below. Adjusted income and adjusted diluted EPS may be considered non-GAAP financial measures as contemplated by SEC Regulation G, Rule 100. For additional information regarding management’s decision to present this non-GAAP financial information, see the introduction to this Item 2., “Management’s Discussion and Analysis of Financial Condition and Results of Operations.”

| Three Months Ended November 30, 2023
| Income |  | Diluted EPS
(in thousands, except per share data) | Before Tax |  | Tax |  | Net of Tax |  | Before Tax |  | Tax |  | Net of Tax
As reported (GAAP) | $ | 94,248 |  |  | $ | 18,350 |  |  | $ | 75,898 |  |  | $ | 3.96 |  |  | $ | 0.77 |  |  | $ | 3.19 |
Gain on sale of distribution and office facilities | (34,190) |  |  | (8,787) |  |  | (25,403) |  |  | (1.44) |  |  | (0.37) |  |  | (1.07) |
Restructuring charges | 3,890 |  |  | 49 |  |  | 3,841 |  |  | 0.16 |  |  | — |  |  | 0.16 |
Subtotal | 63,948 |  |  | 9,612 |  |  | 54,336 |  |  | 2.69 |  |  | 0.40 |  |  | 2.28 |
Amortization of intangible assets | 4,608 |  |  | 606 |  |  | 4,002 |  |  | 0.19 |  |  | 0.03 |  |  | 0.17 |
Non-cash share-based compensation | 8,579 |  |  | 532 |  |  | 8,047 |  |  | 0.36 |  |  | 0.02 |  |  | 0.34 |
Adjusted (non-GAAP) | $ | 77,135 |  |  | $ | 10,750 |  |  | $ | 66,385 |  |  | $ | 3.24 |  |  | $ | 0.45 |  |  | $ | 2.79 |
Weighted average shares of common stock used in computing diluted EPS | 23,813 |

| Three Months Ended November 30, 2022
| Income |  | Diluted EPS
(in thousands, except per share data) | Before Tax |  | Tax |  | Net of Tax |  | Before Tax |  | Tax |  | Net of Tax
As reported (GAAP) | $ | 64,049 |  |  | $ | 12,223 |  |  | $ | 51,826 |  |  | $ | 2.66 |  |  | $ | 0.51 |  |  | $ | 2.15 |
Acquisition-related expenses | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |
EPA compliance costs | 2,103 |  |  | 32 |  |  | 2,071 |  |  | 0.09 |  |  | — |  |  | 0.09 |
Gain from insurance recoveries | (9,676) |  |  | (121) |  |  | (9,555) |  |  | (0.40) |  |  | (0.01) |  |  | (0.40) |
Restructuring charges | 10,463 |  |  | 131 |  |  | 10,332 |  |  | 0.43 |  |  | 0.01 |  |  | 0.43 |
Subtotal | 66,939 |  |  | 12,265 |  |  | 54,674 |  |  | 2.78 |  |  | 0.51 |  |  | 2.27 |
Amortization of intangible assets | 4,652 |  |  | 534 |  |  | 4,118 |  |  | 0.19 |  |  | 0.02 |  |  | 0.17 |
Non-cash share-based compensation | 7,941 |  |  | 474 |  |  | 7,467 |  |  | 0.33 |  |  | 0.02 |  |  | 0.31 |
Adjusted (non-GAAP) | $ | 79,532 |  |  | $ | 13,273 |  |  | $ | 66,259 |  |  | $ | 3.30 |  |  | $ | 0.55 |  |  | $ | 2.75 |
Weighted average shares of common stock used in computing diluted EPS |  | 24,078 |

49

Table of Contents

| Nine Months Ended November 30, 2023
| Income |  | Diluted EPS
(in thousands, except per share data) | Before Tax |  | Tax |  | Net of Tax |  | Before Tax |  | Tax |  | Net of Tax
As reported (GAAP) | $ | 154,313 |  |  | $ | 28,453 |  |  | $ | 125,860 |  |  | $ | 6.43 |  |  | $ | 1.19 |  |  | $ | 5.25 |
Bed, Bath & Beyond bankruptcy | 4,213 |  |  | 53 |  |  | 4,160 |  |  | 0.18 |  |  | — |  |  | 0.17 |
Gain on sale of distribution and office facilities | (34,190) |  |  | (8,787) |  |  | (25,403) |  |  | (1.42) |  |  | (0.37) |  |  | (1.06) |
Restructuring charges | 14,862 |  |  | 185 |  |  | 14,677 |  |  | 0.62 |  |  | 0.01 |  |  | 0.61 |
Subtotal | 139,198 |  |  | 19,904 |  |  | 119,294 |  |  | 5.80 |  |  | 0.83 |  |  | 4.97 |
Amortization of intangible assets | 13,859 |  |  | 1,819 |  |  | 12,040 |  |  | 0.58 |  |  | 0.08 |  |  | 0.50 |
Non-cash share-based compensation | 25,105 |  |  | 1,558 |  |  | 23,547 |  |  | 1.05 |  |  | 0.06 |  |  | 0.98 |
Adjusted (non-GAAP) | $ | 178,162 |  |  | $ | 23,281 |  |  | $ | 154,881 |  |  | $ | 7.42 |  |  | $ | 0.97 |  |  | $ | 6.45 |
Weighted average shares of common stock used in computing diluted EPS | 23,996 |

| Nine Months Ended November 30, 2022
| Income |  | Diluted EPS
(in thousands, except per share data) | Before Tax |  | Tax |  | Net of Tax |  | Before Tax |  | Tax |  | Net of Tax
As reported (GAAP) | $ | 131,575 |  |  | $ | 24,482 |  |  | $ | 107,093 |  |  | $ | 5.46 |  |  | $ | 1.02 |  |  | $ | 4.45 |
Acquisition-related expenses | 2,784 |  |  | 2 |  |  | 2,782 |  |  | 0.12 |  |  | — |  |  | 0.12 |
EPA compliance costs | 22,101 |  |  | 332 |  |  | 21,769 |  |  | 0.92 |  |  | 0.01 |  |  | 0.90 |
Gain from insurance recoveries | (9,676) |  |  | (121) |  |  | (9,555) |  |  | (0.40) |  |  | (0.01) |  |  | (0.40) |
Restructuring charges | 15,241 |  |  | 192 |  |  | 15,049 |  |  | 0.63 |  |  | 0.01 |  |  | 0.62 |
Subtotal | 162,025 |  |  | 24,887 |  |  | 137,138 |  |  | 6.73 |  |  | 1.03 |  |  | 5.69 |
Amortization of intangible assets | 13,662 |  |  | 1,581 |  |  | 12,081 |  |  | 0.57 |  |  | 0.07 |  |  | 0.50 |
Non-cash share-based compensation | 32,055 |  |  | 2,128 |  |  | 29,927 |  |  | 1.33 |  |  | 0.09 |  |  | 1.24 |
Adjusted (non-GAAP) | $ | 207,742 |  |  | $ | 28,596 |  |  | $ | 179,146 |  |  | $ | 8.63 |  |  | $ | 1.19 |  |  | $ | 7.44 |
Weighted average shares of common stock used in computing diluted EPS |  | 24,086 |

Comparison of Third Quarter Fiscal 2024 to Third Quarter Fiscal 2023
Net income was $75.9 million, compared to $51.8 million. Diluted EPS was $3.19, compared to $2.15. Diluted EPS increased primarily due to higher operating income in both the Home & Outdoor and Beauty & Wellness segments, lower weighted average diluted shares outstanding and a decrease in interest expense, partially offset by an increase in the effective income tax rate.
Adjusted income increased $0.1 million, or 0.2%, to $66.4 million, compared to $66.3 million. Adjusted diluted EPS increased 1.5% to $2.79, compared to $2.75.
Comparison of First Nine Months of Fiscal 2024 to First Nine Months of Fiscal 2023
Net income was $125.9 million, compared to $107.1 million. Diluted EPS was $5.25, compared to $4.45. Diluted EPS increased primarily due to higher operating income in both the Beauty & Wellness and Home & Outdoor segments and lower weighted average diluted shares outstanding, partially offset by higher interest expense.
Adjusted income decreased $24.3 million, or 13.5%, to $154.9 million, compared to $179.1 million. Adjusted diluted EPS decreased 13.3% to $6.45, compared to $7.44.
50

Table of Contents
Liquidity and Capital Resources
We principally rely on our cash flow from operations and borrowings under our Credit Agreement (as defined below) to finance our operations, capital and intangible asset expenditures, acquisitions and share repurchases. Historically, our principal uses of cash to fund our operations have included operating expenses, primarily SG&A, and working capital, predominantly for inventory purchases and the extension of credit to our retail customers. We have typically been able to generate positive cash flow from operations sufficient to fund our operating activities. In the past, we have utilized a combination of available cash and existing, or additional, sources of financing to fund strategic acquisitions, share repurchases and capital investments. We generated $232.5 million in cash from operations during the first nine months of fiscal 2024 and had $25.2 million in cash and cash equivalents at November 30, 2023. As of November 30, 2023, the amount of cash and cash equivalents held by our foreign subsidiaries was $20.7 million. We have no existing activities involving special purpose entities or off-balance sheet financing.
We believe our short-term liquidity requirements will primarily consist of operating and working capital requirements, capital expenditures and interest payments on our debt. We maintained elevated outstanding borrowings under the Credit Agreement during fiscal 2023 in order to fund the acquisitions of Osprey and Curlsmith and the construction of our new distribution facility. With the completion of our new distribution facility in March 2023, we expect a more normalized level of capital expenditures in fiscal 2024. As a result of our expected decrease in cash utilized for investing activities, we plan to continue to repay amounts outstanding under our Credit Agreement. Accordingly, borrowings outstanding under the Credit Agreement have decreased during fiscal 2024, and we expect a further decrease during the remainder of fiscal 2024 compared to fiscal 2023. If interest rates continue to increase and adverse economic changes occur, our access to credit on favorable interest rate terms may be impacted. In an economic downturn, we may also be unable to raise capital through debt or equity financings on terms acceptable to us or at all. Covenants in our Credit Agreement could also have consequences on our operations, including restricting or delaying our ability to obtain additional financing, potentially limiting our ability to adjust to rapidly changing market conditions or respond to business opportunities. Additionally, in challenging and uncertain economic environments, we cannot predict when macroeconomic uncertainty may arise, whether or when such circumstances may improve or worsen or what impact such circumstances could have on our business and our liquidity requirements.
Based on our current financial condition and current operations, we believe that cash flows from operations and available financing sources will continue to provide sufficient capital resources to fund our foreseeable short- and long-term liquidity requirements.
We continue to evaluate acquisition opportunities on a regular basis. We may finance acquisition activity with available cash, the issuance of shares of common stock, additional debt, or other sources of financing, depending upon the size and nature of any such transaction and the status of the capital markets at the time of such acquisition.
We may also elect to repurchase additional shares of common stock under our Board of Directors' authorization, subject to limitations contained in our debt agreements and based upon our assessment of a number of factors, including share price, trading volume and general market conditions, working capital requirements, general business conditions, financial conditions, any applicable contractual limitations, and other factors, including alternative investment opportunities. We may finance share repurchases with available cash, additional debt or other sources of financing. For additional information, see Part II, Item 5. “Market for Registrant’s Common Equity, Related Shareholder Matters and Issuer Purchases of Equity Securities” in our Form 10-K and Part II, Item 2., “Unregistered Sales of Equity Securities and Use of Proceeds” in this report.
51

Table of Contents
Operating Activities
Operating activities provided net cash of $232.5 million for the nine months ended November 30, 2023, compared to net cash provided of $49.5 million for the same period last year. The increase in cash provided by operating activities was primarily driven by an increase in cash earnings and decreases in cash used for inventory purchases, annual incentive compensation payments, and income taxes partially offset by increases in cash used primarily for interest payments, restructuring activities, and accounts receivable to extend credit to our retail customers.
Investing Activities
Investing activities provided net cash of $14.0 million during the nine months ended November 30, 2023, compared to net cash used of $290.7 million for the same period last year. The increase in cash provided by investing activities was primarily due to the comparative impacts of the Curlsmith acquisition during the first quarter of fiscal 2023, and a decrease in capital and intangible asset expenditures during fiscal 2024. Proceeds received from the sale of our distribution and office facilities in El Paso, Texas also contributed to the increase in cash provided by investing activities. We made investments in capital and intangible asset expenditures of $29.7 million during the nine months ended November 30, 2023, compared to $146.2 million for the same period last year. The decrease in capital and intangible asset expenditures was primarily due to the completion of our new two million square foot distribution facility in March 2023 for which we incurred the bulk of capital expenditures during the prior year period. Capital and intangible asset expenditures during both periods also included expenditures for computer, software, furniture and other equipment and tools, molds, and other production equipment.
Financing Activities
Financing activities used net cash of $250.3 million during the nine months ended November 30, 2023, compared to net cash provided of $253.1 million for the same period last year. The increase in cash used by financing activities is primarily due to repayments made on our revolving loans and payments for repurchases of common stock during the nine months ended November 30, 2023 in comparison to net borrowings of $266.5 million during the same period last year.
Credit Agreement
We have a credit agreement (the “Credit Agreement”) with Bank of America, N.A., as administrative agent, and other lenders that provides for an unsecured total revolving commitment of $1.25 billion and a $300 million accordion, which can be used for term loan commitments. In June 2022, we exercised $250 million of the $300 million accordion under the Credit Agreement and borrowed $250 million as term loans. The proceeds from the term loans were used to repay revolving loans under the Credit Agreement. The term loans are payable at the end of each fiscal quarter in equal installments of 0.625% of the term loans made, which began in the third quarter of fiscal 2023, with the remaining balance due at the maturity date. The maturity date of the term loans and the revolving loans under the Credit Agreement is March 13, 2025. Borrowings under the Credit Agreement bear floating interest at either the Base Rate or Term SOFR (as defined in the Credit Agreement), plus a margin based on the Net Leverage Ratio (as defined in the Credit Agreement) of 0% to 1.0% and 1.0% to 2.0% for Base Rate and Term SOFR borrowings, respectively, plus a credit spread of 0.10% for Term SOFR borrowings.
The floating interest rates on our borrowings under the Credit Agreement are hedged with interest rate swaps to effectively fix interest rates on $625 million and $425 million of the outstanding principal balance under the revolving loans as of November 30, 2023 and February 28, 2023, respectively. For additional information regarding our interest rate swaps, see Notes 11, 12, and 13 to the accompanying condensed consolidated financial statements.
52

Table of Contents
As of November 30, 2023, the outstanding Credit Agreement principal balance was $737.2 million (excluding prepaid financing fees), the balance of outstanding letters of credit was $15.5 million and the amount available for borrowings under the Credit Agreement was $739.5 million. Covenants in the Credit Agreement limit the amount of total indebtedness we can incur. As of November 30, 2023, these covenants effectively limited our ability to incur more than $336.2 million of additional debt from all sources, including the Credit Agreement, or $569.6 million in the event a qualified acquisition is consummated.
As of November 30, 2023, we were in compliance with all covenants as defined under the terms of the Credit Agreement.
Critical Accounting Policies and Estimates
The SEC defines critical accounting estimates as those made in accordance with generally accepted accounting principles that involve a significant level of estimation uncertainty and have had or are reasonably likely to have a material impact on a company's financial condition or results of operations. For a discussion of the estimates that we consider to meet this definition and represent our more critical estimates and assumptions used in the preparation of our consolidated financial statements, see the section entitled “Critical Accounting Policies and Estimates” in our Form 10-K. Since the filing of our Form 10-K, there have been no material changes in our critical accounting policies and estimates from those disclosed therein.
Information Regarding Forward-Looking Statements
Certain statements in this report, including those in documents and our other filings with the SEC referenced herein, may constitute “forward-looking statements” as defined under the Private Securities Litigation Reform Act of 1995. Generally, the words “anticipates”, “believes”, “expects”, “plans”, “may”, “will”, “might”, “would”, “should”, “seeks”, “estimates”, “project”, “predict”, “potential”, “currently”, “continue”, “intends”, “outlook”, “forecasts”, “targets”, “could”, and other similar words identify forward-looking statements. All statements that address operating results, events or developments that we expect or anticipate may occur in the future, including statements related to sales, expenses, EPS results, and statements expressing general expectations about future operating results, are forward-looking statements and are based upon our current expectations and various assumptions. We believe there is a reasonable basis for our expectations and assumptions, but there can be no assurance that we will realize our expectations or that our assumptions will prove correct. Forward-looking statements are only as of the date they are made and are subject to risks that could cause them to differ materially from actual results. Accordingly, we caution readers not to place undue reliance on forward-looking statements. We believe that these risks include but are not limited to the risks described or referenced in this report and that are otherwise described from time to time in our SEC reports as filed. We undertake no obligation to publicly update or revise any forward-looking statements as a result of new information, future events or otherwise.
Such risks are not limited to, but may include:
•the occurrence of cyber incidents, or failure by us or our third-party service providers to maintain cybersecurity and the integrity of confidential internal or customer data;
•a cybersecurity breach, obsolescence or interruptions in the operation of our central global Enterprise Resource Planning systems and other peripheral information systems;
•the geographic concentration of certain U.S. distribution facilities which increases our risk to disruptions that could affect our ability to deliver products in a timely manner;
•our ability to develop and introduce a continuing stream of innovative new products to meet changing consumer preferences;
•actions taken by large customers that may adversely affect our gross profit and operating results;
53

Table of Contents
•our dependence on sales to several large customers and the risks associated with any loss of, or substantial decline in, sales to top customers;
•our dependence on third-party manufacturers, most of which are located in Asia, and any inability to obtain products from such manufacturers;
•our ability to deliver products to our customers in a timely manner and according to their fulfillment standards;
•the risks associated with trade barriers, exchange controls, expropriations, and other risks associated with domestic and foreign operations including uncertainty and business interruptions resulting from political changes and events in the U.S. and abroad, and volatility in the global credit and financial markets and economy;
•our dependence on the strength of retail economies and vulnerabilities to any prolonged economic downturn, including a downturn from the effects of macroeconomic conditions, any public health crises or similar conditions;
•the risks associated with the use of licensed trademarks from or to third parties;
•the risks associated with weather conditions, the duration and severity of the cold and flu season and other related factors;
•our reliance on our CEO and a limited number of other key senior officers to operate our business;
•our ability to execute and realize expected synergies from strategic business initiatives such as acquisitions, divestitures and global restructuring plans, including Project Pegasus;
•the risks of potential changes in laws and regulations, including environmental, employment and health and safety and tax laws, and the costs and complexities of compliance with such laws;
•the risks associated with increased focus and expectations on climate change and other environmental, social and governance matters;
•the risks associated with significant changes in or our compliance with regulations, interpretations or product certification requirements;
•the risks associated with global legal developments regarding privacy and data security that could result in changes to our business practices, penalties, increased cost of operations, or otherwise harm our business;
•our dependence on whether we are classified as a “controlled foreign corporation” for U.S. federal income tax purposes which impacts the tax treatment of its non-U.S. income;
•the risks associated with legislation enacted in Bermuda and Barbados in response to the European Union’s review of harmful tax competition;
•the risks associated with accounting for tax positions and the resolution of tax disputes;
•the risks of significant tariffs or other restrictions being placed on imports from China, Mexico or Vietnam or any retaliatory trade measures taken by China, Mexico or Vietnam;
•the risks associated with product recalls, product liability and other claims against us;
•associated financial risks including but not limited to, significant impairment of our goodwill, indefinite-lived and definite-lived intangible assets or other long-lived assets;
•increased costs of raw materials, energy and transportation;
•the risks to our liquidity or cost of capital which may be materially adversely affected by constraints or changes in the capital and credit markets, interest rates and limitations under our financing arrangements;
•the risks associated with foreign currency exchange rate fluctuations; and
•projections of product demand, sales and net income, which are highly subjective in nature, and from which future sales and net income could vary in a material amount.
54

Table of Contents
ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK
There have been no material changes in the information provided in the section entitled “Quantitative and Qualitative Disclosures about Market Risk” in our Form 10-K. Additional information regarding our risk management activities can be found in Notes 10, 11 and 12 to the accompanying condensed consolidated financial statements.
ITEM 4. CONTROLS AND PROCEDURES
Based on their evaluation, as of the end of the period covered by this Quarterly Report on Form 10-Q, our Company’s Chief Executive Officer and Chief Financial Officer have concluded that our Company’s disclosure controls and procedures (as defined in Rule 13a-15(e) under the Securities Exchange Act of 1934) are effective at the reasonable assurance level. During the period covered by this Quarterly Report on Form 10-Q, there were no changes in our internal control over financial reporting that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.
PART II. OTHER INFORMATION
ITEM 1. LEGAL PROCEEDINGS
We are involved in various legal claims and proceedings in the normal course of operations. We believe the outcome of these matters will not have a material adverse effect on our consolidated financial position, results of operations or liquidity, except as described in Part 1, Item 3. “Legal Proceedings” of our Form 10-K. Since the filing of our Form 10-K, there have been no material changes in our legal proceedings from those disclosed therein except as updated herein in the discussion in Note 9 to the accompanying condensed consolidated financial statements.
ITEM 1A. RISK FACTORS
The ownership of our common stock involves a number of risks and uncertainties. When evaluating the Company and our business before making an investment decision regarding our securities, potential investors should carefully consider the risk factors and uncertainties described in Part 1, Item 1A. “Risk Factors” of our Form 10-K. Since the filing of our Form 10-K, there have been no material changes in our risk factors from those disclosed therein.
55

Table of Contents
ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS
In August 2021, our Board of Directors authorized the repurchase of up to $500 million of our outstanding common stock. The authorization became effective August 25, 2021, for a period of three years, and replaced our former repurchase authorization. These repurchases may include open market purchases, privately negotiated transactions, block trades, accelerated stock repurchase transactions, or any combination of such methods. The number of shares purchased and the timing of the purchases will depend on a number of factors, including share price, trading volume and general market conditions, working capital requirements, general business conditions, financial conditions, any applicable contractual limitations, and other factors, including alternative investment opportunities. See Note 7 to the accompanying condensed consolidated financial statements for additional information.
Our current equity-based compensation plans include provisions that allow for the “net exercise” of share-settled awards by all plan participants. In a net exercise, any required payroll taxes, federal withholding taxes and exercise price of the shares due from the option or other share-based award holders are settled by having the holder tender back to us a number of shares at fair value equal to the amounts due. Net exercises are treated as purchases and retirements of shares. The following table summarizes our share repurchase activity for the periods shown:

Period | Total Number of Shares Purchased (1) |  | Average Price Paid per Share |  | Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs (1) |  | Maximum Dollar Value of Shares that May Yet be Purchased Under the Plans or Programs (in thousands) (2)
September 1 through September 30, 2023 | 2,291 |  |  | $ | 116.01 |  |  | 2,291 |  |  | $ | 348,822 |
October 1 through October 31, 2023 | 320 |  |  | 98.28 |  |  | 320 |  |  | 348,791 |
November 1 through November 30, 2023 | 90 |  |  | 97.93 |  |  | 90 |  |  | 348,782 |
Total | 2,701 |  |  | $ | 113.31 |  |  | 2,701 |  |  |

(1)The number of shares includes shares of common stock acquired from associates who tendered shares to: (i) satisfy the tax withholding on equity awards as part of our long-term incentive plans or (ii) satisfy the exercise price on stock option exercises. For the periods presented, there were no common stock open market repurchases.
(2)Reflects the remaining dollar value of shares that could be purchased under our current stock repurchase authorization through the expiration or termination of the plan. For additional information, see Note 7 to the accompanying condensed consolidated financial statements.
ITEM 5. OTHER INFORMATION
Rule 10b5-1 Trading Plans
During the three month period ended November 30, 2023, none of our officers or directors adopted or terminated any contract, instruction or written plan for the purchase or sale of our securities that was intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) or any “non-Rule 10b5-1 trading arrangement.”
56

Table of Contents

ITEM 6. |  | EXHIBITS
|  | (a) |  | Exhibits
|  |  |  | 10.1† |  | Severance Agreement between Helen of Troy Nevada Corporation and Brian Grass, dated September 25, 2023 (incorporated by reference to Exhibit 10.1 to the Company’s Current Report on Form 8-K, filed with the Securities and Exchange Commission on October 4, 2023).
|  |  |  | 31.1* |  | Certification of the Chief Executive Officer required by Rule 13a-14(a) or Rule 15d-14(a) pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
|  |  |  | 31.2* |  | Certification of the Chief Financial Officer required by Rule 13a-14(a) or Rule 15d-14(a) pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
|  |  |  | 32** |  | Joint certification of the Chief Executive Officer and the Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
|  |  |  | 101 |  | Financial statements from the Quarterly Report on Form 10-Q of the Company for the quarter ended November 30, 2023, formatted in Inline eXtensible Business Reporting Language (“iXBRL”): (i) Condensed Consolidated Balance Sheets, (ii) Condensed Consolidated Statements of Income, (iii) Condensed Consolidated Statements of Comprehensive Income, (iv) Condensed Consolidated Statements of Stockholders' Equity, (v) Condensed Consolidated Statements of Cash Flows and (vi) Notes to the Condensed Consolidated Financial Statements.
|  |  |  | 104 |  | Cover Page, Interactive Data File formatted in iXBRL and contained in Exhibit 101.
|  |  |  | * Filed herewith.
|  |  |  | ** Furnished herewith.
|  |  |  |  |  | † Management contract or compensatory plan or arrangement.

57

Table of Contents
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

|  | HELEN OF TROY LIMITED
|  | (Registrant)
Date: | January 8, 2024 | /s/ Julien R. Mininberg
|  | Julien R. Mininberg
|  | Chief Executive Officer, Director and Principal Executive Officer
Date: | January 8, 2024 | /s/ Brian L. Grass
|  | Brian L. Grass
|  | Chief Financial Officer, Principal Financial Officer and Principal Accounting Officer

58